EOS Med Chem Impurity Stock 20201029-37

   

EOS Med Chem is serving more than 100 Pharma companies, we have the original Drug Discovery Compounds, Like Impurity, small molecule and inhibitor.

Impurity we keep stock more than 80000, most in stock, we are World Sole Original Supplier, Each impurity we could supply: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA.

EOS Med Chem Quotation include: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, COA, MSDS.

Welcome to visit: our youtube:  https://youtu.be/r5cJdXKNXHk 

Contact:

EOS Med Chem, Medicinal Chemical is Big

執大象，天下往，往而無害，安平泰

Ms Nina

Youtube: https://youtu.be/r5cJdXKNXHk 

E: info@eosmedchem.com 

W: www.eosmedchem.com 

Tel: 0086-531-69905422

SALE OFFICE: 16F, China Overseas Plaza, Jinan City, China

[2-(1-Piperazinyl)ethoxy]-acetic Acid Dihydrochloride, CAS: 197968-63-1, stock: 3.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆N₂O₃ • 2(HCl).

[2-[4-[(4-Chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]acetyl Chloride, CAS: 776284-33-4, stock: 3.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₄Cl₂N₂O₂.

[2-[4-[(4-Chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]acetyl Chloride Dihydrochloride, CAS: 324047-28-1, stock: 10g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₄Cl₂N₂O₂.

1,1,1-Trifluoro-4-methoxy-4-(4-methylphenyl)-3-buten-2-one, CAS: 187812-31-3, stock: 3.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁F₃O₂.

1-(4-Methylphenyl)-4,4,4-trifluorobutane-1,3-dione, CAS: 720-94-5, stock: 9.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉F₃O₂.

1-Carboxy-1-methylethoxyammonium Hydrochloride, CAS: 89766-91-6, stock: 2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉NO₃•HCl.

2,5-Dimethyl Celecoxib, CAS: 457639-26-8, stock: 9.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆F₃N₃O₂S.

2,5-Dimethyl Celecoxib-d4, CAS: 1346603-87-9, stock: 4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₂D₄F₃N₃O₂S.

2-Acetylphenanthrene, CAS: 5960-69-0, stock: 1.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂O.

2-Methyl-Celecoxib, CAS: 170570-09-9, stock: 5.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆F₃N₃O₂S.

3-Trifluoromethyl-5-(p-tolyl)-1H-pyrazole, CAS: 219986-64-8, stock: 7.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉F₃N₂.

4,4,4-Trifluoro-1-(2-methylphenyl)-1,3-butanedione, CAS: 163266-02-2, stock: 4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉F₃O₂.

4,4,4-Trifluoro-1-(3-methylphenyl)-1,3-butanedione, CAS: 53764-99-1, stock: 10g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉F₃O₂.

4-((Triphenylphosphoranylidene)amino)benzenesulfonamide, CAS: /, stock: 3.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₁N₂O₂PS.

4-Azidobenzenesulfonamide, CAS: 36326-86-0, stock: 3.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₄O₂S.

4-Desmethyl-2-methyl Celecoxib, CAS: 170569-99-0, stock: 9.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄F₃N₃O₂S.

4-Desmethyl-2-methyl Celecoxib-d4, CAS: /, stock: 2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₀D₄F₃N₃O₂S.

4-Desmethyl-3-methyl Celecoxib, CAS: 170570-01-1, stock: 1.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄F₃N₃O₂S.

4-Desmethyl-3-methyl Celecoxib-d4, CAS: 1346604-72-5, stock: 4.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₀D₄F₃N₃O₂S.

4-[2-[1-(4-Methylphenyl)ethylidene]hydrazinyl]benzenesulfonamide, CAS: 1061214-06-9, stock: 7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇N₃O₂S.

4-[[3-(4-Methylphenyl)-3-oxo-1-(trifluoromethyl)propylidene]amino]benzenesulfonamide, CAS: 1061214-09-2, stock: 1.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₅F₃N₂O₃S.

Celecoxib, CAS: 169590-42-5, stock: 2.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄F₃N₃O₂S.

Celecoxib Carboxylic Acid Acyl-β-D-glucuronide, CAS: 264236-79-5, stock: 5.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₀F₃N₃O₁₀S.

Celecoxib Carboxylic Acid Acyl-β-D-glucuronide Benzyl Ester, CAS: /, stock: 2.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₆F₃N₃O₁₀S.

Celecoxib-13C3, CAS: /, stock: 6.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄¹³C₃H₁₄F₃N₃O₂S.

Celecoxib-d4, CAS: 544686-20-6, stock: 6.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₀D₄F₃N₃O₂S.

Celecoxib-d7, CAS: 544686-21-7, stock: 7.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₇D₇F₃N₃O₂S.

Dehydroxy Bromocelecoxib, CAS: 170570-75-9, stock: 8.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₃BrF₃N₃O₂S.

Desmethyl Celecoxib, CAS: 170569-87-6, stock: 3.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂F₃N₃O₂S.

Desmethyl Celecoxib-d4, CAS: /, stock: 1.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₈D₄F₃N₃O₂S.

Hydroxy Celecoxib, CAS: 170571-00-3, stock: 3.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄F₃N₃O₃S.

Hydroxy Celecoxib-d4, CAS: 1276524-56-1, stock: 1.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₀D₄F₃N₃O₃S.

MK-886 Sodium Salt, CAS: 118427-55-7, stock: 8.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₃ClNNaO₂S.

N-De(4-sulfonamidophenyl)-N’-(4-sulfonamidophenyl) Celecoxib, CAS: 331943-04-5, stock: 4.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄F₃N₃O₂S.

N-De(4-sulfonamidophenyl)-N’-[4-sulfonamido(phenyl-d4)] Celecoxib, CAS: 1346604-14-5, stock: 3.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₀D₄F₃N₃O₂S.

N-De(4-sulfonamidophenyl)-Nʼ-(4-sulfonamidophenyl)-4,5-dihydro-5-hydroxy Celecoxib, CAS: /, stock: 3.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆F₃N₃O₃S.

2-Chloro Phenothiazine, CAS: 92-39-7, stock: 5.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈ClNS.

2-Chloro-10-(2-methoxyethyl)-7-(methoxymethoxy)-10H-phenothiazine, CAS: /, stock: 1.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈ClNO₃S.

2-Chloro-10-(3-chloropropyl)-7-(methoxymethoxy)-10H-phenothiazine, CAS: 62835-61-4, stock: 4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇Cl₂NO₂S.

2-Chloro-10-[3-[[3-(dimethyl-d6-amino)propyl]methylamino]propyl]phenothiazine, CAS: /, stock: 9.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂D₆ClN₃S.

2-Chloro-10-[3-[[3-(dimethylamino)propyl]methylamino]propyl]phenothiazine, CAS: 19077-20-4, stock: 8.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₈ClN₃S.

2-Chloro-7-(methoxymethoxy)-10H-phenothiazine, CAS: 62835-54-5, stock: 9.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂ClNO₂S.

2-Chloro-7-(methoxymethoxy)-N,N-dimethyl-10H-phenothiazine-10-propanamine, CAS: 62835-69-2, stock: 1.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃ClN₂O₂S.

2-Chloro-7-(methoxymethoxy)-N,N-dimethyl-10H-phenothiazine-10-propanamine-d6, CAS: /, stock: 5.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇D₆ClN₂O₂S.

2-Chloro-7-hydroxy Phenothiazine, CAS: 2002-32-6, stock: 4.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈ClNOS.

4-Chloro-10-[(dimethylamino)propyl]phenothiazine Hydrochloride, CAS: 72372-62-4, stock: 2.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉ClN₂S  •  HCl.

4-Chloro-3-nitrophenol, CAS: 610-78-6, stock: 9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄ClNO₃.

7-Chlorophenothiazin-3-ol, CAS: 104036-77-3, stock: 3.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈ClNOS.

7-Hydroxy Chlorpromazine Hydrochloride, CAS: 51938-11-5, stock: 4.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀Cl₂N₂OS.

7-Hydroxy Chlorpromazine-d6 Hydrochloride, CAS: /, stock: 7.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄D₆Cl₂N₂OS.

7-Hydroxychlorpromazine O-β-D-Glucuronide, CAS: 15643-03-5, stock: 5.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇ClN₂O₇S.

7-Hydroxychlorpromazine-d6 O-β-D-Glucuronide, CAS: /, stock: 9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₁D₆ClN₂O₇S.

8-Hydroxychlorpromazine Hydrochloride, CAS: 51938-10-4, stock: 3.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀Cl₂N₂OS.

8-Hydroxychlorpromazine-d6 Hydrochloride, CAS: /, stock: 1.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄D₆Cl₂N₂OS.

Chlorpromazine, CAS: 50-53-3, stock: 3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉ClN₂S.

Chlorpromazine Hydrochloride, CAS: 69-09-0, stock: 2.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀Cl₂N₂S.

Chlorpromazine N-Oxide Maleic Acid Salt, CAS: 18683-80-2, stock: 1.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃ClN₂O₅S.

Chlorpromazine N-Oxide Sulfoxide, CAS: 10404-90-7, stock: 4.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉ClN₂O₂S.

Chlorpromazine Sulfone Hydrochloride, CAS: 18683-73-3, stock: 5.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀Cl₂N₂O₂S.

Chlorpromazine Sulfoxide, CAS: 969-99-3, stock: 8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉ClN₂OS.

Chlorpromazine-13C,d3 Hydrochloride, CAS: 1329612-87-4, stock: 6.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆¹³CH₁₇D₃Cl₂N₂S.

Chlorpromazine-d6 Hydrochloride, CAS: 1228182-46-4, stock: 2.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄D₆Cl₂N₂S.

Demethyl Chlorpromazine Hydrochloride, CAS: 3953-65-9, stock: 2.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈Cl₂N₂S.

Demethylchlorpromazine Sulfoxide, CAS: 2037-58-3, stock: 1.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇ClN₂OS.

Didesmethylchlorpromazine Hydrochloride, CAS: 3763-80-2, stock: 7.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆Cl₂N₂S.

N-(3-Methanethiosulfonylpropyl)-2-chloro Phenothiazine, CAS: /, stock: 8.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆ClNO₂S₃.

Prochlorperazine, CAS: 58-38-8, stock: 9.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄ClN₃S.

Promazine Hydrochloride, CAS: 53-60-1, stock: 2.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁ClN₂S.

Promazine Sulfoxide, CAS: 146-21-4, stock: 3.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀N₂OS.

1-Methyl-L-histidine, CAS: 332-80-9, stock: 3.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₁N₃O₂.

1-Methyl-L-histidine-d5, CAS: 1795786-96-7, stock: 1.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆D₅N₃O₂.

Cerivastatin, CAS: 145599-86-6, stock: 7.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₄FNO₅.

Cerivastatin lactone, CAS: 158878-47-8, stock: 8.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₂FNO₄.

Cerivastatin Sodium Salt, CAS: 143201-11-0, stock: 8.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₃FNNaO₅.

Cerivastatin-D3, Sodium Salt, CAS: 916314-45-9, stock: 5.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₀D₃FNNaO₅.

Cerivastatin-D5, Sodium Salt, CAS: /, stock: 8.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₈D₅FNNaO₅.

Desmethyl Cerivastatin, Sodium Salt, CAS: 157199-28-5, stock: 6.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₁FNNaO₅.

Desmethyl Cerivastatin-O-β-D-glucuronide, CAS: 212616-56-3, stock: 3.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₄₀FNO₁₁.

Desmethyl Hydroxy Cerivastatin Sodium Salt, CAS: 201793-00-2, stock: 5.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₁FNNaO₆.

Desmethyl Hydroxy Cerivastatin-d6 Sodium Salt, CAS: /, stock: 3.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₅D₆FNNaO₆.

Hydroxy Cerivastatin Sodium Salt, CAS: 189060-31-9, stock: 7.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₃FNNaO₆.

Hydroxy Cerivastatin-d3 Sodium Salt, CAS: /, stock: 2.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₀D₃FNNaO₆.

Cefamandole Nafate, CAS: 42540-40-9, stock: 9.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇N₆NaO₆S₂.

(+/-)-Cannabichromevarinic Acid, CAS: 1628112-69-5, stock: 4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆O₄.

(2S,3R,4E)-2-Amino-4-decene-1,3-diol, CAS: 235431-59-1, stock: 7.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₁NO₂.

(2S,3R,4E)-2-Azido-tert-butyldimethylsilyl-3-hydroxy-4-octadecenyl α-D-Galactopyranoside, CAS: /, stock: 6.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₉N₃O₇Si.

(2S,3R,4E)-2-Butyrylamino-4-decene-1,3-diol, CAS: 850264-01-6, stock: 6.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₇NO₃.

(2S,3S,E)-ethyl 2-amino-3-hydroxydec-4-enoate, CAS: /, stock: 6.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₃NO₃.

(S)-3-Ketosphingosine Hydrochloride, CAS: 263352-66-5, stock: 4.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₅NO₂ •HCl.

1,2,3,4,6-Pentakis-O-(trimethylsilyl) α-D-Galactose, CAS: 32166-80-6, stock: 3.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₅₂O₆Si₅.

1-Nonanesulfonyl Chloride, CAS: 63353-34-4, stock: 7.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₉ClO₂S.

1-O-Benzoyl C2 Ceramide, CAS: 78715-90-9, stock: 8.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₃NO₄.

1-O-Benzoyl C4 Ceramide, CAS: /, stock: 2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₇NO₄.

1-[(1-Oxotetracosyl)oxy]-2,5-pyrrolidinedione, CAS: 39782-75-7, stock: 5.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₅₁NO₄.

15-Methylhexadeca Sphinganine, CAS: 26048-10-2, stock: 5.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₇NO₂.

2,3,4,6-Tetra-O-acetyl-1-S-acetyl-1-thio-(α/β)-D-galactopyranoside(mixture of α/β), CAS: /, stock: 9.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂O₁₀S.

2,3,4,6-Tetra-O-benzyl-1,5-di-O-methanesulfonyl-D-glucitol, CAS: 77698-99-8, stock: 6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₄₂O₁₀S₂.

2,3,4,6-Tetra-O-benzyl-1-L-ido-miglustat, CAS: 441061-29-6, stock: 3.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₄₅NO₄.

2-O-tert-Butyldimethylsilyl C2 Ceramide, CAS: /, stock: 5.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₅₃NO₃Si.

2-O-tert-Butyldimethylsilyl C2 Ceramide-1-(bis(2-cyanoethyl)phosphate, CAS: /, stock: 1.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₆₀N₃O₆PSi.

2-O-tert-Butyldimethylsilyl C4 Ceramide, CAS: /, stock: 6.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₅₇NO₃Si.

2-O-tert-Butyldimethylsilyl C4 Ceramide-1-(bis(2-cyanoethyl)phosphate, CAS: /, stock: 7.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₆₄N₃O₆PSi.

2-O-tert-Butyldimethylsilyl-1-O-benzoyl C2 Ceramide, CAS: /, stock: 1.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₅₇NO₄Si.

2-O-tert-Butyldimethylsilyl-1-O-benzoyl C4 Ceramide, CAS: /, stock: 9.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₆₁NO₄Si.

3,4,6-Tri-O-benzyl-D-galactose, CAS: 114179-79-2, stock: 4.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₀O₆.

5,5-Difluoro-10-(11-methoxy-11-oxoundecyl)-1,3,7,9-tetramethyl-5H-dipyrrolo[1,2-c:2’,1’-f][1,3,2]diazaborinin-4-ium-5-uide, CAS: /, stock: 3.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₇BF₂N₂O₂.

5,5-Difluoro-10-(undecanoate)-1,3,7,9-tetramethyl-5H-dipyrrolo[1,2-c:2’,1’-f][1,3,2]diazaborinin-4-ium-5-uide, CAS: 1807381-06-1, stock: 8.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₄BF₂N₂O₂⁻.

5-Bromo-3-fluorobenzene-1,2-diol, CAS: 876861-29-9, stock: 1.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄BrFO₂.

6-Amino-6-deoxy α-Galactosyl-C18-ceramide, CAS: /, stock: 9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₈₂N₂O₇.

AAL Toxin TD2, CAS: 176590-36-6, stock: 9.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₉NO₁₀.

AAL Toxin TE2, CAS: 176590-38-8, stock: 6.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₉NO₉.

Bodipy C12-Ceramide, CAS: 1246355-58-7, stock: 1.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₇₀BF₂N₃O₃.

C-12 NBD-dihydro-Ceramide, CAS: 474943-05-0, stock: 2.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₆₃N₅O₆.

C-6 NBD Ceramide, CAS: 86701-10-2, stock: 4.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₉N₅O₆.

C-6 NBD-dihydro-Ceramide, CAS: 114301-95-0, stock: 6.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₁N₅O₆.

C-8 Ceramide, CAS: 74713-59-0, stock: 3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₅₁NO₃.

C12 Ceramide, CAS: 74713-60-3, stock: 9.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₉NO₃.

C14 Ceramide, CAS: 34227-72-0, stock: 5.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₆₃NO₃.

C14 Dihydroceramide, CAS: 61389-70-6, stock: 3.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₆₅NO₃.

C16 Dihydroceramide, CAS: 5966-29-0, stock: 8.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₆₉NO₃.

C16-Ceramide, CAS: 24696-26-2, stock: 8.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₆₇NO₃.

C16-Ceramide-13C2,d2, CAS: /, stock: 8.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂¹³C₂H₆₅D₂NO₃.

C16-Ceramide-d31, CAS: 852043-41-5, stock: 6.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₆D₃₁NO₃.

C18 Ceramide, CAS: 2304-81-6, stock: 2.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₇₁NO₃.

C18 Ceramide-13C2,D2, CAS: /, stock: 3.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄¹³C₂H₆₉D₂NO₃.

C18 Dihydroceramide, CAS: 2304-80-5, stock: 2.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₇₃NO₃.

C2 Ceramide, CAS: 3102-57-6, stock: 9.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₉NO₃.

C2 Ceramide-1-phosphate, CAS: 151729-55-4, stock: 1.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₄₀NO₆P.

C2 Dihydroceramide, CAS: 13031-64-6, stock: 5.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₄₁NO₃.

C2 Phytoceramide, CAS: 475995-69-8, stock: 6.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₄₁NO₄.

C20 Ceramide, CAS: 07/02/7344, stock: 6.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₇₅NO₃.

C20 Dihydroceramide, CAS: 121459-06-1, stock: 5.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₇₇NO₃.

C22 Ceramide, CAS: 869501-30-4, stock: 9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₇₉NO₃.

C22 Dihydroceramide, CAS: 147492-65-7, stock: 1.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₈₁NO₃.

C24 Ceramide, CAS: 34435-05-7, stock: 1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₈₃NO₃.

C24:1 Ceramide, CAS: 54165-50-0, stock: 2.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₈₁NO₃.

C26 Ceramide, CAS: 121459-09-4, stock: 8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₈₇NO₃.

C26-Dihydro Ceramide, CAS: 182362-38-5, stock: 5.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₈₉NO₃.

C3 Ceramide, CAS: 362678-52-2, stock: 1.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₄₁NO₃.

C3 Ceramide-d5, CAS: /, stock: 1.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₆D₅NO₃.

C30 : 1-Ceramide, CAS: /, stock: 6.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₉₃NO₃.

C30 : 1-DihydroCeramide, CAS: /, stock: 3.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₉₅NO₃.

C30 : 2-Ceramide, CAS: /, stock: 4.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₉₁NO₃.

C30 : 2-DihydroCeramide, CAS: /, stock: 4.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₉₃NO₃.

C4 Ceramide, CAS: 74713-58-9, stock: 5.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₄₃NO₃.

C4 Ceramide-1-phosphate, CAS: /, stock: 3.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₄₄NO₆P.

C4 Dihydroceramide, CAS: 202467-76-3, stock: 8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₄₅NO₃.

C6 Ceramide, CAS: 124753-97-5, stock: 8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₇NO₃.

C6 Ceramide-13C2,d2, CAS: /, stock: 3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂¹³C₂H₄₅D₂NO₃.

C6 Dihydroceramide, CAS: 171039-13-7, stock: 3.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₉NO₃.

C8 Ceramide, CAS: 74713-59-0, stock: 2.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₅₁NO₃.

C8 Ceramide-1-phosphate, CAS: 887353-95-9, stock: 7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₅₂NO₆P.

C8 Ceramine, D-erythro, CAS: 170926-06-4, stock: 5.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₅₃NO₂.

C8 Dihydroceramide, CAS: 145774-33-0, stock: 6.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₅₃NO₃.

Chicken SGMS1 (Phosphatidylcholine:ceramide cholinephosphotransferase 1) ELISA Kit (96T), CAS: /, stock: 2.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

D-erythro-Dihydro-D-sphingosine-1-phosphate, CAS: 19794-97-9, stock: 4.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₄₀NO₅P.

D-erythro-Sphingosine-N-tert-butyloxycarbonyl-O-tert-butyldimethylsilyl, CAS: 342655-72-5, stock: 1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₅₉NO₄Si.

Destearaldehyde β-Galactosyl-C18-ceramide Tetraacetate, CAS: /, stock: 6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₅₅NO₁₁.

Destearaldehyde-N-tert-butyloxycarbonyl β-Galactosyl-C18-ceramide Tetraacetate, CAS: /, stock: 2.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₆₃NO₁₃.

Destearaldehyde-O-tert-butyldimethylsilyl-N-tert-butyloxycarbonyl β-Galactosyl-C18-ceramide Tetraacetate, CAS: /, stock: 5.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₇₇NO₁₃Si.

DL-PDMP, CAS: 73257-80-4, stock: 6.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₈N₂O₃ • HCl.

DL-threo-PPMP Hydrochloride, CAS: 139974-41-7, stock: 9.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₅₁ClN₂O₃.

Eliglustat, CAS: 491833-29-5, stock: 2.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₆N₂O₄.

Eliglustat Tartrate, CAS: 928659-70-5, stock: 2.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  2(C₂₃H₃₆N₂O₄) • (C ₄H₆O₆).

Eliglustat-d15, CAS: /, stock: 6.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₁D₁₅N₂O₄.

EOS, CAS: 1318771-31-1, stock: 6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₈H₁₂₇NO₅.

Ethyl (2R,3R,4E)-2-Amino-3-hydroxy-4-octadecenoate-13C2, CAS: /, stock: 9.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈¹³C₂H₃₉NO₃.

Fumonisin B2, CAS: 116355-84-1, stock: 6.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₅₉NO₁₄.

Fumonisin B2-13C4, CAS: 1327642-63-6, stock: 1.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀¹³C₄H₅₉NO₁₄.

Ganglioside GD3 Diodium Salt, CAS: 497932-19-1, stock: 1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇₀H₁₂₃N₃Na₂O₂₉.

Ganglioside GD3 Sodium Salt, CAS: /, stock: 4.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇₀H₁₂₅N₃O₂₉ • x(Na).

Ganglioside GM1 Sodium Salt (bovine brain), CAS: 37758-47-7, stock: 3.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇₃H₁₃₁N₃O₃₁ • x(Na).

Hexacosanoic Acid ((1S,2S,3R)-2,3-Dihydroxy-1-hydroxymethyl-heptadecyl)-amide, CAS: 182362-51-2, stock: 2.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₈₉NO₄.

Human CERK (Ceramide kinase) ELISA Kit (96T), CAS: /, stock: 4.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human CERK(Ceramide kinase) ELISA Kit (96T), CAS: /, stock: 7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human SGMS2 (Phosphatidylcholine:ceramide cholinephosphotransferase 2) ELISA Kit (96T), CAS: /, stock: 3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human UGCG(Ceramide glucosyltransferase) ELISA Kit (96T), CAS: /, stock: 4.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Hydroxypropyl Bislauramide Monoethanolamide, CAS: 211184-48-4, stock: 9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₆₂N₂O₅.

Hydroxypropyl Bispalmitamide Monoethanolamide, CAS: 211184-47-3, stock: 2.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₇₈N₂O₅.

α-Galactosyl erythro-Sphingosine, CAS: /, stock: 9.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₇NO₇.

α-Galactosyl-3-(t-butyldimethylsilyl) erythro-Sphingosine, CAS: /, stock: 1.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₆₁NO₇Si.

α-Galactosyl-C16-ceramide, CAS: /, stock: 1.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₇₇NO₈.

α-Galactosyl-C18-ceramide, CAS: 148347-40-4, stock: 9.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₈₁NO₈.

β-D-Glucosyl C4-Ceramide, CAS: 111956-45-7, stock: 3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₅₃NO₈.

β-Galactosyl-C18-ceramide, CAS: 36271-49-5, stock: 9.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₈₁NO₈.

β-Galactosyl-C18-ceramide Tetraacetate, CAS: /, stock: 2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₀H₈₉NO₁₂.

KRN7000, CAS: 158021-47-7, stock: 3.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₀H₉₉NO₉.

Lactosylceramide, CAS: 4682-48-8, stock: 7.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₉₁NO₁₃.

Methyl 12-Chloro-12-oxo-dodecanoic Acid Ester, CAS: 4082-57-9, stock: 9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₃ClO₃.

Monosialoganglioside GM3 Sodium Salt, CAS: /, stock: 2.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₉H₁₀₇N₂NaO₂₁.

Mouse Cerk (Ceramide kinase) ELISA Kit (96T), CAS: /, stock: 1.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Sgms1 (Phosphatidylcholine:ceramide cholinephosphotransferase 1) ELISA Kit (96T), CAS: /, stock: 3.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Sgms2 (Phosphatidylcholine:ceramide cholinephosphotransferase 2) ELISA Kit (96T), CAS: /, stock: 5.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Myriocin, CAS: 35891-70-4, stock: 6.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₉NO₆.

N-(2-Hydroxystearoyl) Sphingosine(Mixture of Diastereomers), CAS: 34249-41-7, stock: 3.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₇₁NO₄.

N-(2S-Hydroxypropyl)-linoleamide, CAS: /, stock: 5.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₉NO₂.

N-Butyldeoxynojirimycin Hydrochloride, CAS: 210110-90-0, stock: 3.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₂ClNO₄.

N-Butyroyl Phytosphingosine, CAS: 409085-57-0, stock: 8.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₄₅NO₄.

N-Heptadecanoyl-D-erythro-sphingosine, CAS: 67492-16-4, stock: 5.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₆₉NO₃.

N-Heptadecanoyl-D-erythro-sphingosine-13C2,d2, CAS: /, stock: 8.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃¹³C₂H₆₇D₂NO₃.

N-Nervonoyl-D-sphingosine, CAS: 54164-50-0, stock: 3.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₈₁NO₃.

N-Oleoyl-D-erythro-sphingosine, CAS: 5966-28-9, stock: 7.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₆₉NO₃.

N-Stearoyl Phytosphingosine, CAS: 34354-88-6, stock: 4.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₇₃NO₄.

N-Stearoyl Phytosphingosine-13C2,d2, CAS: /, stock: 7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄¹³C₂H₇₁D₂NO₄.

N-Succinimidyl Palmitate, CAS: 14464-31-4, stock: 3.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₅NO₄.

N-Succinimidyl Palmitate-d31, CAS: /, stock: 7.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₄D₃₁NO₄.

N-[(1S,2S,3R)-1-[[(6-Amino-6-deoxy-α-D-galactopyranosyl)oxy]methyl]-2,3-dihydroxyheptadecyl]hexacosanamide, CAS: 424823-18-7, stock: 7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₀H₁₀₀N₂O₈.

Nervonoyl Chloride, CAS: 145411-43-4, stock: 4.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₅ClO.

NVP-231, CAS: 362003-83-6, stock: 5.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₅N₃O₂S.

O’-Ethyl-1-oxo-N-boc-D-erythro-sphingosine, CAS: /, stock: 3.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₇NO₅.

O’Ethly-N-boc-1-oxo-3-tertbutyldimethylsilyl-D-erythro-sphingosine, CAS: /, stock: 2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₆₁NO₅Si.

Oleic Acid N-Hydroxysuccinimide, CAS: 81480-40-2, stock: 4.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₇NO₄.

Oleic Acid N-Hydroxysuccinimide-d17, CAS: /, stock: 3.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₀D₁₇NO₄.

PBS 57, CAS: 898531-99-2, stock: 3.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₀H₉₆N₂O₉.

PGW-310, CAS: /, stock: 8.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₂H₁₁₇NO₁₇.

Potassium Nitrite, CAS: 7758-09-0, stock: 5.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  KNO₂.

Rat Sgms1 (Phosphatidylcholine:ceramide cholinephosphotransferase 1) ELISA Kit (96T), CAS: /, stock: 4.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat Sgms2 (Phosphatidylcholine:ceramide cholinephosphotransferase 2) ELISA Kit (96T), CAS: /, stock: 1.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Ruthenium(III) Chloride Hydrate (Technical Grade), CAS: 14898-67-0, stock: 3.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  Cl₃Ru•x[H₂O].

Sphingomyelin, CAS: 85187-10-6, stock: 6.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  N/A.

(Z)-2-[[(1,1-Dimethylethoxy)carbonyl]amino]-α-propylidene-4-thiazoleacetic Acid, CAS: 86978-24-7, stock: 5.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂O₄S.

N-Boc Cefcapene N,N-Diisopropylamine, CAS: 153012-37-4, stock: 4.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₂N₆O₈S₂.

Cefathiamidine, CAS: 33075-00-2, stock: 8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₈N₄O₆S₂.

Cefathiamidine-d14, CAS: /, stock: 7.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₄D₁₄N₄O₆S₂.

Desacetyl Cefathiamidine, CAS: 958001-61-1, stock: 8.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₆N₄O₅S₂.

N,N’-Diisopropylthiourea, CAS: 2986-17-6, stock: 8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆N₂S.

Chloro Cephalexin, CAS: 22039-59-4, stock: 3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆ClN₃O₄S.

D-Phenylglycyl Cephalexin-d5, CAS: /, stock: 4.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₉D₅N₄O₅S.

Δ2-Cephalexin, CAS: 79750-46-2, stock: 4.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇N₃O₄S.

Phenylglycyl Cephalexin (Mixture of diastereomers), CAS: 72528-40-6, stock: 5.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₄N₄O₅S.

7-ADCA Pivalamide, CAS: 146794-70-9, stock: 5.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂O₄S.

7-Aminodesacetoxycephalosporanic Acid, CAS: 22252-43-3, stock: 9.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀N₂O₃S.

Cefadroxil, CAS: 50370-12-2, stock: 5.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇N₃O₅S.

3-Hydroxy-4-methyl-2(5H)-thiophenone, CAS: 34876-35-2, stock: 1.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆O₂S.

7-Amino-3-chloro-3-cephem-4-carboxylic Acid, CAS: 53994-69-7, stock: 4.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇ClN₂O₃S.

Cefaclor, CAS: 53994-73-3, stock: 1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄ClN₃O₄S.

Loracarbef, CAS: 76470-66-1, stock: 7.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆ClN₃O₄.

Phenoxyacetic Acid Methyl Ester, CAS: 2065-23-8, stock: 4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀O₃.

5-(2,3-Epoxypropoxy)-3,4-dihydrocarbostyril, CAS: 51781-14-7, stock: 6.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃NO₃.

Carteolol Hydrochloride, CAS: 51781-21-6, stock: 6.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₅ClN₂O₃.

Carteolol-d9 Hydrochloride, CAS: 1346602-13-8, stock: 6.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆D₉ClN₂O₃.

Dehydrocarteolol Hydrochloride, CAS: 53371-79-2, stock: 1.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂N₂O₃•HCl.

Dehydrocarteolol Hydrochloride-d9, CAS: /, stock: 1.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄D₉ClN₂O₃.

(+)-3’,4’,3,5,7-Penta-O-benzylcatechin, CAS: 85443-49-8, stock: 6.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₀H₄₄O₆.

(+)-Catechin, CAS: 154-23-4, stock: 8.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄O₆.

(+)-Catechin Monohydrate, CAS: 225937-10-0, stock: 2.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄O₆•H₂O.

(+)-Catechin-13C3, CAS: 1261254-33-4, stock: 7.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂¹³C₃H₁₄O₆.

(+)-Catechin-d3, CAS: /, stock: 5.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁D₃O₆.

(+)-Gallocatechin, CAS: 970-73-0, stock: 1.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄O₇.

(+)-Gallocatechin-13C3, CAS: /, stock: 1.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂¹³C₃H₁₄O₇.

(+/-)-Catechin, CAS: 7295-85-4, stock: 6.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄O₆.

(-)-Catechin, CAS: 18829-70-4, stock: 1.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄O₆.

(-)-Epicatechin, CAS: 490-46-0, stock: 8.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄O₆.

(-)-Epicatechin-13C3, CAS: /, stock: 1.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂¹³C₃H₁₄O₆.

(-)-Epigallocatechin, CAS: 970-74-1, stock: 3.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄O₇.

(-)-Epigallocatechin Gallate, CAS: 989-51-5, stock: 3.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₈O₁₁.

(-)-Epigallocatechin Gallate-13C3, CAS: /, stock: 4.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉¹³C₃H₁₈O₁₁.

(-)-Epigallocatechin Gallate-d3/d4, CAS: /, stock: 4.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₅D₃O₁₁.

(-)-Epigallocatechin-13C3, CAS: /, stock: 7.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂¹³C₃H₁₄O₇.

(2E)-2,3-Dihydroxy-2-butenedioic Acid Hydrate (1:?), CAS: 199926-38-0, stock: 2.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄O₆ .xH₂O.

(2E,4S)-4-(Acetyloxy)-5-[3,4-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]phenyl]-2-pentenoic Acid, CAS: 1235828-19-9, stock: 1.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆O₆Si₂.

(2S)-[3,4-Bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]phenyl]-1,2-propanediol, CAS: 1235828-10-0, stock: 8.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₄₂O₅Si₂.

(4R)-5-(3,4-Dihydroxyphenyl)-γ-hydroxyvaleric Acid Sodium Salt, CAS: /, stock: 1.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃O₅  • xNa.

(4R)-5-(3’,4’-Dihydroxyphenyl)-γ-valerolactone ((-)-Epicatechin Metabolite), CAS: 191666-22-5, stock: 2.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₄.

(4R)-5-(3’,4’-Dihydroxyphenyl)-γ-valerolactone-3’-O-sulfate Sodium Salt (>75%), CAS: /, stock: 4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁NaO₇S.

(4R)-5-(3’,4’-Dihydroxyphenyl)-γ-valerolactone-4’-O-sulfate Sodium Salt, CAS: /, stock: 2.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁NaO₇S.

(4R)-5-(3’,4’-Dihydroxyphenyl)-γ-valerolactone-d3 ((-)-Epicatechin Metabolite), CAS: /, stock: 5.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉D₃O₄.

(γR)- 3,4-Bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-γ-hydroxybenzenepentanoic Acid Ethyl Ester, CAS: 1235828-36-0, stock: 7.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₆O₅Si₂.

(R)-2-(Benzyloxy)-4-((5-oxotetrahydrofuran-2-yl)methyl)phenyl Neopentyl Sulfate, CAS: /, stock: 3.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈O₇S.

(R)-2-(Benzyloxy)-4-((5-oxotetrahydrofuran-2-yl)methyl)phenyl sulfate Sodium Salt, CAS: /, stock: 8.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇NaO₇S.

(R)-2-(Benzyloxy)-5-((5-oxotetrahydrofuran-2-yl)methyl)phenyl Neopentyl Sulfate, CAS: /, stock: 7.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈O₇S.

(R)-5-(3,4-Bis(benzyloxy)benzyl)dihydrofuran-2(3H)-one, CAS: /, stock: 5.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₄O₄.

(R)-5-(3-(Benzyloxy)-4-hydroxybenzyl)dihydrofuran-2(3H)-one, CAS: /, stock: 8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈O₄.

(R)-5-(4-(Benzyloxy)-3-hydroxybenzyl)dihydrofuran-2(3H)-one, CAS: /, stock: 2.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈O₄.

(S)-1-(Benzyloxy)-3-(3,4-bis((tert-butyldimethylsilyl)oxy)phenyl)propan-2-yl acetate, CAS: 1235828-02-0, stock: 8.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₈O₅Si₂.

2-rac Epigallocatechin Ethanol Complex, CAS: /, stock: 7.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄O₇ •  (C₂H₆O).

3’-O-Methylcatechin, CAS: 60383-97-3, stock: 1.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆O₆.

4-Bromo-1,2-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]benzene, CAS: 1108192-19-3, stock: 4.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₃BrO₂Si₂.

4-Methylcatechol, CAS: 452-86-8, stock: 3.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈O₂.

4’-O-Methylcatechin, CAS: 69912-75-0, stock: 3.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆O₆.

5,7,3’,4’-Tetra-O-benzyl-4-(2-hydroxyethoxy)-(-)-epicatechin, CAS: 256236-25-6, stock: 5.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₄₂O₈.

5,7,3’,4’-Tetra-O-benzylcatechin, CAS: 20728-73-8, stock: 7.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₃₈O₆.

5,7,3’,4’-Tetra-O-benzylepicatechin, CAS: 87292-49-7, stock: 3.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₃₈O₆.

5,7,3’,4’-Tetra-O-benzylepicatechin-4β→8-5,7,3’,4’-tetra-O-benzylepicatechin, CAS: 223387-28-8, stock: 3.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈₆H₇₄O₁₂.

Catechol, CAS: 120-80-9, stock: 5.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆O₂.

Catechol-13C6, CAS: 115881-16-8, stock: 5.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆H₆O₂.

Catechol-d4, CAS: 103963-58-2, stock: 2.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₂D₄O₂.

Catecholborane, CAS: 274-07-7, stock: 5.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅BO₂.

Epicatechin 5-O-β-D-glucuronide, CAS: 223614-70-8, stock: 3.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂O₁₂.

Gallocatechin Ethanol Complex, CAS: /, stock: 2.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄O₇  (C₂H₆O).

Phloroglucinol Dihydrate, CAS: 6099-90-7, stock: 5.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀O₅.

Procyanidin B1, CAS: 20315-25-7, stock: 5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₆O₁₂.

Procyanidin B1-d3, CAS: /, stock: 6.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₃D₃O₁₂.

Prodelphinidin A1, CAS: 307504-23-0, stock: 9.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₄O₁₄.

Prodelphinidin A2, CAS: 1116056-07-5, stock: 7.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₄O₁₄.

Prodelphinidin B1, CAS: 78362-04-6, stock: 2.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₆O₁₄.

Prodelphinidin B2, CAS: 87392-61-8, stock: 9.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₆O₁₄.

Prodelphinidin B3, CAS: 78362-05-7, stock: 9.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₆O₁₄.

Prodelphinidin B4, CAS: 68964-95-4, stock: 6.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₆O₁₄.

Prodelphinidin B9, CAS: 86631-36-9, stock: 8.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₆O₁₄.

Pyrocatechol Violet, CAS: 115-41-3, stock: 1.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₄O₇S.

((Trimethylacetyl)oxy)methyl 4-Nitrophenyl Carbonate, CAS: 101623-83-0, stock: 4.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅NO₇.

(2R)-2-((R)-(2-(2-Aminothiazol-4-yl)acetamido)(carboxy)methyl)-5-(((1-(2-(dimethylamino)ethyl)-1H-tetrazol-5-yl)thio)methyl)-3,4-dihydro-2H-1,3-thiazine-4-carboxylic Acid, CAS: /, stock: 4.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₅N₉O₅S₃.

(2R)-2-((R)-(2-(2-Aminothiazol-4-yl)acetamido)(carboxy)methyl)-5-(((1-(2-(dimethylamino)ethyl)-1H-tetrazol-5-yl)thio)methyl)-5,6-dihydro-2H-1,3-thiazine-4-carboxylic Acid, CAS: /, stock: 2.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₅N₉O₅S₃.

(2R)-2-((R)-(2-(2-Aminothiazol-4-yl)acetamido)(carboxy)methyl)-5-(hydroxymethyl)-5,6-dihydro-2H-1,3-thiazine-4-carboxylic Acid, CAS: /, stock: 5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆N₄O₆S₂.

(2R)-2-Amino-2-((2R)-5-methyl-7-oxo-2,4,5,7-tetrahydro-1H-furo[3,4-d][1,3]thiazin-2-yl)acetic Acid (Mixture of Diastereomers), CAS: /, stock: 1.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₄S.

(2S,3’Z)-Cefprozil, CAS: 110764-35-7, stock: 6.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉N₃O₅S.

(4aS,7aS)-Octahydro-1-methyl-1H-pyrrolo[3,4-b]pyridine, CAS: 151213-45-5, stock: 8.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆N₂.

(6R,7R)-3-Hydroxymethyl-7-((2-aminothiazol-4-yl)acetamido)ceph-3-em-4-carboxylic Acid, CAS: 775233-43-7, stock: 9.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄N₄O₅S₂.

(6R,7R)-7-((E)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic Acid, CAS: /, stock: 5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃N₅O₅S₂.

(6R,7R)-7-(2-(2-Aminothiazol-4-yl)-2-oxoacetamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid, CAS: 79350-14-4, stock: 8.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂N₄O₅S₂.

(6R,7R)-7-(2-(2-Aminothiazol-4-yl)acetamido)-3-(((1-(2-(dimethylamino)ethyl)-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxamide, CAS: /, stock: 4.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄N₁₀O₃S₃.

(6R,7R)-7-Amino-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Diphenylmethyl Ester Hydrochloride, CAS: 79349-67-0, stock: 6.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₁ClN₂O₃S.

(6R,7R)-7-Amino-3-[(5-methyl-2H-tetrazol-2-yl)methyl]-8-oxo-5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid, CAS: 82549-51-7, stock: 9.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₆O₃S.

(6R,7R)-7-Amino-3-[(Z)-2-(4-methylthiazol-5-yl)ethenyl]-3-cephem-4-carboxylic Acid, CAS: 155723-02-7, stock: 8.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃N₃O₃S₂.

(6R,7R)-7-Amino-3-[[[1-[2-(dimethylamino)ethyl]-1H-tetrazol-5-yl]thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid, CAS: 61607-66-7, stock: 5.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉N₇O₃S₂.

(6R,7R)-7-Amino-8-oxo-3-(1Z)-1-propen-1-yl-5--thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid (>90%), CAS: 106447-44-3, stock: 4.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O₃S.

(6R,7R)-7-Phenylacetamido-3-[(Z)-2-(4-methylthiazol-5-yl)ethenyl]-3-cephem-4-carboxylic Acid Diphenyl Methyl Ester, CAS: 112953-21-6, stock: 2.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₂₉N₃O₄S₂.

(6R,7R)-7-[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-(1Z)-1-propen-1-yl-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic Acid, CAS: 1000980-59-5, stock: 1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉N₃O₅S.

(6R,7R)-Benzhydryl 7-((Z)-2-((2-(Benzhydryloxy)-2-oxoethoxy)imino)-2-(2-((Z)-2-((2-(tert-butoxy)-2-oxoethoxy)imino)-2-(2-((tert-butoxycarbonyl)amino)thiazol-4-yl)acetamido)thiazol-4-yl)acetamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, CAS: /, stock: 6.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₈H₅₆N₈O₁₃S₃.

(6R,7S)-7-(2-(2-Aminothiazol-4-yl)acetamido)-3-(((1-(2-(dimethylamino)ethyl)-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid, CAS: /, stock: 3.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₃N₉O₄S₃.

(6R,7S)-7-Amino-3-(1-methyl-5-tetrazolylthio)methyl-3-cephem-4-carboxylic Acid, CAS: /, stock: 8.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₆O₃S₂.

(6R-trans)-3-Ethenyl-7-[[[2-(formylamino)-4-thiazolyl]oxoacetyl]amino]-8-oxo-5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid, CAS: 79350-22-4, stock: 7.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂N₄O₆S₂.

(6R-trans)-3-[(Acetyloxy)methyl]-7-[[(2-amino-4-thiazolyl)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid, CAS: 58233-18-4, stock: 2.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆N₄O₆S₂.

(6R-trans)-7-[[(2-Amino-4-thiazolyl)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid, CAS: 79350-10-0, stock: 5.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄N₄O₄S₂.

(7S)-Cefaclor, CAS: 143059-69-2, stock: 1.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄ClN₃O₄S.

(E)-(2-(Furan-2-yl)-2-(methoxyimino)acetic Acid, CAS: 69384-96-9, stock: 3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇NO₄.

(E)-2-(((2-(2-Aminothiazol-4-yl)-3-oxo-3-((2-oxoethyl)amino)prop-1-en-1-yl)amino)oxy)-2-methylpropanoic Acid, CAS: /, stock: 9.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₄O₅S.

(E)-Cefixime (Cefixime EP Impurity D), CAS: 97164-56-2, stock: 5.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅N₅O₇S₂.

(E)-Cefotaxime, CAS: 63527-53-7, stock: 5.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇N₅O₇S₂.

(E)-Cefpodoxime Proxetil, CAS: 947692-13-9, stock: 4.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₇N₅O₉S₂.

(E)-Cefpodoxime Proxetil-d3, CAS: /, stock: 4.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₄D₃N₅O₉S₂.

(E)-Ceftiofur, CAS: 120882-20-4, stock: 4.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇N₅O₇S₃.

(E)-Ceftriaxone, CAS: 92143-31-2, stock: 3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈N₈O₇S₃.

(E)-Ceftriaxone Disodium, CAS: 97164-54-0, stock: 5.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆N₈Na₂O₇S₃.

(E)-Ceftriaxone Sodium, CAS: /, stock: 6.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇N₈NaO₇S₃.

(αE)-α-(Methoxyimino)-2-Furanacetic Acid Ammonium Salt, CAS: /, stock: 2.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀N₂O₄.

(αR)-α-[[(1,1-Dimethylethoxy)carbonyl]amino]-4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]benzeneacetic Acid, CAS: 1286280-61-2, stock: 3.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₁NO₅Si.

(αR)-α-[[(4-Ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino]-4-hydroxy-benzeneacetic Acid, CAS: 62893-24-7, stock: 3.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇N₃O₆.

(αZ)-2-Amino-α-(hydroxyimino)-4-thiazoleacetamide, CAS: 1450758-21-0, stock: 3.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆N₄O₂S.

(αZ)-2-[[(1,1-Dimethylethoxy)carbonyl]amino]-α-[[2-(1,1-dimethylethoxy)-2-oxoethoxy]imino]-4-thiazoleacetic Acid, CAS: 102988-14-7, stock: 9.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃N₃O₇S.

(αZ)-α-(Methoxyimino)-N-[(5aR,6R)-1,4,5a,6-tetrahydro-1,7-dioxo-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl]-2-furanacetamide, CAS: 947723-87-7, stock: 7.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃N₃O₆S.

(αZ)-α-(Methoxyimino)-N-[(5aR,6R)-1,4,5a,6-tetrahydro-1,7-dioxo-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl]-2-furanacetamide-d3, CAS: /, stock: 7.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀D₃N₃O₆S.

(αZ)-α-[(Acetyloxy)imino]-2-(formylamino)-4-thiazoleacetic Acid, CAS: 189099-01-2, stock: 3.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇N₃O₅S.

(αZ)-α-[(Acetyloxy)imino]-2-(formylamino)-4-thiazoleacetic Acid-13C,15N2, CAS: /, stock: 8.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇¹³CH₇N¹⁵N₂O₅S.

(αZ)-α-[(Acetyloxy)imino]-2-amino-4-thiazoleacetic Acid + (αZ)-α-[(Acetyloxy)imino]-2-(formylamino)-4-thiazoleacetic Acid (Mixture), CAS: /, stock: 3.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇N₃O₄S + C  ₈H₇N₃O₅S.

(R)-(+)-α-[(3-Methoxy-1-methyl-3-oxo-1-propenyl)amino]-1,4-cyclohexadiene-1-acetic-d5 Acid Sodium Salt, CAS: /, stock: 1.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁D₅NNaO₄.

(R)-(-)-2-(2,5-Dihydrophenyl)glycine, CAS: 26774-88-9, stock: 5.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁NO₂.

(R)-(-)-2-(2,5-Dihydrophenyl)glycine-d5, CAS: /, stock: 8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆D₅NO₂.

(R)-(-)-2-Phenylglycine Methyl Ester Hydrochloride, CAS: 19883-41-1, stock: 1.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₂ • HCl.

(R)-1-Amino-1-(4-hydroxyphenyl)propan-2-one N-Cefprozil, CAS: /, stock: 5.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₆N₄O₇S.

(R)-2-((R)-(2-(2-aminothiazol-4-yl)acetamido)(carboxy)methyl)-5-(((1-(2-(dimethylamino)ethyl)-1H-tetrazol-5-yl)thio)methyl)-3,6-dihydro-2H-1,3-thiazine-4-carboxylic Acid, CAS: /, stock: 3.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₅N₉O₅S₃.

(Z)-2-(((1-(2-Aminothiazol-4-yl)-2-((2-hydroxy-2-sulfoethyl)amino)-2-oxoethylidene)amino)oxy)-2-methylpropanoic acid, CAS: /, stock: 9.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₄O₈S₂.

(Z)-2-(((1-(2-Aminothiazol-4-yl)-2-((2-hydroxy-2-sulfonatoethyl)amino)-2-oxoethylidene)amino)oxy)-2-methylpropanoate Disodium Hydrate, CAS: /, stock: 3.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₄Na₂O₈S₂•xH₂O.

(Z)-2-((2-Ethoxy-2-oxoethoxy)imino)-2-(2-formamidothiazol-4-yl)acetic Acid, CAS: 68401-60-5, stock: 9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₃O₆S.

(Z)-2-(2-Aminothiazol-4-yl)-2-(hydroxyimino)acetic Acid, CAS: 66338-96-3, stock: 1.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅N₃O₃S10.

(Z)-2-(2-Aminothiazol-4-yl)-2-(tert-butoxycarbonylmethoxyimino)acetic Acid, CAS: 74440-02-1, stock: 2.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅N₃O₅S.

(Z)-2-(2-Aminothiazol-4-yl)-N-(2-hydroxyethyl)-2-(hydroxyimino)acetamide, CAS: 177703-28-5, stock: 4.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀N₄O₃S.

(Z)-2-(2-Tritylaminothiazol-4-yl)-2-methoxyiminoacetic Acid, CAS: 64485-90-1, stock: 8.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₁N₃O₃S.

(Z)-2-(2-Tritylaminothiazol-4-yl)-2-methoxyiminoacetic Acid Methyl Ester, CAS: 1331643-44-7, stock: 3.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₃N₃O₃S.

(Z)-2-(2-Tritylaminothiazol-4-yl)-2-methoxyiminoacetic Acid-d3 Methyl Ester, CAS: 1331643-08-3, stock: 9.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₀D₃N₃O₃S.

(Z)-2-(Trityloxyimino)-2-[2-(tritylamino)thiazol-4-yl]acetic Acid-13C,15N2, CAS: /, stock: 6.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂¹³CH₃₃N¹⁵N₂O₃S.

(Z)-2-Methoxyimino-2-furanacetic Acid Ammonium Salt, CAS: 97148-39-5, stock: 2.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀N₂O₄.

(Z)-2-Methoxyimino-2-furanacetic Acid-d3 Ammonium Salt, CAS: /, stock: 3.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇D₃N₂O₄.

(Z)-2-[2-(Tritylamino)thiazol-4-yl]-2-(trityloxyimino)acetic Acid Ethyl Ester-13C,15N2, CAS: /, stock: 6.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄¹³CH₃₇N¹⁵N₂O₃S.

(Z)-5-(2-Aminothiazol-4-yl)-8-ethoxy-2,2-dimethyl-3,9-dioxa-4,6-diazaundec-4-en-1-oic Acid tert-Butyl Ester, CAS: /, stock: 5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₂N₄O₅S.

(Z)-α-[(Triphenylmethoxy)imino]-2-[(triphenylmethyl)amino]-4-thiazoleethanethioic Acid S-2-Benzothiazolyl Ester-13C,15N2, CAS: /, stock: 1.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₉¹³CH₃₆N₂¹⁵N₂O₂S₃.

(Z)-N-(2,2-Dimethoxyethyl)-2-(2-(tritylamino)thiazol-4-yl)-2-((trityloxy)imino)acetamide, CAS: /, stock: 2.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₇H₄₂N₄O₄S.

(Z)-tert-Butyl 2-(2-(2-(Tritylamino)thiazol-4-yl)-2-((trityloxy)imino)acetamido)acetate, CAS: /, stock: 3.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₉H₄₄N₄O₄S.

1-(2-Dimethylaminoethyl)-5-mercaptotetrazole, CAS: 61607-68-9, stock: 5.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁N₅S.

1-(3-Chlorophenyl)cyclopentanecarboxylic Acid, CAS: 143328-21-6, stock: 3.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃ClO₂.

1-Benzotriazolyl-(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetate, CAS: /, stock: 9.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀N₆O₃S.

1-Chloroethyl Isopropyl-d7 Carbonate, CAS: /, stock: 1.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄D₇ClO₃.

1-Iodoethyl Isopropyl-d7 Carbonate, CAS: /, stock: 4.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄D₇IO₃.

1-[[(6R,7R)-2-Carboxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-pyridinium Thiocyanate, CAS: 10353-05-6, stock: 1.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₈N₃O₄S₂⁺ • CNS ⁻.

1-[[(6R,7R)-7-Amino-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-methylpyrrolidinium Chloride, CAS: 103121-85-3, stock: 6.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀ClN₃O₃S.

1-[[(6R,7R)-7-Amino-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-methylpyrrolidinium-d3 Chloride, CAS: 131857-25-5, stock: 2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇D₃ClN₃O₃S.

1-[[(6R,7R)-7-Amino-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]pyridinium-d5 Iodide, CAS: /, stock: 6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₉D₅IN₃O₃S.

1-[[(6R,7R)-7-[[(2Z)-2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-[2-[(2-chloro-3,4-dihydroxybenzoyl)amino]ethyl]-pyrrolidinium Inner Salt, CAS: 1225208-43-4, stock: 1.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₃ClN₈O₁₀S₂.

2,2’-Dithiobis[5-methyl-1,3,4-thiadiazole], CAS: 66666-63-5, stock: 5.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₄S₄.

2,3-Dihydro-2-thioxo-4-thiazolepropanoic Acid, CAS: 106120-06-3, stock: 4.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇NO₂S₂.

2,6-Dimethoxybenzoyl Chloride, CAS: 1989-53-3, stock: 1.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉ClO₃.

2-(2-Aminothiazole-4-yl)-2-hydroxyiminoacetate-13C,15N2, CAS: /, stock: 1.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³CH₉N¹⁵N₂O₃S.

2-(2-Formamido-4-thiazolyl)glyoxylic Acid Hydrate, CAS: /, stock: 5.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄N₂O₄S  •xH₂O.

2-(2-Tritylamino-4-thiazolyl)glyoxylic Acid, CAS: 68363-44-0, stock: 3.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₈N₂O₃S.

2-(Aminomethyl)thiazole, CAS: 55661-33-1, stock: 9.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆N₂S.

2-Amino-4-thiazoleglyoxylic Acid, CAS: 73150-67-1, stock: 4.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄N₂O₃S.

2-Amino-α-oxo-4-thiazoleethanethioic Acid S-2-Benzothiazolyl Ester, CAS: 102253-97-4, stock: 9.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₇N₃O₂S₃.

2-Aminomethylphenylacetic Acid, CAS: 40851-65-8, stock: 4.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₂.

2-Fluoroimidazole HCl, CAS: 42309-92-2, stock: 7.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₃FN₂•HCl.

2-Formyl-cefpodoxime Proxetil, CAS: 96680-30-7, stock: 8.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₇N₅O₁₀S₂.

2-Hydroxy Cephalexin, CAS: 215172-75-1, stock: 3.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇N₃O₅S.

2-Mercaptobenzothiazolyl-(Z)-(2-aminothiazol-4-yl)-2-(tert-butoxycarbonyl)isopropoxyiminoacetate, CAS: 89604-92-2, stock: 4.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂N₄O₄S₃.

2-[(Cyanomethyl)thio]acetyl Chloride, CAS: 52069-55-3, stock: 3.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄ClNOS.

3(6R,7R)-Hydroxy-8-oxo-7-[(2-phenylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Diphenylmethyl Ester, CAS: 54639-48-4, stock: 3.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₄N₂O₅S.

3-(Hydroxymethylene)-6-phenyl-2,5-piperazinedione, CAS: 142975-48-2, stock: 7.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀N₂O₃.

3-Amino-2-(4-(((5aR,6S)-6-methoxy-1,7-dioxo-1,3,4,5a,6,7-hexahydroazeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl)carbamoyl)-1,3-dithietan-2-ylidene)-3-oxopropanoic Acid, CAS: /, stock: 4.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃N₃O₈S₃.

3-Desacetyl Cefotaxime Lactone, CAS: 66340-33-8, stock: 2.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃N₅O₅S₂.

3-Desethenyl-3-methyl Cefdinir, CAS: 71091-93-5, stock: 1.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃N₅O₅S₂.

3-Desethenyl-3-methyl Cefixime (Cefixime EP Impurity E), CAS: 72701-01-0, stock: 6.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅N₅O₇S₂.

3-Ethyl Cefadroxil, CAS: /, stock: 6.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉N₃O₅S.

3-Ethyl Cefadroxil-d4, CAS: /, stock: 3.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₅D₄N₃O₅S.

4-Pyridylmercaptoacetyl Chloride, CAS: 27230-51-8, stock: 4.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇Cl₂NOS.

4’,5’-Dihydrocephradine, CAS: 37051-00-6, stock: 6.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁N₃O₄S.

5,​10-​Dioxo-5H,​10H-​diimidazo[1,​5-​a:1’,​5’-​d]​pyrazine-​1,​6-​dicarboxylic Acid, CAS: 77015-05-5, stock: 9.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₄N₄O₆.

5,​10-​Dioxo-5H,​10H-​diimidazo[1,​5-​a:1’,​5’-​d]​pyrazine-​1,​6-​diyl-bis(methylene) Dihypochlorite, CAS: /, stock: 5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆Cl₂N₄O₄.

5-Mercapto-1-tetrazolylacetic Acid, CAS: 57658-36-3, stock: 2.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₄N₄O₂S.

7(S)-Cefdinir, CAS: 178601-89-3, stock: 9.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃N₅O₅S₂.

7-ACA Dimer, CAS: /, stock: 8.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀N₄O₈S₂.

7-Amino-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic Acid, CAS: 37539-03-0, stock: 7.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁N₅O₃S₂.

7-Amino-3-(1-methyl-5-tetrazolylthio)methyl-3-cephem-4-carboxylic Acid, CAS: 24209-38-9, stock: 4.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₆O₃S₂.

7-Amino-3-(methoxymethyl)-3-cephem-4-carboxylic Acid, CAS: 24701-69-7, stock: 1.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₄S.

7-Amino-3-cephem-4-carboxylic Acid, CAS: 36923-17-8, stock: 4.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O₃S.

7-Amino-3-chloromethyl-3-cephem-4-carboxylic Acid Diphenylmethyl Ester Hydrochloride, CAS: 79349-53-4, stock: 6.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀Cl₂N₂O₃S.

7-Amino-3-vinyl-3-cephem-4-carboxylic Acid, CAS: 79349-82-9, stock: 4.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀N₂O₃S.

7-Amino-3-vinyl-3-cephem-4-carboxylic Acid tert-Butyl Ester, CAS: 46962-26-9, stock: 9.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂O₃S.

7-Amino-deacetylcephalosporanic Acid, CAS: 15690-38-7, stock: 8.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀N₂O₄S.

7-Aminocephalosporanic Acid, CAS: 957-68-6, stock: 6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O₅S.

7-epi Cefepime Disulfate, CAS: /, stock: 4.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄N₆O₅S₂ •2[H₂SO₄].

7-epi-Cefixime (Cefixime EP Impurity C), CAS: 108691-83-4, stock: 8.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅N₅O₇S₂.

7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-[(carboxymethoxy)imino]acetyl]amino]-cefixime (>85%), CAS: /, stock: 6.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₀N₈O₁₁S₃.

7β-Amino-7α-methoxy-3-(1-methyl-5-tetrazolylthio)methyl-3-cephem-4-carboxylic Acid Diphenylmethyl Ester, CAS: 56610-72-1, stock: 6.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₄N₆O₄S₂.

Ammonium Dithiocarbamate, CAS: 513-74-6, stock: 8.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  CH₃NS₂ •  NH₃.

Anticefepime, CAS: 97164-57-3, stock: 4.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄N₆O₅S₂.

∆2-(E)-Cefpodoxime Proxetil, CAS: /, stock: 3.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₇N₅O₉S₂.

∆2-Cefpodoxime Proxetil, CAS: 339528-86-8, stock: 3.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₇N₅O₉S₂.

∆2-Cefteram Pivoxil, 1:1 mixture with Cefteram Pivoxil (C244300), CAS: 104712-44-9, stock: 3.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₇N₉O₇S₂.

∆2-Ceftiofur, CAS: 120962-17-6, stock: 6.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇N₅O₇S₃.

Benzhydryl 7-Amino-7-methoxycephalosporanate, CAS: 35565-04-9, stock: 6.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₄N₂O₆S.

Cefacetrile, CAS: 10206-21-0, stock: 5.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃N₃O₆S.

Cefacetrile Sodium, CAS: 23239-41-0, stock: 3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂N₃NaO₆S.

Cefacetrile-13C3, CAS: /, stock: 9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀¹³C₃H₁₃N₃O₆S.

Cefaclor Monohydrate, CAS: 70356-03-5, stock: 9.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆ClN₃O₅S.

Cefaclor-d5, CAS: 1426173-90-1, stock: 10g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₉D₅ClN₃O₄S.

Cefadroxil, CAS: 66592-87-8, stock: 9.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉N₃O₆S.

Cefadroxil Carbonate, CAS: 64915-10-2, stock: 7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁N₃O₇S.

Cefadroxil Dimer, CAS: /, stock: 9.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₂N₆O₉S₂.

Cefadroxil Sulfoxide, CAS: 182290-77-3, stock: 9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇N₃O₆S.

Cefadroxil Sulfoxide-d4, CAS: /, stock: 1.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃D₄N₃O₆S.

Cefadroxil-d4 (Major), CAS: 1426174-38-0, stock: 3.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅D₄N₃O₆S.

Cefalonium Hydrate, CAS: 5575-21-3, stock: 9.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈N₄O₅S₂•xH₂O.

Cefalonium Hydrate-d4, CAS: /, stock: 6.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₄D₄N₄O₅S₂•xH₂O.

Cefamandole Lithium, CAS: 58648-57-0, stock: 6.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇LiN₆O₆S₂.

Cefamandole Sodium Salt, CAS: 30034-03-8, stock: 3.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇N₆NaO₅S₂.

Cefatrizine, CAS: 51627-14-6, stock: 8.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈N₆O₅S₂.

Cefatrizine 1,2-propanediol, CAS: 64217-62-5, stock: 1.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆N₆O₇S₂.

Cefatrizine-d4, CAS: /, stock: 5.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₄D₄N₆O₅S₂.

Cefazedone, CAS: 56187-47-4, stock: 3.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₅Cl₂N₅O₅S₃.

Cefbuperazone, CAS: 76610-84-9, stock: 5.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₉N₉O₉S₂.

Cefcapene, CAS: 135889-00-8, stock: 5.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉N₅O₆S₂.

Cefcapene Pivoxil, CAS: 105889-45-0, stock: 8.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₉N₅O₈S₂.

Cefcapene Pivoxil Hydrochloride, CAS: 147816-23-7, stock: 3.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₀ClN₅O₈S₂.

Cefcapene Pivoxil-d9, CAS: /, stock: 7.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₉D₉N₅O₈S₂.

Cefcapene-d5, CAS: /, stock: 1.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄D₅N₅O₆S₂.

Cefdaloxime, CAS: 80195-36-4, stock: 1.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅N₅O₆S₂.

Cefdinir, CAS: 91832-40-5, stock: 6.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃N₅O₅S₂.

Cefdinir Sulfoxide, CAS: 934986-48-8, stock: 1.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃N₅O₆S₂.

Cefdinir-15N2,13C Trifluoroacetic Acid Salt Hydrate, CAS: /, stock: 7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃¹³CH₁₃N₃¹⁵N₂O₅S₂ • C ₂HF₃O₂ •xH2O.

Cefditoren Acid Sodium Salt, CAS: 104146-53-4, stock: 6.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇N₆NaO₅S₃.

Cefditoren Acid-d3 Sodium Salt, CAS: /, stock: 7.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₄D₃N₆NaO₅S₃.

Cefditoren Pivoxil, CAS: 117467-28-4, stock: 8.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₈N₆O₇S₃.

Cefditoren Pivoxil-d3, CAS: /, stock: 8.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₅D₃N₆O₇S₃.

Cefepime Dihydrochloride, CAS: 107648-80-6, stock: 2.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄N₆O₅S₂ • 2(HCl).

Cefepime Dihydrochloride Monohydrate, CAS: 123171-59-5, stock: 6.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₈Cl₂N₆O₆S₂.

Cefepime-d3 Sulfate, CAS: /, stock: 1.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃D₃N₆O₉S₃.

Cefepime-D3,13C Sulfate, CAS: /, stock: 6.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈¹³CH₂₄D₃N₆O₉S₃.

Cefepime-D8 Sulfate, CAS: 131857-33-5, stock: 7.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₈D₈N₆O₉S₃.

Cefetamet, CAS: 65052-63-3, stock: 7.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅N₅O₅S₂.

Cefetamet Pivoxil, CAS: 65243-33-6, stock: 9.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅N₅O₇S₂.

Cefetamet-d3, CAS: /, stock: 7.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂D₃N₅O₅S₂.

Cefixime, CAS: 79350-37-1, stock: 1.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅N₅O₇S₂.

Cefixime Acid, Thiazine Isomer Impurity Sodium Salt (>80%), CAS: /, stock: 1.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇N₅O₈S₂ • x(Na).

Cefixime EP Impurity A (Technical Grade)(Mixture of Diastereomers), CAS: 1614255-90-1, stock: 9.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇N₅O₈S₂.

Cefixime EP Impurity B Acetic Acid Salt, CAS: /, stock: 7.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁N₅O₈S₂.

Cefixime Ethyl Ester Sodium Salt (Cefixime EP Impurity F), CAS: /, stock: 9.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈N₅NaO₇S₂.

Cefixime Methyl Ester, CAS: 88621-01-6, stock: 7.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇N₅O₇S₂.

Cefixime O,O’-Diphenylmethane, CAS: 86027-28-3, stock: 4.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₃₅N₅O₇S₂.

Cefixime-13C,15N2, CAS: /, stock: 5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅¹³CH₁₅N₃¹⁵N₂O₇S₂.

Cefmenoxime Hydrochloride, CAS: 75738-58-8, stock: 6.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇N₉O₅S₃•1/2HCl.

Cefodizime, CAS: 69739-16-8, stock: 9.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₀N₆O₇S₄.

Cefonicid Disodium Salt, CAS: 190181-58-9, stock: 5.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆N₆Na₂O₈S₃.

Cefonicid Sodium, CAS: 61270-78-8, stock: 8.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈N₆O₈S₃ • 2Na.

Cefoperazone Sodium Salt, CAS: 62893-20-3, stock: 8.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₆N₉NaO₈S₂.

Ceforanide, CAS: 60925-61-3, stock: 4.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁N₇O₆S₂.

Cefotaxime Bromoacetyl Analogue, CAS: 83305-12-8, stock: 1.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆BrN₃O₈S.

Cefotaxime Dimer, CAS: 175032-97-0, stock: 9.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₀N₁₀O₁₂S₄.

Cefotaxime Proxetil, CAS: 217803-89-9, stock: 9.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₇N₅O₁₀S₂.

Cefotaxime Proxetil-d3, CAS: /, stock: 5.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄D₃N₅O₁₀S₂.

Cefotaxime Sodium, CAS: 64485-93-4, stock: 8.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆N₅NaO₇S₂.

Cefotaxime Sodium Impurity G, CAS: /, stock: 6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₁N₈NaO₉S₃.

Cefotaxime Sodium Impurity G-d3, CAS: /, stock: 9.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₈D₃N₈NaO₉S₃.

Cefotaxime-d3, CAS: /, stock: 2.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄D₃N₅O₇S₂.

Cefotetan, CAS: 69712-56-7, stock: 4.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇N₇O₈S₄.

Cefotetan Disodium, CAS: 74356-00-6, stock: 8.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇N₇Na₂O₈S₄.

Cefotetan-13C3, CAS: /, stock: 4.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄¹³C₃H₁₇N₇O₈S₄.

Cefotiam Dihydrochloride, CAS: 66309-69-1, stock: 2.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₅Cl₂N₉O₄S₃.

Cefotiam Hexetil Hydrochloride (mixture of Diastereomers), CAS: 95789-30-3, stock: 4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₉Cl₂N₉O₇S₃.

Cefovecin Sodium, CAS: 141195-77-9, stock: 4.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈N₅NaO₆S₂.

Cefpimizole Disodium Salt (>90%), CAS: 84324-56-1, stock: 9.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₄N₆Na₂O₁₀S₂.

Cefpirome Sulfate, CAS: 98753-19-6, stock: 3.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄N₆O₉S₃.

Cefpodoxime Proxetil, CAS: 87239-81-4, stock: 2.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₇N₅O₉S₂.

Cefpodoxime Proxetil Isopropylcarbamate, CAS: 1192365-87-9, stock: 5.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₃N₅O₁₁S₂.

Cefpodoxime Proxetil Isopropylcarbamate-d7, CAS: /, stock: 9.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₆D₇N₅O₁₁S₂.

Cefpodoxime Proxetil-d7 (~85%), CAS: /, stock: 4.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀D₇N₅O₉S₂.

Cefprozil (E)-Isomer, CAS: 92676-86-3, stock: 7.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉N₃O₅S.

Cefprozil (Z)-Isomer, CAS: 121412-77-9, stock: 7.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉N₃O₅S.

Cefprozil Amide, CAS: /, stock: 8.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₆N₄O₇S.

Cefprozil Dimer, CAS: /, stock: 6.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₃₆N₆O₉S₂.

Cefprozil-d4 (E/Z mixture), CAS: 1426173-48-9, stock: 2.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₅D₄N₃O₅S.

Cefsulodin Sodium Salt, CAS: 52152-93-9, stock: 7.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₉N₄NaO₈S₂.

Ceftaroline Fosamil Inner salt, CAS: 229016-73-3, stock: 3.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₁N₈O₈PS₄.

Ceftaroline Fosamil Inner salt-d3, CAS: /, stock: 4.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₈D₃N₈O₈PS₄.

Ceftazidime Pentahydrate(Contain 1 equivalent of Na2CO3 as stabilizer), CAS: 78439-06-2, stock: 5.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₂N₆O₁₂S₂.

Ceftazidime-d5 (90%), CAS: /, stock: 7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₇D₅N₆O₇S₂.

Cefteram, CAS: 82547-58-8, stock: 4.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇N₉O₅S₂.

Cefteram Pivoxil, CAS: 82547-81-7, stock: 4.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₇N₉O₇S₂.

Ceftibuten-13C3, CAS: /, stock: 8.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂¹³C₃H₁₄N₄O₆S₂.

Ceftiofur, CAS: 80370-57-6, stock: 9.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇N₅O₇S₃.

Ceftiofur Dimer Impurity, CAS: /, stock: 1.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₂₉N₇O₁₁S₄.

Ceftiofur Sodium, CAS: 104010-37-9, stock: 8.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆N₅NaO₇S₃.

Ceftiofur Sulfoxide, CAS: /, stock: 6.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇N₅O₈S₃.

Ceftiolene, CAS: 77360-52-2, stock: 4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈N₈O₈S₃.

Ceftiolene-d3, CAS: /, stock: 7.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₅D₃N₈O₈S₃.

Ceftizoxime, CAS: 68401-81-0, stock: 5.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃N₅O₅S₂.

Ceftizoxime Open Lactam, CAS: /, stock: 2.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅N₅O₆S₂.

Ceftizoxime-d3, CAS: /, stock: 4.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀D₃N₅O₅S₂.

Ceftolozane Sulfate, CAS: 936111-69-2, stock: 6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₂N₁₂O₁₂S₃.

Ceftriaxone, CAS: 73384-59-5, stock: 5.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈N₈O₇S₃.

Ceftriaxone Disodium Salt Hemiheptahydrate, CAS: 104376-79-6, stock: 6.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆N₈Na₂O₇S₃•3.5H₂O.

Ceftriaxone-d3 Disodium Salt, CAS: 1132650-38-4, stock: 6.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₃D₃N₈Na₂O₇S₃.

Cefuroxime, CAS: 55268-75-2, stock: 4.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆N₄O₈S.

Cefuroxime Axetil, CAS: 64544-07-6, stock: 7.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂N₄O₁₀S.

Cefuroxime Axetil Impurity C (85%), CAS: 76598-06-6, stock: 9.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₅Cl₃N₄O₉S.

Cefuroxime Axetil Impurity C-d3, CAS: /, stock: 3.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₂D₃Cl₃N₄O₉S.

Cefuroxime Axetil-d3, CAS: /, stock: 3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₉D₃N₄O₁₀S.

Cephalexin Diketopiperazine Hydrochloride, CAS: /, stock: 7.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈ClN₃O₄S.

Cephalexin Dimer Hydrochloride, CAS: /, stock: 5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₃ClN₆O₇S₂.

Cephalexin Dimer Trifluoroacetate, CAS: /, stock: 8.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₃F₃N₆O₉S₂.

Cephalexin Hydrate, CAS: 1212823-95-4, stock: 9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇N₃O₄S.

Cephalexin Sulfoxide, CAS: 56193-21-6, stock: 4.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇N₃O₅S.

Cephalexin Sulfoxide Trifluoroacetic Acid Salt, CAS: /, stock: 8.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈F₃N₃O₇S.

Cephalexin-d5 Hydrate, CAS: /, stock: 1.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄D₅N₃O₅S.

Cephaloglycin, CAS: 03/01/3577, stock: 7.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉N₃O₆S.

Cephaloridine Monohydrate, CAS: 102039-86-1, stock: 4.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇N₃O₄S₂•H₂O.

Cephalosporin C Zinc Salt, CAS: 59143-60-1, stock: 9.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉N₃O₈SZn.

Cephalothin, CAS: 153-61-7, stock: 3.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆N₂O₆S₂.

Cephalothin Sodium, CAS: 58-71-9, stock: 4.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅N₂NaO₆S₂.

Cephradine, CAS: 38821-53-3, stock: 5.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉N₃O₄S.

Cephradine Sulfoxide, CAS: /, stock: 7.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉N₃O₅S.

Cephradine-d5, CAS: /, stock: 2.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄D₅N₃O₄S.

D-(-)-2-Phenylglycine Cephalexinate, CAS: /, stock: 4.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₄N₄O₅S.

D-(-)-2-Phenylglycine Cephalexinate-d5, CAS: /, stock: 5.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₉D₅N₄O₅S.

D-(-)-4-Hydroxyphenyl-d4-glycine, CAS: 1217854-79-9, stock: 7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅D₄NO₃.

D-Phenylglycyl Cefaclor, CAS: /, stock: 5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₁ClN₄O₅S.

D-Phenylglycyl Cefaclor-d5, CAS: /, stock: 9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₆D₅ClN₄O₅S.

Deacetoxycephalothin, CAS: 34691-02-6, stock: 4.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄N₂O₄S₂.

Deacetylcephalothin, CAS: 5935-65-9, stock: 8.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄N₂O₅S₂.

Deacetylcephalothin Lactone, CAS: 10590-10-0, stock: 1.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂N₂O₄S₂.

Deacetylcephalothin Sodium Salt, CAS: 5547-29-5, stock: 9.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃N₂NaO₅S₂.

Decarboxy De(N-methyl-1H-tetrazol-5-yl) Moxalactam (Latamoxef), CAS: /, stock: 4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈N₂O₇S.

Desacetyl-7-ACA Lactone Hydrochloride, CAS: /, stock: 7.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈N₂O₃S  •  (HCl).

Descarbamoyl Cefuroxime, CAS: 56271-94-4, stock: 2.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅N₃O₇S.

Descarbamoyl Cefuroxime-d3, CAS: /, stock: 7.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂D₃N₃O₇S.

Desfuroyl Ceftiofur Dimer (>90%), CAS: 120905-00-2, stock: 2.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₈N₁₀O₁₀S₆.

Desphenol 1-Hydroxyethyl Cefoperazone Furolactone, CAS: 85916-94-5, stock: 7.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅N₅O₉S.

Di-2-(Hydroxyphenyl)acetamido Cefprozil (Mixture of E/Z isomers), CAS: /, stock: 2.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₆N₄O₇S.

Diphenylmethyl 7-amino-3-chloromethyl-3-cephem-4-carboxylate, CAS: 56040-80-3, stock: 4.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₉ClN₂O₃S.

E-Ceftazidime, CAS: 97148-38-4, stock: 7.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂N₆O₇S₂.

Ethoxy Carbonyl Cefprozil, CAS: /, stock: 1.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃N₃O₇S.

Ethyl 2-((1,3-Dioxoisoindolin-2-yl)oxy)acetate, CAS: 5251-81-0, stock: 8.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁NO₅.

Ethyl 2-(2-Formamidothiazol-4-yl)-2-oxoacetate, CAS: 64987-03-7, stock: 5.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈N₂O₄S.

Ethyl 3-Mercaptopropanoate, CAS: 08/06/5466, stock: 4.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₂S.

Formyl-ACA, CAS: 27267-35-2, stock: 6.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂N₂O₆S.

Isobutyl Bromoacetate, CAS: 59956-48-8, stock: 9.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁BrO₂.

Δ-2-Cefodizime (~2:1 C242885 to C242865), CAS: 120533-30-4, stock: 9.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₀N₆O₇S₄.

Δ2-Cefadroxil, CAS: 147103-94-4, stock: 7.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇N₃O₅S.

Δ2-Cefbuperazone, CAS: /, stock: 3.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₉N₉O₉S₂.

Δ2-Cefbuperazone-d3, CAS: /, stock: 1.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆D₃N₉O₉S₂.

Δ2-Cefcapene Pivoxil, CAS: /, stock: 8.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₉N₅O₈S₂.

Δ2-Cefdinir, CAS: 934986-49-9, stock: 6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃N₅O₅S₂.

Δ2-Cefditoren Pivoxil, CAS: 148774-47-4, stock: 4.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₈N₆O₇S₃.

Δ2-Cefepime, CAS: 88040-25-9, stock: 7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄N₆O₅S₂.

Δ2-Ceftizoxime Sodium Salt (Mixture of Diastereomers), CAS: /, stock: 8.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂N₅NaO₅S₂.

Δ2-Cefuroxime, CAS: 229499-08-5, stock: 4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆N₄O₈S.

Δ2-Cefuroxime Axetil(Cefuroxime Axetil Delta-3 Isomer), CAS: 123458-61-7, stock: 3.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂N₄O₁₀S.

Δ2-Cefuroxime Methyl Ester, CAS: /, stock: 2.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈N₄O₈S.

Δ2-N-Acetyl Cefixime, CAS: /, stock: 9.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇N₅O₈S₂.

α-(Methoxyimino)-2-furanacetyl Chloride, CAS: 64076-56-8, stock: 6.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆ClNO₃.

α-[[(2-Amino-4-thiazolyl)(hydroxyimino)acetyl]amino]-1,2,5,7-tetrahydro-5-methyl-7-oxo-4H-Furo[3,4-d][1,3]thiazine-2-acetic Acid Sodium Salt(Mixture of Diastereomers), CAS: /, stock: 8.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄N₅NaO₆S₂.

δ-2-Cefodizime, CAS: 120533-30-4, stock: 7.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₀N₆O₇S₄.

δ-3 Cefaclor, CAS: 152575-13-8, stock: 3.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄ClN₃O₄S.

L-Cefadroxil, CAS: 144790-28-3, stock: 5.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇N₃O₅S.

ME 1207E, CAS: 138514-32-6, stock: 8.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₈N₆O₇S₃.

Methoxy Cefadroxil, CAS: /, stock: 7.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉N₃O₆S.

Methoxycarbonyl Cefadroxil, CAS: /, stock: 5.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉N₃O₇S.

Methoxycarbonyl Cefadroxil-d4, CAS: /, stock: 4.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₅D₄N₃O₇S.

Methyl 3-(2-((2,5-Dioxohexyl)thio)thiazol-4-yl)propanoate, CAS: /, stock: 1.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₄S₂.

Moxalactam Sodium Salt(Mixture of diastereomers), CAS: 64953-12-4, stock: 2.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈N₆Na₂O₉S.

N,O-Ditrityl (E)-Cefdinir-13C,15N2, CAS: /, stock: 9.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₁¹³CH₄₁N₃¹⁵N₂O₅S₂.

N-Acetyl Cefixime, CAS: /, stock: 6.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇N₅O₈S₂.

N-Acetyl Cefpodoxime Proxetil, CAS: 947692-15-1, stock: 9.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₉N₅O₁₀S₂.

N-Acetyl Cefpodoxime Proxetil-d3, CAS: /, stock: 6.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆D₃N₅O₁₀S₂.

N-Boc D-(-)-2-Phenylglycine Cephalexinate, CAS: /, stock: 3.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₂N₄O₇S.

N-Boc Di-2-(Hydroxyphenyl)acetamido Cefprozil tert-Butyldimethylsilyl Ether, CAS: /, stock: 8.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₈N₄O₉SSi.

N-Boc-Cephalexin, CAS: 28180-92-9, stock: 6.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅N₃O₆S.

N-Boc-Cephalexin Dimer, CAS: /, stock: 6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₀N₆O₉S₂.

N-Formyl Cefotaxime, CAS: 66403-32-5, stock: 1.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇N₅O₈S₂.

N-Furoyl Ceftiofur, CAS: /, stock: 8.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₉N₅O₉S₃.

N-Hydroxyphenylglycyl Cefadroxil, CAS: 147103-95-5, stock: 5.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₄N₄O₇S.

N-Hydroxyphenylglycyl Cefadroxil-d4, CAS: /, stock: 7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₀D₄N₄O₇S.

N-Methylbut-2-enoate Ethyl Ester D-(-)Phenylglycine Potassium Salt, CAS: 961-69-3, stock: 9.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆KNO₄.

N-MOM-Cefditoren Pivoxil, CAS: /, stock: 8.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₂N₆O₈S₃.

N-Pivaly-Cefditoren Pivoxil, CAS: 878002-84-7, stock: 2.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₆N₆O₈S₃.

N-tert-Butoxycarbonylcephalexin, CAS: 28180-92-9, stock: 7.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅N₃O₆S.

O-(Pivaloyloxymethyl) Carbonochloridate, CAS: 133217-74-0, stock: 8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₁ClO₄.

O-Acetyl Cefdinir, CAS: 127770-93-8, stock: 1.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅N₅O₆S₂.

O-Desisopropyl-O-ethyl Cefpodoxime Proxetil, CAS: 82619-01-0, stock: 7.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅N₅O₉S₂.

O-Desisopropyl-O-ethyl Cefpodoxime Proxetil-d3, CAS: /, stock: 7.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂D₃N₅O₉S₂.

S-(5-Methyl-1,3,4-thiadiazol-2-yl) 2-(2-Aminothiazol-4-yl)-2-oxoethanethioate, CAS: /, stock: 2.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆N₄O₂S₃.

S-Decyanomethyl-S-(1-methyl-1H-tetrazol-5-yl) Cefmetazole Sodium Salt, CAS: 74228-11-8, stock: 9.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇N₁₀NaO₅S₃.

seco-Lactam (E)-Cefdinir Lactone, CAS: /, stock: 3.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₄N₁₀O₈S₄.

TACS, CAS: 111298-82-9, stock: 8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅N₃O₅S₃.

tert-Butyl-4-chloro-3-oxobutanoate, CAS: 74530-56-6, stock: 5.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₃ClO₃.

Thiazolylacetylglycine Oxime, CAS: 178949-03-6, stock: 6.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₄O₄S.

Thiazolylacetylglycine Oxime- 13C2,15N, CAS: /, stock: 9.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³C₂H₈N₃¹⁵NO₄S.

Trimethylsilyl 7-(Trimethylsilylamino)-3-methyl-3-cephem-4-carboxylate, CAS: 31461-05-9, stock: 5.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₆N₂O₃SSi₂.

[2R-[2α,6α,7β(R*)]]-7-[[[[(1,1-Dimethylethoxy)carbonyl]amino]phenylacetyl]amino]-3-methylene-8-oxo-5-thia-1-azabicyclo[4.2.0]octane-2-carboxylic Acid 5-Oxide, CAS: 54238-49-2, stock: 7.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅N₃O₇S.

[6R-​[6α,​7β(R*)​]​]​-3-​[(Acetyloxy)​methyl]​-​7-​[[[[(5-​carboxy-​1H-​imidazol-​4-​yl)​carbonyl]​amino]​phenylacetyl]​amino]​-​8-​oxo-5-​thia-​1-​azabicyclo[4.2.0]​oct-​2-​ene-​2-​carboxylic Acid, CAS: 69579-35-7, stock: 8.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₁N₅O₉S.

[6R-[6α,7β(R*)]]-7-[(Aminophenylacetyl)amino]-3-methylene-8-oxo-5-thia-1-azabicyclo[4.2.0]octane-2-carboxylic Acid, CAS: 67308-21-8, stock: 6.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇N₃O₄S.

[6R-[6α,7β(Z)]]-7-[[(2-Amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-[[[4-(2-carboxyethyl)-2-thiazolyl]thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid, CAS: 111874-09-0, stock: 6.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₀N₆O₇S₄.

Carbocisteine, CAS: 638-23-3, stock: 5.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉NO₄S.

Carbocisteine Lactam Sodium Salt, CAS: 88933-48-6, stock: 3.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆NNaO₃S.

Carbocisteine Sulfoxide(Mixture of diastereomers), CAS: 5439-87-2, stock: 8.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉NO₅S.

Carbocisteine-13C3, CAS: 1391068-19-1, stock: 4.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂¹³C₃H₉NO₄S.

Carbocisteine-d3, CAS: /, stock: 2.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆D₃NO₄S.

2-Allyl-2-methyl-1,3-propanediol Isopropylcarbamate, CAS: 1797946-61-2, stock: 6.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₁NO₃.

2-Methyl-2-propyl-1,3-propanediol, CAS: 78-26-2, stock: 7.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆O₂.

2-Methyl-d3-2-propyl-1,3-propanediol, CAS: 1185023-23-7, stock: 9.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃D₃O₂.

5-Methyl-5-propyl-2-dioxanone (80%), CAS: 7148-50-7, stock: 9.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄O₃.

5-Methyl-5-propyl-2-dioxanone-d3, CAS: 1184973-36-1, stock: 1.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁D₃O₃.

Carbamyl Benzyl Ester, CAS: 621-84-1, stock: 9.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₂.

Carisoprodol, CAS: 78-44-4, stock: 6.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₄N₂O₄.

1,3-Bis(2-chloroethyl)urea, CAS: 2214-72-4, stock: 5.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀Cl₂N₂O.

Carisoprodol (1.0mg/ml in Methanol), CAS: 78-44-4, stock: 1.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₄N₂O₄.

Carisoprodol Glucuronide, CAS: /, stock: 8.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₂N₂O₁₀.

Carmustine, CAS: 154-93-8, stock: 2.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉Cl₂N₃O₂.

cis-4-Hydroxy-lomustine, CAS: 52049-26-0, stock: 9.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆ClN₃O₃.

Carisoprodol-d3, CAS: 1215602-82-6, stock: 7.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₁D₃N₂O₄.

Carisoprodol-d7, CAS: 1218911-70-6, stock: 5.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇D₇N₂O₄.

cis-4-Hydroxy-lomustine-d10, CAS: /, stock: 3.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇D₉ClN₃O₃.

Lomustine, CAS: 13010-47-4, stock: 5.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆ClN₃O₂.

Carisoprodol-d7 (1.0 mg/mL in Methanol), CAS: 1218911-70-6, stock: 1.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇D₇N₂O₄.

Decarboxamide Meprobamate, CAS: 1471-56-3, stock: 4.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₇NO₃.

trans-4-Hydroxy-lomustine, CAS: 56239-24-8, stock: 5.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆ClN₃O₃.

trans-4-Hydroxy-lomustine-d10, CAS: /, stock: 4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇D₉ClN₃O₃.

Dehydro Carisoprodol, CAS: /, stock: 2.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂N₂O₄.

Dehydro Carisoprodol-d3, CAS: /, stock: 6.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₉D₃N₂O₄.

Dehydro Carisoprodol-d7, CAS: /, stock: 5.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅D₇N₂O₄.

Hydroxy Carisoprodol (mixture of diastereomers), CAS: 3424-34-8, stock: 3.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₄N₂O₅.

Hydroxy Carisoprodol-d4, CAS: 1794759-19-5, stock: 7.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₀D₄N₂O₅.

Isopropylcarbamic Acid 2-Methyl-2-propyltrimethylene Ester, CAS: 1729-14-2, stock: 2.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₃₀N₂O₄.

N-Isopropyl-2-methyl-2-propyl-3-hydroxypropyl Carbamate, CAS: 25462-17-3, stock: 5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₃NO₃.

N-Isopropyl-2-methyl-d3-2-propyl-3-hydroxypropyl Carbamate, CAS: 1189878-05-4, stock: 1.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₀D₃NO₃.

(S)-3-((tert-Butoxycarbonyl)amino)-3-(4-methoxyphenyl)propanoic Acid, CAS: 159990-12-2, stock: 5.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁NO₅.

(S)-3-Phenyl-3-(tert-butoxycarbonylamino)propanoic Acid, CAS: 103365-47-5, stock: 1.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₄.

1-[(Phenylmethoxy)carbonyl]-L-prolyl-β-alanine, CAS: 113332-46-0, stock: 2.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀N₂O₅.

1-[(Phenylmethoxy)carbonyl]-L-prolyl-β-alanine Methyl Ester, CAS: 59543-05-4, stock: 7.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂N₂O₅.

Chicken CARNS1 (Carnosine synthase 1) ELISA Kit (96T), CAS: /, stock: 5.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

α-Amino-N-methyl-1-(triphenylmethyl)-1H-imidazole-4-propanamide, CAS: 145695-69-8, stock: 3.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₆N₄O.

β-Alanine, CAS: 107-95-9, stock: 6.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₇NO₂.

β-Alanine-13C3,15N, CAS: 285978-07-6, stock: 1.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₃H₇¹⁵NO₂.

β-Alanine-2,2,3,3-D4, CAS: 116173-67-2, stock: 5.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₃D₄NO₂.

L-Carnosine, CAS: 305-84-0, stock: 3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄N₄O₃.

L-Histidine, CAS: 71-00-1, stock: 7.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉N₃O₂.

Mouse Carns1 (Carnosine synthase 1) ELISA Kit (96T), CAS: /, stock: 4.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

N-(L-Prolyl)-β-alanine, CAS: 112558-45-9, stock: 2.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄N₂O₃.

N-Acetyl-L-carnosine, CAS: 56353-15-2, stock: 6.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₄O₄.

N-L-Prolyl-L-histidine, CAS: 92027-43-5, stock: 2.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₄O₃.

Polaprezinc, CAS: 107667-60-7, stock: 2.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₄O₃Zn.

rac Histidine-13C6,15N3, CAS: /, stock: 9.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆H₉¹⁵N₃O₂.

Carbinoxamine β-D-Glucuronide, CAS: /, stock: 5.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₇ClN₂O₇.

Carbinoxamine Maleate Salt, CAS: 3505-38-2, stock: 6.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃ClN₂O₅.

Carbinoxamine N-Oxide Dihydrochloride, CAS: /, stock: 4.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁Cl₃N₂O₂.

Carbinoxamine N-Oxide-d6, CAS: /, stock: 5.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃D₆ClN₂O₂.

Carbinoxamine-d6 Maleate Salt, CAS: 1216872-59-1, stock: 2.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₇D₆ClN₂O₅.

(R)-(+)-1’-Hydroxy Carvedilol, CAS: /, stock: 8.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₆N₂O₅.

(R)-(+)-2’-O-Benzyloxy-2-O-desmethylcarvedilol, CAS: 1217688-35-1, stock: 6.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₀N₂O₄.

(R)-(+)-3’-Hydroxyphenyl Carvedilol, CAS: /, stock: 9.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₆N₂O₅.

(R)-(+)-4’-Benzyloxyphenyl Carvedilol, CAS: 1217846-55-3, stock: 2.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₂N₂O₅.

(R)-(+)-4’-Hydroxyphenyl Carvedilol, CAS: 1217770-29-0, stock: 9.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₆N₂O₅.

(R)-(+)-5’-Benzyloxy Carvedilol, CAS: 1217637-76-7, stock: 7.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₂N₂O₅.

(R)-(+)-5’-Hydroxyphenyl Carvedilol, CAS: 1217757-71-5, stock: 1.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₆N₂O₅.

(R)-(+)-8’Hydroxy Carvedilol, CAS: /, stock: 3.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₆N₂O₅.

(R)-(+)-Carvedilol, CAS: 95093-99-5, stock: 9.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₆N₂O₄.

(+)-Carnitine Benzyl Ester Chloride, CAS: 14548-21-1, stock: 6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂ClNO₃.

(R)-(+)-O-Desmethyl Carvedilol, CAS: 123372-14-5, stock: 2.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₄N₂O₄.

(S)-(-)-1’-Hydroxy Carvedilol, CAS: /, stock: 9.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₆N₂O₅.

(+/-)-Decanoylcarnitine Chloride, CAS: 18822-87-2, stock: 5.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₄ClNO₄.

(+/-)-Myristoylcarnitine Chloride, CAS: 14919-38-1, stock: 9.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₄₂ClNO₄.

(S)-(-)-3’-Hydroxyphenyl Carvedilol, CAS: /, stock: 1.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₆N₂O₅.

(S)-(-)-4’-Benzyloxyphenyl Carvedilol, CAS: 1217733-91-9, stock: 4.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₂N₂O₅.

(2E,4Z)-Deca-2,4-dien-oyl (R)-Carnitine Inner Salt, CAS: 128305-29-3, stock: 6.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₉NO₄.

(2E,4Z)-Deca-2,4-dien-oyl (R)-Carnitine Inner Salt-d3, CAS: /, stock: 9.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₆D₃NO₄.

(S)-(-)-4’-Hydroxyphenyl Carvedilol, CAS: 1217853-93-4, stock: 5.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₆N₂O₅.

(S)-(-)-5’-Benzyloxyphenyl Carvedilol, CAS: 1217822-96-2, stock: 7.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₂N₂O₅.

(2R)-2-[6-(4-Chlorophenoxy)hexyl]-oxiranecarboxylic Acid Sodium Salt, CAS: 828934-41-4, stock: 8.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈ClNaO₄.

(2R)-3-Carboxy-2-(3-carboxy-1-oxopropoxy)-N,N,N-trimethyl-1-propanaminium Bromide, CAS: /, stock: 3.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₀BrNO₆.

(S)-(-)-5’-Hydroxyphenyl Carvedilol, CAS: 1217723-80-2, stock: 2.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₆N₂O₅.

(S)-(-)-8’Hydroxy Carvedilol, CAS: /, stock: 8.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₆N₂O₅.

(2R)-3-Carboxy-2-[(9-carboxy-1-oxononyl)oxy]-N,N,N-trimethyl-1-propanaminium Inner Salt, CAS: 102636-85-1, stock: 4.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₁NO₆.

(2R)-3-Carboxy-2-[(9-carboxy-1-oxononyl)oxy]-N,N,N-trimethyl-1-propanaminium-d3 Inner Salt (Sebacoyl-L-Carnitine-d3), CAS: /, stock: 7.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₈D₃NO₆.

(S)-(-)-Carvedilol, CAS: 95094-00-1, stock: 2.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₆N₂O₄.

(S)-(-)-O-Benzyl-O-desmethylcarvedilol, CAS: 1217640-12-4, stock: 4.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₀N₂O₄.

(2R)-3-Hydroxyisovaleroyl Carnitine, CAS: 99159-87-2, stock: 6.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₃NO₅.

(2R)-3-Hydroxyisovaleroyl Carnitine tert-Butyl Ester, CAS: 1058635-94-1, stock: 3.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₃₂ClNO₅.

(S)-(-)-O-Desmethyl Carvedilol, CAS: 123372-13-4, stock: 8.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₄N₂O₄.

(S)-Oxiran-2-ylmethyl Methanesulfonate, CAS: 67800-62-8, stock: 8.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈O₄S.

(2R)-3-Hydroxyisovaleroyl-d3 Carnitine, CAS: 1058636-00-2, stock: 8.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₀D₃NO₅.

1,3-Bis(9H-carbazol-4-yloxy)-2-propanol(Carvedilol Impurity), CAS: 1276477-91-8, stock: 1.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₂N₂O₃.

1-Amino-3-(9H-carbazol-4-yloxy)-2-propanol, CAS: 72955-96-5, stock: 2.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆N₂O₂.

(2R)-Oxiraneacetic Acid 1,1-Dimethylethyl Ester, CAS: /, stock: 4.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄O₃.

(3R)-3-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]hexadecanoic Acid Ethyl Ester, CAS: 245489-84-3, stock: 9.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₅₀O₃Si.

1-Amino-3-(9H-carbazol-4-yloxy)-2-propanol-d5, CAS: /, stock: 7.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁D₅N₂O₂.

1-Hydroxy Carvedilol, CAS: 146574-41-6, stock: 2.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₆N₂O₅.

(5Z,8Z)-Tetradecadienoylcarnitine, CAS: 1469901-01-6, stock: 9.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₇NO₄.

(5Z,8Z)-Tetradecadienoylcarnitine-13C3, CAS: /, stock: 9.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈¹³C₃H₃₇NO₄.

1-Hydroxy Carvedilol 1-O-β-D-Glucuronide, CAS: 131087-98-4, stock: 6.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₄N₂O₁₁.

1-Hydroxy Carvedilol-d3, CAS: /, stock: 4.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₃D₃N₂O₅.

(9Z)-3-Hydroxy-9-hexadecenoic Acid Ethyl Ester, CAS: /, stock: 6.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₄O₃.

(±)-Acetylcarnitine Chloride, CAS: 02/11/2504, stock: 2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₈NO₄⁺ • Cl ⁻.

1-Hydroxy Carvedilol-d3 1-O-β-D-Glucuronide, CAS: /, stock: 4.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₁D₃N₂O₁₁.

1-[Bis[2-(2-methoxyphenoxy)ethyl]amino]-3-(9H-carbazol-4-yloxy)-2-propanol, CAS: 1059573-45-3, stock: 2.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₆N₂O₆.

(±)-Hexanoylcarnitine Chloride, CAS: 6920-35-0, stock: 3.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₆NO₄⁺ • Cl ⁻.

(±)-Octanoylcarnitine Chloride, CAS: 18822-86-1, stock: 2.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₃₀NO₄⁺ • Cl ⁻.

(±)-Propionylcarnitine Chloride, CAS: 18828-58-5, stock: 4.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₀ClNO₄.

2-(2-Methoxyphenoxy)ethylamine Hydrochloride, CAS: 64464-07-9, stock: 4.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄ClNO₂.

(R)-Carprofen, CAS: 52263-83-9, stock: 5.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂ClNO₂.

(E)-2-Octenoyl-L-carnitine Inner Salt, CAS: 152064-94-3, stock: 7.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₇NO₄.

(E)-2-Octenoyl-L-carnitine Inner Salt-d3, CAS: /, stock: 4.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₄D₃NO₄.

2-(4-(Benzyloxy)-2-methoxyphenoxy)acetonitrile, CAS: /, stock: 5.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅NO₃.

2-(9H-Carbazol-4-yloxy)-ethenol, CAS: 1801551-41-6, stock: 2.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁NO₂.

(R)-Carprofen-D3, CAS: /, stock: 2.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₉D₃ClNO₂.

(S)-Carprofen, CAS: 52263-84-0, stock: 6.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂ClNO₂.

(E)-4-Bromocrotonic Acid, CAS: 13991-36-1, stock: 4.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅BrO₂.

(E)-Butenoyl Carnitine, CAS: /, stock: 4.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₉NO₄.

2’-O-Benzyloxy-2-O-desmethyl Carvedilol, CAS: 72955-92-1, stock: 8.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₀N₂O₄.

3-(9H-Carbazol-4-yloxy)-1,2-propanediol, CAS: 123119-89-1, stock: 7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅NO₃.

(S)-Carprofen-D3, CAS: /, stock: 1.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₉D₃ClNO₂.

1-(6-Chloro-9H-carbazol-2-yl)ethanone (Carprofen Impurity), CAS: 92841-22-0, stock: 8.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀ClNO.

(L)-Suberyl Carnitine Trifluoroacetic Acid Salt, CAS: /, stock: 3.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₈NO₆  •  x(C  ₂HF₃O₂).

(R)-3-Carboxy-2-hydroxy-N,N,N-trimethylpropan-1-aminium Chloride, CAS: 6645-46-1, stock: 5.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅NO₃ • HCl.

3-Amino-1,2-propandiol, CAS: 616-30-8, stock: 1.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₉NO₂.

3-Benzyloxy Carvedilol-d5 N-Carboxylic Acid tert-Butyl Ester, CAS: /, stock: 6.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₃₅D₅N₂O₇.

6-Chloro-β,β-dimethoxy-α-methyl-9H-carbazole-2-ethanol, CAS: 114041-35-9, stock: 4.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈ClNO₃.

9-Acetyl-6-chloro-2-(2-chloro-1-oxopropyl)-9H-carbazole, CAS: 114041-34-8, stock: 1.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₃Cl₂NO₂.

(R)-4-(Benzyloxy)-2-hydroxy-N,N,N-trimethyl-4-oxobutan-1-aminium Sulfate, CAS: /, stock: 7.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂NO₇S.

(R)-Amino Carnitine, CAS: 98063-21-9, stock: 8.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆N₂O₂.

3-Benzyloxy-2-bromo-9H-carbazole N-Carboxylic Acid tert-Butyl Ester, CAS: 1798043-12-5, stock: 8.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₂BrNO₃.

3-Benzyloxy-4-oxiranylmethyl-d5-9H-carbazole N-Carboxylic Acid tert-Butyl Ester, CAS: /, stock: 6.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₂D₅NO₄.

9H-Carbazole, CAS: 86-74-8, stock: 4.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉N.

9H-Carbazole 3-Oxoacetic Acid, CAS: 1094264-08-0, stock: 1.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₉NO₃.

(R)-Butyryl Carnitine Chloride, CAS: 162067-50-7, stock: 7.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₂ClNO₄.

(R)-Butyryl Carnitine-d3 Chloride, CAS: 1334532-21-6, stock: 6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₉D₃ClNO₄.

3-Benzyloxy-9H-carbazol-4-ol N-Carboxylic Acid tert-Butyl Ester, CAS: 1797817-81-2, stock: 8.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₃NO₄.

3-Benzyloxy-9H-carbazole N-Carboxylic Acid tert-Butyl Ester, CAS: 1796929-66-2, stock: 7.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₃NO₃.

Carprofen Ethyl Ester, CAS: 52262-89-2, stock: 2.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆ClNO₂.

Carprofen Glucuronide, CAS: 76319-13-6, stock: 9.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀ClNO₈.

(R)-Butyryl Carnitine-d5 Chloride, CAS: /, stock: 3.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇D₅ClNO₄.

(R)-Propionyl Carnitine Chloride, CAS: 119793-66-7, stock: 4.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₀ClNO₄.

3-Hydroxy Carvedilol, CAS: 146574-43-8, stock: 4.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₆N₂O₅.

3-Hydroxy Carvedilol-d5, CAS: 1329836-56-7, stock: 6.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₁D₅N₂O₅.

rac Carprofen, CAS: 53716-49-7, stock: 9.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂ClNO₂.

rac Carprofen-d3, CAS: 1173019-42-5, stock: 9.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₉D₃ClNO₂.

(R)-Propionyl Carnitine-d3 Chloride, CAS: 1334532-19-2, stock: 4.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇D₃ClNO₄.

(R)-Propionyl-d3 Carnitine Chloride, CAS: /, stock: 9.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇D₃ClNO₄.

4-(2,3-Epoxypropoxy)carbazole, CAS: 51997-51-4, stock: 8.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃NO₂.

4-(2,3-Epoxypropoxy-d5)carbazole, CAS: /, stock: 1.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₈D₅NO₂.

4-(Cyclopropylcarbonyl)-α,α-dimethylbenzeneacetic Acid Methyl Ester, CAS: 880088-78-8, stock: 4.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈O₃.

(S)-4-(Benzhydryloxy)-2-hydroxy-N,N,N-trimethyl-4-oxobutan-1-aminium Chloride, CAS: /, stock: 3.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆ClNO₃.

(S)-Amino Carnitine, CAS: 125377-87-9, stock: 2.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆N₂O₂.

4-​(2-​Oxiranylmethoxy)​-​9-​(2-​oxiranylmethyl)​-9H-​carbazole, CAS: 1198090-71-9, stock: 4.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇NO₃.

4-[1’-(3’-Amino-1’,2’-propanediol)]carbazole 2’-O-β-D-Glucuronide, CAS: /, stock: 7.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₄N₂O₈.

Carebastine, CAS: 90729-42-3, stock: 2.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₇NO₄.

Carebastine Methyl Ester, CAS: 189064-48-0, stock: 6.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₉NO₄.

(S)-Benzhydryl 4-(Dimethylamino)-3-hydroxybutanoate, CAS: /, stock: 3.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃NO₃.

(S)-Carnitine Isobutylester, Chloride Salt, CAS: 161886-61-9, stock: 2.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₄ClNO₃.

4-[1’-(3’-Azido-1’,2’-propanediol)]carbazole, CAS: 1253696-17-1, stock: 4.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄N₄O₂.

4-[1’-(3’-Azido-1’,2’-propanediol)]carbazole 2’-O-(Tri-O-benzoyl-β-D-Glucuronide Methyl Ester), CAS: /, stock: 4.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₃₆N₄O₁₁.

Carebastine-d5, CAS: 1189661-02-6, stock: 9.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₂D₅NO₄.

(S)-Carnitine Mesylate Isobutylester, Mesylate Salt, CAS: 161886-59-5, stock: 7.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₉NO₈S₂.

(S)-Carnitine Mesylate, Mesylate Salt, CAS: 161886-60-8, stock: 9.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₁NO₈S₂.

4-[1’-(3’-Azido-1’,2’-propanediol)]carbazole 2’-O-β-D-Glucuronide, CAS: /, stock: 8.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂N₄O₈.

4-[1’-(3’-Azido-1’,2’-propanediol)]carbazole β-D-Glucuronide Methyl Ester, CAS: /, stock: 8.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄N₄O₈.

Carebastine-d5 Methyl Ester, CAS: 1190019-51-2, stock: 1.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₄D₅NO₄.

(Z)-4-(Benzhydryloxy)-2-((3-((tert-butyldimethylsilyl)oxy)hexadec-9-enoyl)oxy)-N,N,N-trimethyl-4-oxobutan-1-aminium Chloride, CAS: /, stock: 7.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₆₈ClNO₅Si.

(Z)-4-(Benzhydryloxy)-2-((3-hydroxyhexadec-9-enoyl)oxy)-N,N,N-trimethyl-4-oxobutan-1-aminium Chloride, CAS: /, stock: 4.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₅₄ClNO₅.

4’-Benzyloxy Carvedilol, CAS: 887352-95-6, stock: 5.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₂N₂O₅.

4’-Hydroxyphenyl Carvedilol, CAS: 142227-49-4, stock: 1.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₆N₂O₅.

1-Hydroxy-N,N,N-trimethyl-3-oxopropan-1-aminium Bromide Benzoyl Ester, CAS: /, stock: 7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀BrNO₃.

2,6-Dimethylheptanoyl D,L-Carnitine, CAS: /, stock: 1.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₃₂ClNO₄.

4’-Hydroxyphenyl Carvedilol Hydrochloride, CAS: /, stock: 9.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₇ClN₂O₅.

4’-Hydroxyphenyl Carvedilol Sulfate Ammonium Salt, CAS: /, stock: 8.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₉N₃O₈S.

2,6-Dimethylheptanoyl D,L-Carnitine-d9, CAS: /, stock: 1.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃D₉ClNO₄.

2-Methylbutyryl-L-Carnitine Chloride(Mixture of Diastereomers), CAS: /, stock: 4.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₄ClNO₄.

4’-Hydroxyphenyl Carvedilol-d3, CAS: 1189675-28-2, stock: 9.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₃D₃N₂O₅.

5-(2-Aminoethoxy)-3-methoxyphenol, CAS: 1076198-81-6, stock: 9.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃NO₃.

2-Methylbutyryl-L-Carnitine-d3 Chloride, CAS: /, stock: 9.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₁D₃ClNO₄.

2-Methylbutyryl-L-Carnitine-d9 Chloride, CAS: /, stock: 8.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅D₉ClNO₄.

5-(Hydroxymethyl)-3-[2-(2-methoxyphenoxy)ethyl]-2-oxazolidinone, CAS: 1798014-64-8, stock: 6.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₅.

5-(Oxiranylmethoxy)-2,3,4,9-tetrahydrocarbazole, CAS: 58457-32-2, stock: 3.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇NO₂.

3-(Phenylmethoxy)-octadecanoic Acid, CAS: /, stock: 2.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₂O₃.

5-Hydroxy-2,3,4,9-tetrahydrocarbazole, CAS: 35618-96-3, stock: 6.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃NO.

5’-Benzyloxy Carvedilol, CAS: 887353-00-6, stock: 9.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₂N₂O₅.

3-Carboxy-N,N,N-trimethyl-2-[(1-oxo-2-hexen-1-yl)oxy]-1-propanaminium Inner Salt, CAS: 99452-58-1, stock: 6.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₃NO₄.

5’-Hydroxyphenyl Carvedilol, CAS: 142227-51-8, stock: 8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₆N₂O₅.

5’-Hydroxyphenyl Carvedilol Sulfate Ammonium Salt, CAS: /, stock: 1.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₉N₃O₈S.

3-Carboxy-N.N,N-trimethyl-2-oxo-1-propanaminium Chloride, CAS: 94291-69-7, stock: 2.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄ClNO₃.

3-Hydromyristoyl Carnitine Inner Salt, CAS: 282523-64-2, stock: 2.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₄₁NO₅.

5’-Hydroxyphenyl Carvedilol-d5, CAS: 1189704-21-9, stock: 7.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₁D₅N₂O₅.

6,7,8,9-Tetrahydro Carvedilol, CAS: 1246820-73-4, stock: 7.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₀N₂O₄.

3-Hydromyristoyl Carnitine Inner Salt-d3, CAS: /, stock: 3.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₈D₃NO₅.

3-Hydroxy-9-hexadecenoyl-L-carnitine, CAS: /, stock: 1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₄₃NO₅.

8-Hydroxy Carvedilol, CAS: 159426-95-6, stock: 7.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₆N₂O₅.

8-Hydroxy Carvedilol 8-O-β-D-Glucuronide, CAS: 131087-99-5, stock: 6.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₄N₂O₁₁.

3-Hydroxy-9-hexadecenoyl-L-carnitine-d3, CAS: /, stock: 5.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₄₀D₃NO₅.

3-Hydroxy-cis-5-tetradecenoylcarnitine Inner Salt, CAS: /, stock: 5.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₉NO₅.

8-Hydroxy Carvedilol-d3, CAS: /, stock: 2.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₃D₃N₂O₅.

8-Hydroxy Carvedilol-d3 8-O-β-D-Glucuronide, CAS: /, stock: 4.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₁D₃N₂O₁₁.

3-Hydroxybutyrylcarnitine Chloride, CAS: /, stock: 6.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₂ClNO₅.

3-Hydroxybutyrylcarnitine-d3 Chloride, CAS: /, stock: 8.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₉D₃ClNO₅.

Bis(O-(N-benzyl-N-(1,1-dimethylethoxy)carbonyl-ethylamine)) Catechol, CAS: 1391054-05-9, stock: 7.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₄₄N₂O₆.

Bis(O-(N-benzyl-N-(1,1-dimethylethoxy)carbonyl-ethylamine)) Catechol, CAS: 1391053-19-2, stock: 1.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂N₂O₆.

3-Hydroxydecanoyl (R)-Carnitine Inner Salt (Mixture of Diastereomers), CAS: 1245943-08-1, stock: 3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₃NO₅.

3-Hydroxydodecanoyl (R)-Carnitine Inner Salt (Mixture of Diastereomers), CAS: 287716-52-3, stock: 3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₇NO₅.

Carvedilol, CAS: 72956-09-3, stock: 5.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₆N₂O₄.

3-Hydroxyheptanoyl Carnitine Chloride, CAS: /, stock: 2.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₈ClNO₅.

3-Hydroxyhexadecanoic Acid Ethyl Ester, CAS: 105918-27-2, stock: 1.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₆O₃.

Carvedilol Bis(N-benzylalkylpyrocatechol) Impurity, CAS: 1391054-59-3, stock: 5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₄H₅₄N₄O₆.

Carvedilol Bis-carbazole, CAS: 918903-20-5, stock: 8.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₃₉N₃O₆.

3-Hydroxyhexadecanoyl-d3-carnitine Chloride, CAS: /, stock: 9.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₄₃D₃ClNO₅.

3-Hydroxyhexadecanoylcarnitine Inner Salt (Mixture of Diastereomers), CAS: 195207-76-2, stock: 2.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₄₅NO₅.

Carvedilol Bisalkylpyrocatechol Impurity, CAS: 1346602-98-9, stock: 1.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₄₂N₄O₆.

Carvedilol β-D-Glucuronide (mixture of diasteromers), CAS: 114869-83-9, stock: 5.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₄N₂O₁₀.

3-Hydroxyhexadecanoylcarnitine-d3, CAS: /, stock: 3.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₄₂D₃NO₅.

3-Hydroxyoctanoyl (R)-Carnitine Inner Salt (Mixture of Diastereomers), CAS: 875668-60-3, stock: 5.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₉NO₅.

Carvedilol Ketone Hydrochloride, CAS: /, stock: 2.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₄N₂O₄ • (HCl).

Carvedilol Monoalkylpyrocatechol Hydrochloride, CAS: /, stock: 3.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₉N₃O₄ • (HCl).

3-Hydroxyoleyl-d3-carnitine Chloride, CAS: /, stock: 8.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₅D₃ClNO₅.

3-Hydroxyoleylcarnitine(Mixture of Diastereomers), CAS: 851132-91-7, stock: 9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₇NO₅.

Carvedilol N-β-D-Glucuronide, CAS: 216973-69-2, stock: 2.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₄N₂O₁₀.

Carvedilol N’-2-Hydroxy-3-[[2-(methoxyphenoxy)ethyl]amine, CAS: 1076199-79-5, stock: 4.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₄₃N₃O₇.

3-Hydroxyoleylcarnitine-d3, CAS: /, stock: 5.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₄D₃NO₅.

3-Hydroxystearoylcarnitine Hydrochloride, CAS: /, stock: 9.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₅₀ClNO₅.

Carvedilol N’-Carbamate β-D-Glucopyranuronic Acid, CAS: 216973-68-1, stock: 4.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₄N₂O₁₂.

Carvedilol N’-β-D-Glucuronide, CAS: 216973-70-5, stock: 8.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₄N₂O₁₀.

3-Hydroxystearoylcarnitine-d3 Hydrochloride, CAS: /, stock: 6.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₇D₃ClNO₅.

3-Methylcrotonyl L-Carnitine Chloride, CAS: /, stock: 4.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂ClNO₄.

Carvedilol Tetra(alkylpyrocatechol) Impurity, CAS: 1391052-20-2, stock: 9.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇₀H₆₈N₆O₁₀.

Carvedilol-d3, CAS: 1020719-25-8, stock: 1.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₃D₃N₂O₄.

3-Methylglutarylcarnitine, CAS: 102673-95-0, stock: 9.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₃NO₆.

3-Methylglutarylcarnitine Chloride, CAS: 821794-55-2, stock: 3.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₄ClNO₆.

Carvedilol-d3 N-β-D-Glucuronide, CAS: /, stock: 6.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₁D₃N₂O₁₀.

Carvedilol-d3 N’-Carbamate β-D-Glucopyranuronic Acid, CAS: /, stock: 4.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₁D₃N₂O₁₂.

Carbimazole, CAS: 22232-54-8, stock: 8.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀N₂O₂S.

3-tert-Butyldimethylsilyloxyoleyl Carnitine 4-Methoxybenzyl Ester, CAS: /, stock: 7.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₆₈ClNO₅Si.

3-tert-Butyldimethylsilyloxyoleyl Carnitine Ester (Mixture of Chloride and Bromide Salts), CAS: /, stock: 3.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₆₂NO₅Si  Br/Cl.

Carvedilol-d5, CAS: 929106-58-1, stock: 7.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₁D₅N₂O₄.

Carvedilol-d5 N’-β-D-Glucuronide, CAS: /, stock: 1.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₉D₅N₂O₁₀.

Carbimazole-d3, CAS: /, stock: 3.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇D₃N₂O₂S.

3-tert-Butyldimethylsilyloxyoleyl O-(Methoxymethoxy)carnitine Ester Chloride Salt, CAS: /, stock: 8.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₆₆ClNO₆Si.

3S-Hydroxy-N6,N6,N6-trimethyl-L-lysine Chloride, CAS: /, stock: 4.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₁ClN₂O₃.

Carvedilol-N-β-D-Lactose, CAS: /, stock: 6.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₄₆N₂O₁₄.

Decarbazolyl Carvedilol, CAS: 10461-27-5, stock: 9.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₉NO₄.

4,8-Dimethylnonanoyl-CoA, CAS: 204120-61-6, stock: 9.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₅₆N₇O₁₇P₃S.

Decarbazolyl Carvedilol-d4, CAS: /, stock: 4.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅D₄NO₄.

Decarbazolyl Desmethyl Carvedilol, CAS: 114849-42-2, stock: 9.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇NO₄.

4-cis-Decenoylcarnitine, CAS: 1256380-16-1, stock: 6.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₁NO₄.

4-cis-Decenoylcarnitine-13C3, CAS: /, stock: 7.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄¹³C₃H₃₁NO₄.

Decarbazolyl Desmethyl Carvedilol-d4, CAS: /, stock: 7.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃D₄NO₄.

Keto Carvedilol Hydrochloride, CAS: /, stock: 4.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₅ClN₂O₄.

4-cis-Decenoylcarnitine-d9, CAS: /, stock: 6.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂D₉NO₄.

Keto Carvedilol-d3 Hydrochloride, CAS: /, stock: 3.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₂D₃ClN₂O₄.

N-2-Hydroxy-3-[[2-(methoxyphenoxy)ethyl]amine Carvedilol, CAS: 1198090-73-1, stock: 1.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₄₃N₃O₇.

4-Ethoxy-N,N,N-trimethyl-2,4-dioxo-1-butanaminium, CAS: 10485-47-9, stock: 1.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₈NO₃.

4-Ethoxy-N,N,N-trimethyl-2,4-dioxo-1-butanaminium Chloride, CAS: 10485-23-1, stock: 4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₈ClNO₃.

N-2-Hydroxy-3-[[2-(methoxyphenoxy)ethyl]amine Carvedilol-d5, CAS: /, stock: 9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₃₈D₅N₃O₇.

N-Benzyl 6,7,8,9-Tetrahydro Carvedilol, CAS: 1329616-22-9, stock: 5.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₆N₂O₄.

4-Hydroxy-L-(+)-2-phenylglycine, CAS: 32462-30-9, stock: 6.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₃.

4-Hydroxybutyryl-L-carnitine, CAS: 107870-81-5, stock: 7.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₁NO₅.

N-Benzyl Carvedilol, CAS: 72955-94-3, stock: 5.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₂N₂O₄.

N-Benzyl Carvedilol-d5, CAS: 1329792-68-8, stock: 7.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₂₇D₅N₂O₄.

4-Hydroxybutyryl-L-carnitine-13C3, CAS: /, stock: 8.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³C₃H₂₁NO₅.

4-O-Benzyl 3-Hydroxybenzyl-stearoylcarnitine Chloride, CAS: /, stock: 3.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₆₂ClNO₅.

N-Formyl Carvedilol, CAS: /, stock: 8.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₆N₂O₅.

N-Isopropyl Carvedilol, CAS: 1246819-01-1, stock: 3.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₂N₂O₄.

5-cis-Tetradecenoyl Carnitine, CAS: 1186416-86-3, stock: 4.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₉NO₄.

5-cis-Tetradecenoyl Carnitine-d3 Chloride, CAS: /, stock: 5.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₇D₃ClNO₄.

N-Isopropyl Carvedilol-d6, CAS: 1246815-40-6, stock: 1.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₆D₆N₂O₄.

N-Methyl Carvedilol Hydrochloride, CAS: 1346599-33-4, stock: 5.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₉ClN₂O₄.

5-cis-Tetradecenoyl-d3 Carnitine, CAS: /, stock: 6.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₆D₃NO₄.

Acetyl L-Carnitine Hydrochloride, CAS: 5080-50-2, stock: 5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₈ClNO₄.

N-Methyl Carvedilol-d3 Hydrochloride Salt, CAS: 1794766-62-3, stock: 4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₆D₃ClN₂O₄.

N-[2-(2-Methoxyphenoxy)ethyl]benzoylamine, CAS: 1323864-93-2, stock: 7.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇NO₃.

Acetyl L-Carnitine-13C3 Chloride, CAS: /, stock: 2.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³C₃H₁₇ClNO₄.

Acetyl L-Carnitine-d3 Hydrochloride, CAS: 1334532-17-0, stock: 10g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅D₃ClNO₄.

N-[2-(o-Methoxyphenoxy)ethyl]phthalimide, CAS: 26646-63-9, stock: 5.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₅NO₄.

Acetyl-d3 L-Carnitine Hydrochloride, CAS: 362049-62-5, stock: 6.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅D₃ClNO₄.

Adipoyl-L-carnitine Trifluoroacetate, CAS: /, stock: 7.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₃NO₆  •C₂HF₃O₂.

N-[2-(o-Methoxyphenoxy)ethyl]phthalimide-d3, CAS: /, stock: 3.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₂D₃NO₄.

N2-Methyl Carvedilol, CAS: 72956-35-5, stock: 1.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₈N₂O₄.

Adipoyl-L-carnitine-d3 Trifluoroacetate, CAS: /, stock: 7.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀D₃NO₆ •C₂HF₃O₂.

Arachidonoyl-L-carnitine-d3, CAS: /, stock: 8.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₂D₃NO₄.

O-Desmethyl Carvedilol, CAS: 72956-44-6, stock: 9.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₄N₂O₄.

O-Desmethyl Carvedilol β-D-Glucuronide, CAS: 142227-50-7, stock: 6.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₂N₂O₁₀.

Bovine CROT (Peroxisomal carnitine O-octanoyltransferase) ELISA Kit (96T), CAS: /, stock: 5.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Carnitine Methoxymethyl Ester Chloride Salt, CAS: /, stock: 8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₀ClNO₄.

O-Desmethyl Carvedilol-d5, CAS: 1794817-24-5, stock: 6.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₉D₅N₂O₄.

O-Desmethyl Carvedilol-d5 β-D-Glucuronide, CAS: /, stock: 9.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₇D₅N₂O₁₀.

Carnitine Orotate, CAS: 32543-38-7, stock: 8.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₉N₃O₇.

cis-5-Dodecenoyl Carnitine Inner Salt, CAS: /, stock: 3.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₅NO₄.

Phenyl N-methylphenylcarvedilol, CAS: /, stock: 8.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₃₆N₂O₄.

[3-(9H-Carbazol-4-yloxy)-2-hydroxy]propyl Carvedilol, CAS: 1391052-16-6, stock: 4.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₃₉N₃O₆.

cis-5-Dodecenoyl Carnitine Inner Salt-d3, CAS: /, stock: 3.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₂D₃NO₄.

cis-9-Hexadecenoylcarnitine Inner Salt, CAS: 329321-94-0, stock: 8.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₄₃NO₄.

cis-9-Hexadecenoylcarnitine Inner Salt-d3, CAS: /, stock: 3.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₄₀D₃NO₄.

Crotonobetaine Hydrochloride, CAS: 6538-82-5, stock: 9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄ClNO₂.

Crotonobetaine Hydrochloride-d9, CAS: /, stock: 3.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅D₉ClNO₂.

D,L Carnitine-d9 Chloride, CAS: 1219386-75-0, stock: 2.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇D₉ClNO₃.

D,L-Carnitine Chloride, CAS: 461-05-2, stock: 5.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆ClNO₃.

D,L-Carnitine-d3 Chloride, CAS: 119766-67-5, stock: 9.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃D₃ClNO₃.

D-Carnitine, CAS: 541-14-0, stock: 8.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅NO₃.

Decanoyl-10,10,10,d3-L-carnitine Chloride, CAS: 1297271-50-1, stock: 7.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₁D₃ClNO₄.

Decanoyl-L-carnitine Chloride, CAS: 369651-88-7, stock: 9.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₄ClNO₄.

Decanoyl-L-carnitine-d3 Chloride, CAS: /, stock: 3.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₁D₃ClNO₄.

Dimethyl Trimethylsilyl Phosphite, CAS: 36198-87-5, stock: 6.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₅O₃PSi.

DL-Carnitine, CAS: 406-76-8, stock: 5.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅NO₃.

DL-Carnitine Benzyl Ester Chloride, CAS: 16224-32-1, stock: 4.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂ClNO₃.

DL-Carnitine Hydrochloride, CAS: 461-05-2, stock: 3.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆N⁺O₃ . Cl ⁻.

DL-Lauroylcarnitine Chloride, CAS: 14919-37-0, stock: 5.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₈ClNO₄.

Ethyl 3-(Benzyloxy)octadecanoate, CAS: /, stock: 5.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆O₃.

1-(2-(Benzyloxy)-5-(2-(tert-butylamino)acetyl)phenyl)urea-d9 Hydrochloride, CAS: /, stock: 1.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₇D₉ClN₃O₃.

Ethyl 3-Hydroxyoctadecanoate, CAS: 65144-03-8, stock: 8.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₄₀O₃.

Ethyl 6-Bromohexanoate, CAS: 25542-62-5, stock: 9.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅BrO₂.

1-(5-(2-(Benzyl(tert-butyl)amino)acetyl)-2-(benzyloxy)phenyl)urea Hydrochloride, CAS: 34270-93-4, stock: 1.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₄ClN₃O₅.

Carbuterol Hemisulfate Salt, CAS: /, stock: 3.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₂ClN₃O₃ • 1/2 H₂SO₄.

Hexadecanedioic Acid Mono-L-carnitine Ester Chloride, CAS: 42150-38-9, stock: 7.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₄₄ClNO₆.

Hexadecanedioic Acid Mono-L-carnitine-d3 Ester Chloride, CAS: /, stock: 5.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₄₁D₃ClNO₆.

Carbuterol-d9 Hemisulfate Salt, CAS: 1346747-24-7, stock: 5.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂D₉N₃O₃  • 1/2 H ₂SO₄.

Hexanoyl-d3-L-carnitine Chloride, CAS: /, stock: 2.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₃D₃ClNO₄.

Hexanoyl-L-carnitine Chloride, CAS: 162067-53-0, stock: 8.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₆ClNO₄.

N-[5-Acetyl-2-(phenylmethoxy)phenyl]urea, CAS: 34241-97-9, stock: 4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆N₂O₃.

Hexanoyl-L-carnitine-(N-methyl-d3) Chloride, CAS: /, stock: 2.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₃D₃ClNO₄.

Human CPT1A(Carnitine O-palmitoyltransferase 1, liver isoform) ELISA Kit (96T), CAS: /, stock: 3.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human SLC25A20(Mitochondrial carnitine/acylcarnitine carrier protein) ELISA Kit (96T), CAS: /, stock: 2.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Isobutyryl L-Carnitine Chloride, CAS: 6920-31-6, stock: 2.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₂ClNO₄.

Isobutyryl L-Carnitine-d6 Chloride, CAS: /, stock: 6.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆D₆ClNO₄.

Isopentyl Carnitine Inner Salt, CAS: 256928-63-9, stock: 2.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₁NO₄.

Isopentyl Carnitine Inner Salt-d3, CAS: /, stock: 9.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈D₃NO₄.

Isovaleryl L-Carnitine Chloride, CAS: 139144-12-0, stock: 7.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₄ClNO₄.

Isovaleryl L-Carnitine-d3 Chloride, CAS: /, stock: 1.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₁D₃ClNO₄.

Isovaleryl L-Carnitine-d9 Chloride, CAS: 1334532-23-8, stock: 5.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅D₉ClNO₄.

β-Ketopalmitoyl-L-carnitine Perchlorate, CAS: /, stock: 5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₆NO₅⁺•ClO₄⁻.

γ-Butyrobetaine Hydrochloride, CAS: 6249-56-5, stock: 7.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆ClNO₂.

γ-Butyrobetaine-d9, CAS: 479677-53-7, stock: 6.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆D₉NO₂.

γ-Butyrobetaine-d9 Hydrochloride, CAS: 85806-17-3, stock: 1.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇D₉ClNO₂.

L-​Palmitoyl Carnitine, CAS: 2364-67-2, stock: 8.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₄₅NO₄.

L-Carnitine, CAS: 541-15-1, stock: 7.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅NO₃.

L-Carnitine Orotate, CAS: 160468-17-7, stock: 8.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆NO₃ •C₅H₃N₂O₄.

L-Carnitine-13C Chloride, CAS: /, stock: 1.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³CH₁₆ClNO₃.

L-Carnitine-d3 Chloride, CAS: 350818-62-1, stock: 2.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃D₃ClNO₃.

L-Carnitine-d9, CAS: 126827-79-0, stock: 6.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆D₉NO₃.

L-Carnitine-d9 Chloride, CAS: /, stock: 4.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇D₉ClNO₃.

L-Carnitine-L-tartrate, CAS: 36687-82-8, stock: 1.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅NO₃ • 1/2C ₄H₆O₆.

L-Glutaryl Carnitine Chloride, CAS: /, stock: 2.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂ClNO₆.

L-Glutaryl Carnitine-d6 Chloride, CAS: /, stock: 3.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆D₆ClNO₆.

L-Glutaryl Carnitine-d9 Chloride, CAS: /, stock: 9.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃D₉ClNO₆.

1,3-bis((1r,4R)-4-(2-(4-(2,3-Dichlorophenyl)piperazin-1-yl)ethyl)cyclohexyl)urea, CAS: /, stock: 7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₅₂Cl₄N₆O.

Lauroyl Chloride-d3, CAS: /, stock: 7.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₀D₃ClO.

Cariprazine, CAS: 839712-12-8, stock: 1.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₂Cl₂N₄O.

Cariprazine (N,N-Dimethyl-d3) Hydrochloride, CAS: /, stock: 4.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆D₆Cl₂N₄O  •HCl.

Lauroyl-d3-L-carnitine Hydrochloride, CAS: 1297271-52-3, stock: 5.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₅D₃ClNO₄.

Lauroyl-L-carnitine Hydrochloride, CAS: 6919-91-1, stock: 2.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₈ClNO₄.

Cariprazine-d8, CAS: 1308278-69-4, stock: 9.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₄D₈Cl₂N₄O.

Lauroyl-L-carnitine-d3 Hydrochloride, CAS: /, stock: 1.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₅D₃ClNO₄.

Linoleoyl Carnitine, CAS: 36816-10-1, stock: 7.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₅NO₄.

Desmethyl Cariprazine Hydrochloride, CAS: 1231947-91-3, stock: 6.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀Cl₂N₄O  •xHCl.

Didesmethyl Cariprazine Hydrochloride, CAS: 1231947-92-4, stock: 5.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₈Cl₂N₄O  •xHCl.

Linoleoyl Carnitine (N-methyl-D3), CAS: /, stock: 9.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₂D₃NO₄.

Malonyl-L-carnitine Trifluoroacetate, CAS: /, stock: 4.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈F₃NO₈.

Hydroxy Cariprazine, CAS: 1084891-95-1, stock: 4.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₂Cl₂N₄O₂.

Hydroxy Cariprazine Glucuronide, CAS: /, stock: 4.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₀Cl₂N₄O₈.

Malonyl-L-carnitine(N,N,N-tri-13C-methyl) Trifluoroacetate, CAS: /, stock: 9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇¹³C₃H₁₈NO₆⁺• C₂F₃O₂⁻.

Malonyl-L-carnitine-13C3, CAS: /, stock: 7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇¹³C₃H₁₇NO₆.

Hydroxy Cariprazine Sulfate, CAS: /, stock: 3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₁Cl₂N₄O₅S⁻.

Hydroxy Desmethyl Cariprazine Glucuronide, CAS: /, stock: 4.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₈Cl₂N₄O₈.

Malonyl-L-carnitine-d3 Trifluoroacetate, CAS: /, stock: 4.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅D₃F₃NO₈.

MCPA-L-carnitine (Mixture of Diastereomers), CAS: /, stock: 8.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₁NO₄.

Hydroxy Didesmethyl Cariprazine Gluconoride, CAS: /, stock: 8.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₆Cl₂N₄O₈.

MCPA-L-carnitine-d9 Chloride (Mixture of Diastereomers), CAS: /, stock: 5.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃D₉ClNO₄.

Methanesulfonic Anhydride, CAS: 03/01/7143, stock: 6.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₆O₅S₂.

trans-1-(Boc-amino)-4-(2-hydroxyethyl)cyclohexane, CAS: 917342-29-1, stock: 7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₅NO₃.

trans-2-[4-[(tert-Butoxycarbonyl)amino]cyclohexyl]acetic Acid Methyl Ester, CAS: 215789-45-0, stock: 6.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₅NO₄.

Methylmalonyl DL-Carnitine Chloride (Mixture of Diastereomers), CAS: 821794-54-1, stock: 3.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₀ClNO₆.

Methylmalonyl DL-Carnitine-d3 Chloride (Mixture of Diastereomers), CAS: /, stock: 2.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇D₃ClNO₆.

trans-4-[2-[4-(2,3-Dichlorophenyl)piperazin-1-yl]ethyl]cyclohexanamine, CAS: 791778-53-5, stock: 2.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₇Cl₂N₃.

trans-N-[4-[2-[4-(2,3-Dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]carbamic Acid Isopropyl Ester, CAS: 1231947-90-2, stock: 7.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₃Cl₂N₃O₂.

Mouse Crat (Carnitine O-acetyltransferase) ELISA Kit (96T), CAS: /, stock: 2.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Crot (Peroxisomal carnitine O-octanoyltransferase) ELISA Kit (96T), CAS: /, stock: 8.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Myristoyl-L-carnitine Hydrochloride, CAS: 173686-73-2, stock: 4.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₄₂ClNO₄.

Myristoyl-L-carnitine-13C3 Hydrochloride, CAS: /, stock: 9.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈¹³C₃H₄₂ClNO₄.

Myristoyl-L-carnitine-d3 Hydrochloride, CAS: 1334532-25-0, stock: 6.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₉D₃ClNO₄.

N,N,N-Trimethyl-2-oxo-1-propanaminium Chloride, CAS: 54541-46-7, stock: 7.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄ClNO.

N-(5-Fluoresceinyl)-L-carnitine-O-thiocarbamate, CAS: 1258239-73-4, stock: 7.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₆N₂O₈S.

n-Butyltriphenylphosphonium Bromide, CAS: 1779-51-7, stock: 3.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄BrP.

N-Heptanoylglycine, CAS: 23783-23-5, stock: 5.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇NO₃.

N-Pivaloylglycine, CAS: 23891-96-5, stock: 9.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃NO₃.

O-3-Hydroxybutyryl Carnitine(N,N,N-tri-13C-methyl) Chloride, CAS: /, stock: 7.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³C₃H₂₂ClNO₅.

O-5-cis-Tetradecenoyl Carnitine(N,N,N-tri-13C-methyl) Inner Salt, CAS: /, stock: 3.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈¹³C₃H₃₉NO₄.

O-TBS 9-Hexadecenoic Acid Ethyl Ester, CAS: /, stock: 6.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₈O₃Si.

O-TBS Hexadec-9-enoic acid, CAS: /, stock: 8.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₄₄O₃Si.

Octadecanedioic Acid Mono-L-carnitine Ester Chloride, CAS: 123233-50-1, stock: 7.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₈ClNO₆.

Octadecanedioic Acid Mono-L-carnitine-d3 Ester Chloride, CAS: /, stock: 8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₅D₃ClNO₆.

Octanoyl L-Carnitine Chloride, CAS: 54377-02-5, stock: 7.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₃₀ClNO₄.

Octanoyl L-Carnitine-d3 Chloride, CAS: 1334532-24-9, stock: 1.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₇D₃ClNO₄.

Oleoyl-L-carnitine, CAS: 38677-66-6, stock: 6.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₇NO₄.

Oleoyl-L-carnitine Chloride, CAS: 31062-78-9, stock: 4.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₈O₄NCl.

Oleoyl-L-carnitine-13C3, CAS: /, stock: 3.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂¹³C₃H₄₇NO₄.

Oleoyl-L-carnitine-d3 Hydrochloride, CAS: /, stock: 7.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₅D₃ClNO₄.

Oleoyl-L-carnitine-d3 Inner Salt, CAS: /, stock: 8.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₄D₃NO₄.

Palmitoyl-16,16,16-d3-L-carnitine Hydrochloride, CAS: /, stock: 4.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₄₃D₃ClNO₄.

Palmitoyl-DL-carnitine chloride, CAS: 6865-14-1, stock: 8.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₄₆ClNO₄.

Palmitoyl-L-carnitine Hydrochloride, CAS: 18877-64-0, stock: 3.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₄₆ClNO₄.

Palmitoyl-L-carnitine-13C3 Hydrochloride, CAS: /, stock: 4.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀¹³C₃H₄₆ClNO₄.

Palmitoyl-L-carnitine-13C3 Hydrochloride, CAS: /, stock: 3.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀¹³C₃H₄₅ClNO₄.

Palmitoyl-L-carnitine-d3 Hydrochloride, CAS: 1334532-26-1, stock: 1.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₄₃D₃ClNO₄.

R-(+)-Etomoxir, CAS: 124083-20-1, stock: 4.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₃ClO₄.

R-Stearoyl Carnitine Chloride, CAS: 32350-57-5, stock: 5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₅₀ClNO₄.

rac Octanoyl Carnitine Chloride, CAS: 14919-35-8, stock: 7.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₃₀ClNO₄.

rac- Etomoxir, CAS: 82258-36-4, stock: 6.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₃ClO₄.

Rat Cpt1a(Carnitine O-palmitoyltransferase 1, liver isoform) ELISA Kit (96T), CAS: /, stock: 8.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat Crot (Peroxisomal carnitine O-octanoyltransferase) ELISA Kit (96T), CAS: /, stock: 1.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat Slc25a20(Mitochondrial carnitine/acylcarnitine carrier protein) ELISA Kit (96T), CAS: /, stock: 3.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

S-(-)-Etomoxir, CAS: 828934-40-3, stock: 9.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₃ClO₄.

Stearoyl-L-carnitine-13C3 Chloride, CAS: /, stock: 2.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂¹³C₃H₅₀ClNO₄.

Stearoyl-L-carnitine-d3 Hydrochloride, CAS: /, stock: 8.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₇D₃ClNO₄.

Succinyl Carnitine Chloride Salt, CAS: 8217914-56-3, stock: 2.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₉NO₆Cl.

Succinyl-L-carnitine-13C3 Chloride, CAS: /, stock: 8.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³C₃H₂₀ClNO₆.

tert-Butyldiphenylsilyloxy Carnitine Chloride Salt, CAS: /, stock: 5.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₃₀ClNO₃Si.

Tetradeca-2,4-dien-oyl Carnitine, CAS: /, stock: 1.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₇NO₄.

Tetradeca-2,4-dien-oyl Carnitine (N,N,N-tri-13C3-methyl), CAS: /, stock: 5.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈¹³C₃H₃₇NO₄.

Thionicotinamide Adenine Dinucleotide, CAS: 4090-29-3, stock: 6.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₇N₇O₁₃P₂S.

Tiglylcarnitine Hydrochloride, CAS: /, stock: 1.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂ClNO₄.

Tiglylcarnitine-d3, CAS: /, stock: 1.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈D₃NO₄.

Trimethylamine (~25 wt. % solution in methanol), CAS: 75-50-3, stock: 1.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₉N.

Valeryl-L-carnitine Chloride, CAS: 162040-64-4, stock: 4.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₃ClNO₄.

Valeryl-L-carnitine Chloride-13C3, CAS: /, stock: 6.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉¹³C₃H₂₃ClNO₄.

[(3R)-3-Hydroxydodecanoyl]-L-carnitine-d3 Inner Salt, CAS: /, stock: 4.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₄D₃NO₅.

[(3R)-3-Hydroxyhexadecanoyl]-L-carnitine-d3 Inner Salt, CAS: /, stock: 9.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₄₂D₃NO₅.

[(3R)-3-Hydroxyhexanoyl]-L-carnitine-d3 Inner Salt, CAS: /, stock: 9.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₂D₃NO₅.

[(3R)-3-Hydroxyoctadecanoyl]-L-carnitine-d3 Inner Salt, CAS: /, stock: 5.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₆D₃NO₅.

[3-(Carboxybenzhydryl)-2 3-[3-(tert-Butyldimethylsilyloxy)prop-1-yl]dimethyl Trideuterio Methyl Ammonium Iodide, CAS: /, stock: 4.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₆₅D₃INO₅Si.

(1E,2E)-1,2-Bis(1-(6-bromobenzo[d][1,3]dioxol-5-yl)propan-2-ylidene)hydrazine, CAS: /, stock: 3.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈Br₂N₂O₄.

(2S)-2-Hydrazino-3-(3-hydroxy-4-methoxyphenyl)-2-methylpropanoic Acid, CAS: 1361017-74-4, stock: 2.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂O₄.

(S)-(-)-Carbidopa, CAS: 28860-95-9, stock: 9.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂O₄.

(S)-(-)-Carbidopa-d5, CAS: 1426174-03-9, stock: 9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉ D₅N₂O₄.

(S)-Carbidopa Methyl Ester, CAS: 52514-63-3, stock: 8.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂O₄.

(S)-Carbidopa Methyl Ester N-Cyclohexylidene, CAS: 934371-48-9, stock: 3.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₄N₂O₄.

(S)-Carbidopa Methyl-d3 Ester N-cyclohexylidene, CAS: /, stock: 8.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁D₃N₂O₄.

1-(2-Bromo-4-hydroxy-5-methoxyphenyl)-2-propanone, CAS: 1017083-10-1, stock: 2.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁BrO₃.

1-(3-Bromo-4-hydroxy-5-methoxyphenyl)-2-propanone, CAS: 205826-79-5, stock: 6.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁BrO₃.

1-(6-Bromo-1,3-benzodioxol-5-yl)-2-propanone, CAS: 43197-28-0, stock: 4.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉BrO₃.

2-(1-(3-Bromo-4-hydroxy-5-methoxyphenyl)propan-2-ylidene)hydrazinecarboxylic Acid tert-Butyl Ester, CAS: /, stock: 9.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁BrN₂O₄.

2-Amino-3-(3-bromo-4-hydroxy-5-methoxyphenyl)-2-methylpropanenitrile, CAS: 2092269-25-3, stock: 8.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃BrN₂O₂.

2-Bromo (S)-Carbidopa, CAS: 43197-33-7, stock: 5.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃BrN₂O₄.

2-Bromo Carbidopa, CAS: 1246817-47-9, stock: 3.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃BrN₂O₄.

2-Bromo-6-methoxy-4-(2-nitro-1-propenyl)phenol, CAS: 312510-64-8, stock: 4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀BrNO₄.

2-Hydrazinyl-3-(3-hydroxy-4-methoxyphenyl)-2-methylpropanenitrile, CAS: /, stock: 7.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅N₃O₂.

3,4-Dimethoxyphenylacetone, CAS: 776-99-8, stock: 8.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄O₃.

3,5-Bis((6-bromobenzo[d][1,3]dioxol-5-yl)methyl)-5-methyl-4,5-dihydro-1H-pyrazole, CAS: /, stock: 4.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈Br₂N₂O₄.

3-(2-Bromo-4-hydroxy-5-methoxyphenyl)-2-hydrazinyl-2-methylpropanenitrile, CAS: /, stock: 6.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄BrN₃O₂.

3-(3,4-Dihydroxyphenyl)-2-methylpropanoic Acid Ethyl Ester, CAS: /, stock: 6.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O₄.

3-(3-Boryl-4,5-dimethoxyphenyl)-2-methyl-2-ureidopropanoic Acid, CAS: /, stock: 5.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉BN₂O₅.

3-(3-Bromo-4-hydroxy-5-methoxyphenyl)-2-hydrazinyl-2-methylpropanamide, CAS: /, stock: 4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆BrN₃O₃.

3-(3-Bromo-4-hydroxy-5-methoxyphenyl)-2-hydrazinyl-2-methylpropanenitrile, CAS: /, stock: 8.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄BrN₃O₂.

3-(3-Bromo-4-hydroxy-5-methoxyphenyl)-2-hydrazinyl-2-methylpropanoic Acid, CAS: /, stock: 1.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅BrN₂O₄.

3-Bromo-5-methoxy-α-methyltyrosine Hydrochloride, CAS: /, stock: 3.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅BrClNO₄.

3-Hydroxy-α-methyl-tyrosine Methyl Ester, CAS: 158190-23-9, stock: 5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₄.

3-O-Methyl Carbidopa, CAS: 85933-19-3, stock: 3.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂O₄.

3-O-Methyl Carbidopa-d5, CAS: 1794810-91-5, stock: 3.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁D₅N₂O₄.

3’,4’-Dihydroxyphenylacetone, CAS: 2503-44-8, stock: 7.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀O₃.

4-O-Methyl-d3-carbidopa, CAS: /, stock: 7.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃D₃N₂O₄.

4-O-Methylcarbidopa, CAS: /, stock: 2.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂O₄.

5-Bromo-2-methoxy-4-(2-nitroprop-1-en-1-yl)phenol, CAS: /, stock: 8.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀BrNO₄.

Ammonium Carbonate, CAS: 506-87-6, stock: 7.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  CH₈N₂O₃.

Carbidopa 4-Phosphate Trihydrate, CAS: 1907686-07-0, stock: 1.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅N₂O₇P•3(H₂O).

Carbidopa Ethyl Ester Hydrochloride Salt, CAS: 96115-88-7, stock: 1.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₉ClN₂O₄.

Carbidopa Methyl Ester, CAS: 91431-01-5, stock: 6.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂O₄.

D,L- Carbidopa-d5, CAS: 1185134-76-2, stock: 1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉D₅N₂O₄.

D,L-Carbidopa, CAS: 302-53-4, stock: 1.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂O₄.

D,L-Carbidopa Methyl Ester N-Cyclohexylidene, CAS: /, stock: 9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₄N₂O₄.

D-α-Hydrazino-α-methyl-β-(3,4-dihydroxyphenyl)propionic Acid (Mixture of Diasteromers), CAS: /, stock: 6.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₅N₃O₄.

α-Methyl-3,4-dihydroxyphenylpropionic Acid, CAS: 53832-94-3, stock: 2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₄.

L-Carbidopa-3’, 4’-Diphosphate, CAS: 1907685-82-8, stock: 1.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆N₂O₁₀P₂.

R-(+)-Carbidopa, CAS: 28875-92-5, stock: 6.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂O₄.

R-(+)-Carbidopa-d5, CAS: /, stock: 2.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉D₅N₂O₄.

S-(-)-Carbidopa-d3, CAS: 1276732-89-8, stock: 3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁D₃N₂O₄.

(2R)-2-Amino-4-methyl-1-[(2R)-2-methyloxiran-2-yl]pentan-1-one Trifluoroacetate Salt, CAS: /, stock: 5.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₈F₃NO₄.

(2R,4S)-4-((t-Butoxycarbonyl)amino)-1,2-dihydroxy-2,6-dimethyl-3-oxohepan-4-tyl, CAS: 1541172-78-4, stock: 9.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₇NO₅.

(2R,4S)-4-((t-Butoxycarbonyl)amino)-2-hydroxy-2,6-dimethyl-3-oxoheptyl Acetate, CAS: /, stock: 5.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₉NO₆.

(2S)-2-Amino-4-methyl-1-[(2R)-2-methyloxiranyl]-1-pentanone Trifluoroacetate, CAS: 247068-85-5, stock: 7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₈F₃NO₄.

(2S,4R)-4-((t-Butoxycarbonyl)amino)-1,2-dihydroxy-2,6-dimethyl-3-oxohepan-4-tyl, CAS: /, stock: 8.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₇NO₅.

(2S,4R)-4-((t-Butoxycarbonyl)amino)-2-hydroxy-2,6-dimethyl-3-oxoheptyl Acetate, CAS: /, stock: 7.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₉NO₆.

(2S,4R)-4-((t-Butoxycarbonyl)amino)-2-hydroxy-2,6-dimethyl-3-oxoheptyl Acetate Trifluoroacetate Salt, CAS: /, stock: 6.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₁NO₄ • (C ₂HF₃O₂).

(2S,4S)-4-((t-Butoxycarbonyl)amino)-2-hydroxy-2,6-dimethyl-3-oxoheptyl Acetate, CAS: /, stock: 1.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₉NO₆.

(2S,4S)-4-Amino-2-hydroxy-2,6-dimethyl-3-oxoheptyl Acetate Trifluoroacetic Acid Salt, CAS: /, stock: 9.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₁NO₄ • x(C ₂HF₃O₂).

(4S)-4-Amino-2,6-dimethyl-1-hepten-3-one 2,2,2-Trifluoroacetate, CAS: 1619233-32-7, stock: 9.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₈F₃NO₃.

(αS)-α-Aminobenzenebutanoyl-L-leucyl-L-phenylalanine Methyl Ester Mono(trifluoroacetate), CAS: 868539-99-5, stock: 3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₆F₃N₃O₆.

(R)-2-Amino-4-methyl-1-((S)-2-methyloxiran-2-yl)pentan-1-one Trifluoroacetate Salt, CAS: /, stock: 6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₈F₃NO₄.

(R)-t-Butyl (2,6-Dimethyl-3-oxohept-1-en-4-yl)carbamate, CAS: /, stock: 7.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₅NO₃.

(R)-t-Butyl 2-((4-methyl-1-(1-methylcyclopropyl)-1-oxopentan-2-yl)amino)acetate, CAS: /, stock: 2.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₇NO₃.

(S)-2-((S)-4-Methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanoic Acid, CAS: 868540-16-3, stock: 4.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₄₂N₄O₆.

(S)-2-Amino-4-methyl-1-((S)-2-methyloxiran-2-yl)pentan-1-one Trifluoroacetate Salt, CAS: 1528769-14-3, stock: 1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₈F₃NO₄.

4-​Amino-​1,​2-​anhydro-​4,​5,​6,​7-​tetradeoxy-​5-​methyl-​2-​C-​methyl-L-​ribo-​3-​heptulose 2,​2,​2-​Trifluoroacetate, CAS: 1800500-63-3, stock: 3.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇NO₂ • C ₂HF₃O₂.

4-Morpholineacetic Acid Hydrochloride, CAS: 89531-58-8, stock: 4.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂ClNO₃.

Carfilzomib, CAS: 868540-17-4, stock: 6.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₅₇N₅O₇.

Carfilzomib (2R,4R)-Diol, CAS: /, stock: 3.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₅₉N₅O₈.

Carfilzomib (2R,4S)-Diol, CAS: 1541172-75-1, stock: 7.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₅₉N₅O₈.

Carfilzomib (2S,4R)-1,2-Hydroxy-O-acetate, CAS: /, stock: 6.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₆₁N₅O₉.

Carfilzomib (2S,4R)-Diol, CAS: /, stock: 6.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₅₉N₅O₈.

Carfilzomib (2S,4S)-Diol, CAS: /, stock: 3.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₅₉N₅O₈.

Carfilzomib (2S,4S)-Diol Hydrochloride, CAS: /, stock: 3.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₅₉N₅O₈ • HCl.

Carfilzomib-d8, CAS: 1537187-53-3, stock: 2.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₄₉D₈N₅O₇.

N-​[(1R)​-​1-​[(Methoxymethylamino​)​carbonyl]​-​3-​methylbutyl]​-carbamic Acid 1,​1-​Dimethylethyl Ester, CAS: 129603-01-6, stock: 9.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₆N₂O₄.

N-[(1S)-1-[(Dimethylamino)carbonyl]-3-methylbutyl]-carbamic Acid 1,1-Dimethylethyl Ester, CAS: 72080-89-8, stock: 4.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₆N₂O₃.

N-[(1S)-2-Hydroxy-3-methyl-1-(2-methylpropyl)-3-buten-1-yl]-carbamic Acid 1,1-Dimethylethyl Ester, CAS: 1609959-45-6, stock: 9.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇N₅O₂.

rac-N-​[(1R)​-​2-​Hydroxy-​3-​methyl-​1-​(2-​methylpropyl)​-​3-​buten-​1-​yl]​-​carbamic Acid 1,​1-​Dimethylethyl Ester, CAS: /, stock: 8.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₇NO₃.

sec-Butyl 2-Bromoacetate, CAS: 5205-36-7, stock: 9.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁BrO₂.

tert-Butyl ((S)-2,6-Dimethyl-3-oxohept-1-en-4-yl)carbamate, CAS: 247068-81-1, stock: 8.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₅NO₃.

tert-Butyl ((S)-4-Methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)carbamate, CAS: 247068-82-2, stock: 4.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₅NO₄.

Carbazochrome, CAS: 69-81-8, stock: 4.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₄O₃.

Carbazochrome Sodium Sulfonate Hydrate, CAS: 51460-26-5, stock: 8.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁N₄NaO₅S•x(H₂O).

Carbazochrome-d3, CAS: /, stock: 4.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉D₃N₄O₃.

(S)-2-Aminooctanoic Acid, CAS: 116783-26-7, stock: 3.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₇NO₂.

1-Octanoyl-rac-glycerol, CAS: 502-54-5, stock: 7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₂O₄.

1-Octanoyl-rac-glycerol, CAS: 19670-49-6, stock: 2.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₂O₄.

1-Octanoyl-rac-glycerol-d5, CAS: 1794835-68-9, stock: 3.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇D₅O₄.

2-Butyloctanoic Acid, CAS: 27610-92-0, stock: 6.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₄O₂.

2-Hydroxycaprylic Acid, CAS: 617-73-2, stock: 4.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆O₃.

3-Hydroxyoctanoic Acid, CAS: 14292-27-4, stock: 2.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆O₃.

3-Hydroxyoctanoic Acid-d12, CAS: 1215622-76-6, stock: 3.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₄D₁₂O₃.

4-Oxooctanoic Acid, CAS: 4316-44-3, stock: 3.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄O₃.

6-Methylheptanoic Acid, CAS: 929-10-2, stock: 2.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆O₂.

6-Methylheptanoic Acid Ethyl Ester, CAS: 62337-58-0, stock: 6.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₀O₂.

6-Methylheptanoic Acid Ethyl-d5 Ester, CAS: /, stock: 9.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅D₅O₂.

6-Methylheptanoic Acid Methyl Ester, CAS: 2519-37-1, stock: 2.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₈O₂.

6-Methylheptanoic Acid Methyl-d3 Ester, CAS: /, stock: 6.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅D₃O₂.

6-Methyloctanoic Acid, CAS: 504-99-4, stock: 2.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₈O₂.

8-Bromooctanoic Acid, CAS: 17696-11-6, stock: 8.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅BrO₂.

8-Hydroxyoctanoic Acid, CAS: 764-89-6, stock: 7.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆O₃.

Cholesterol Caprylate, CAS: 1182-42-9, stock: 6.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₆₀O₂.

DL-2-Aminocaprylic Acid, CAS: 644-90-6, stock: 5.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₇NO₂.

Ethyl 8-Bromooctanoate, CAS: 29823-21-0, stock: 6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₉BrO₂.

Ethyl Octanoate, CAS: 106-32-1, stock: 7.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₀O₂.

Ethyl Octanoate-d15, CAS: 1219798-38-5, stock: 9.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₅D₁₅O₂.

Ethyl-d5 Octanoate, CAS: /, stock: 7.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅D₅O₂.

Hircinoic Acid, CAS: 54947-74-9, stock: 9.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₈O₂.

Methyl 9-Oxononanoate (90%), CAS: 1931-63-1, stock: 1.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈O₃.

Methyl Octanoate, CAS: 111-11-5, stock: 1.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₈O₂.

Methyl-d3 Octanoate, CAS: /, stock: 3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅D₃O₂.

Octanoic Acid, CAS: 124-07-2, stock: 4.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆O₂.

Octanoic Acid-13C4, CAS: /, stock: 3.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₄H₁₆O₂.

Perfluorooctanoic Acid, CAS: 335-67-1, stock: 8.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈HF₁₅O₂.

Perfluorooctanoic Acid (50μg/mL in Methanol), CAS: 335-67-1, stock: 8.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈HF₁₅O₂.

Tricaprylin, CAS: 538-23-8, stock: 1.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₅₀O₆.

(E)-2-Bromo-2’-nitro-4’-methoxystilbene, CAS: 223787-47-1, stock: 2.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂BrNO₃.

(R)-10-Monohydroxy-10,11-dihydro Carbamazepine, CAS: 104746-03-4, stock: 1.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄N₂O₂.

(R)-10-Monohydroxy-10,11-dihydro Carbamazepine O-β-D-Glucuronide Sodium Salt, CAS: 104746-01-2, stock: 8.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁N₂NaO₈.

(R)-10-Monohydroxy-10,11-dihydro Carbamazepine-d3, CAS: /, stock: 5.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁D₃N₂O₂.

(R)-Licarbazepine Acetate, CAS: 186694-45-1, stock: 7.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆N₂O₃.

(R)-Licarbazepine Acetate-d3, CAS: /, stock: 5.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₃D₃N₂O₃.

(S)-10-Monohydroxy-10,11-dihydro Carbamazepine(Eslicarbazepine), CAS: 104746-04-5, stock: 5.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄N₂O₂.

(S)-10-Monohydroxy-10,11-dihydro Carbamazepine O-β-D-Glucuronide Sodium Salt, CAS: /, stock: 6.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁N₂NaO₈.

(S)-10-Monohydroxy-10,11-dihydro Carbamazepine-D3(Eslicarbazepine-D3), CAS: /, stock: 3.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁D₃N₂O₂.

10,11-Dichloro-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide, CAS: 59690-98-1, stock: 3.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂Cl₂N₂O.

10,11-Dihydro Carbamazepine, CAS: 3564-73-6, stock: 2.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄N₂O.

10,11-Dihydro-10,11-dihydroxy Carbamazepine D4, CAS: /, stock: 6.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₈D₄N₂O₃.

10,11-Dihydro-10-hydroxy Carbamazepine, CAS: 29331-92-8, stock: 6.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄N₂O₂.

10,11-Dihydro-10-hydroxy Carbamazepine O-β-D-Glucuronide Sodium Salt(Mixture of Diastereomers), CAS: /, stock: 4.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁N₂NaO₈.

10,11-Dihydro-10-hydroxy Carbamazepine-d3, CAS: 1189917-36-9, stock: 7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁D₃N₂O₂.

10,11-Dihydro-10-hydroxy Carbamazepine-D4 (Major), CAS: 1020719-39-4, stock: 8.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀D₄N₂O₂.

10-Acetyloxy Oxcarbazepine, CAS: 113952-21-9, stock: 4.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄N₂O₄.

10-Bromo Oxcarbazepine, CAS: 113952-20-8, stock: 7.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁BrN₂O₂.

10-Bromo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carbonyl Bromide, CAS: /, stock: 1.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁Br₂NO.

10-Bromo-5H-dibenzo[b,f]azepine-5-carboxamide, CAS: 59690-97-0, stock: 5.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁BrN₂O.

10-Chloro Carbamazepine, CAS: 59690-92-5, stock: 6.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁ClN₂O.

10-Methoxy Carbamazepine, CAS: 28721-09-7, stock: 3.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄N₂O₂.

11-Keto Oxcarbazepine, CAS: 537693-29-1, stock: 2.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀N₂O₃.

11-oxo-6,11-Dihydro-5H-dibenzo[b,e]azepine-5-carboxamide, CAS: /, stock: 4.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂N₂O₂.

2,2’-Dinitrodibenzyl, CAS: 16968-19-7, stock: 5.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂N₂O₄.

2,3-Bis(acetyloxy)-butanedioic Acid Mono[(10R)-5-(aminocarbonyl)-10,11-dihydro-5H-dibenz[b,f]azepin-10-yl] Ester, CAS: /, stock: 1.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₂N₂O₉.

2-((Triisopropylsilyl)oxy)-5H-dibenzo[b,f]azepine, CAS: /, stock: 3.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₁NOSi.

2-((Triisopropylsilyl)oxy)-5H-dibenzo[b,f]azepine-5-carboxamide, CAS: /, stock: 7.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₂N₂O₂Si.

2-Hydroxy Carbamazepine, CAS: 68011-66-5, stock: 7.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂N₂O₂.

2-Hydroxy Carbamazepine β-D-Glucuronide, CAS: /, stock: 1.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀N₂O₈.

2-Methyl Carbamazepine, CAS: 70401-32-0, stock: 3.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄N₂O.

2-Methyl-5H-dibenzazepine, CAS: 70401-31-9, stock: 5.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃N.

3-((tert-Butyldimethylsilyl)oxy)-5H-dibenzo[b,f]azepine, CAS: /, stock: 3.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅NOSi.

3-Chloroiminodibenzyl, CAS: 32943-25-2, stock: 6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂ClN.

3-Hydroxy Carbamazepine, CAS: 68011-67-6, stock: 5.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂N₂O₂.

3-Hydroxy Carbamazepine β-D-Glucuronide, CAS: /, stock: 3.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀N₂O₈.

3-Hydroxy Carbamazepine tert-Butyldimethylsilyl Ether, CAS: /, stock: 4.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆N₂O₂Si.

3-Methoxy Iminostilbene, CAS: 92483-74-4, stock: 4.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃NO.

5-Acetyl-10,11-dihydro-5H-dibenzo[b,f]azepine, CAS: 13080-75-6, stock: 5.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅NO.

5H-Dibenz[b,f]azepin-2-ol, CAS: 81861-18-9, stock: 6.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁NO.

6-Methoxy-1-phenyl-1H-indole, CAS: 487058-34-4, stock: 8.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃NO.

Carbamazepine, CAS: 298-46-4, stock: 6.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂N₂O.

Carbamazepine 10,11-Epoxide, CAS: 36507-30-9, stock: 5.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂N₂O₂.

Carbamazepine 10,11-Epoxide-d2 (Major), CAS: 1185025-41-5, stock: 3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀D₂N₂O₂.

Carbamazepine 10,11-Epoxide-d8 (Major), CAS: /, stock: 9.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₄D₈N₂O₂.

Carbamazepine-D10, CAS: 132183-78-9, stock: 6.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂D₁₀N₂O.

Carbamazepine-d2 (Major), CAS: 1189902-21-3, stock: 5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀D₂N₂O.

Carbamazepine-d2,15N, CAS: /, stock: 4.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀D₂N¹⁵NO.

Carbamazepine-d8(Major), CAS: /, stock: 5.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₄D₈N₂O.

cis-10,11-Dihydroxy-10,11-dihydrocarbamazepine, CAS: 58955-94-5, stock: 9.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄N₂O₃.

Cyheptamide, CAS: 7199-29-3, stock: 6.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅NO.

Eslicarbazepine Acetate, CAS: 236395-14-5, stock: 1.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆N₂O₃.

Iminodibenzyl 5-Carbonyl Chloride, CAS: 33948-19-5, stock: 8.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂ClNO.

Iminodibenzyl 5-Carbonyl Chloride-d10, CAS: /, stock: 7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄D₁₀ClNO.

Iminodibenzyl-d10, CAS: /, stock: 2.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅D₁₀N.

Iminostilbene, CAS: 256-96-2, stock: 8.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁N.

Iminostilbene 10,11-Epoxide-N-carbonyl Chloride, CAS: 41359-09-5, stock: 5.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀ClNO₂.

Iminostilbene N-Carbonyl Chloride, CAS: 33948-22-0, stock: 9.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀ClNO.

Iminostilbene N-Carbonyl Chloride-d8 (Major), CAS: /, stock: 7.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂D₈ClNO.

Iminostilbene-10,11-dihydrodiol, CAS: 56211-73-5, stock: 6.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃NO₂.

N-Carbamoyl Carbamazepine, CAS: 1219170-51-0, stock: 7.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃N₃O₂.

N-Carbamoyl Oxcarbazepine, CAS: /, stock: 8.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃N₃O₃.

N-Nitroso Iminostilbene, CAS: 38652-29-8, stock: 3.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀N₂O.

Oxcarbazepine, CAS: 28721-07-5, stock: 6.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂N₂O₂.

Oxcarbazepine-D4 (Major), CAS: 1020719-71-4, stock: 7.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₈D₄N₂O₂.

rac trans-10,11-Dihydro-10,11-dihydroxy Carbamazepine, CAS: 58955-93-4, stock: 2.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄N₂O₃.

11α-Hydroxy Canrenone, CAS: 192569-17-8, stock: 7.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈O₄.

3,5β-Dihydroxy-tetrahydro Canrenone Lactol (Mixture of Diastereomers), CAS: /, stock: 10g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₆O₄.

3-Hydroxy-6,7-dihydro Canrenone Lactol (Mixture of Diastereomers), CAS: /, stock: 7.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₄O₃.

5β-Hydroxy-tetrahydro Canrenone, CAS: /, stock: 1.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₂O₄.

5β-Hydroxy-tetrahydro Canrenone Lactol, CAS: /, stock: 7.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₄O₄.

6,7-Dihydro Canrenone Lactol, CAS: 52520-27-1, stock: 2.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₂O₃.

6,7-Dihydrocanrenone, CAS: 976-70-5, stock: 1.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₀O₃.

6,7-Dihydrocanrenone-d4, CAS: /, stock: 4.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆D₄O₃.

7-Carboxy-9(11)Δ-canrenone(Mixture of diastereomers), CAS: /, stock: 8.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈O₅.

(1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-2,3-dicarboxylic Acid 2-(1,1-Dimethylethyl) 3-ethyl Ester, CAS: 214193-11-0, stock: 6.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₁NO₄.

Canrenone, CAS: 976-71-6, stock: 1.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈O₃.

Canrenone-d6 (Major), CAS: /, stock: 6.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂D₆O₃.

(2R)-3-Acetylthio-2-methylpropionyl Chloride, CAS: 74345-73-6, stock: 3.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉ClO₂S.

(2S)​-​1-​(2-​methylpropanoyl)​pyrrolidine-​2-​carboxylic Acid, CAS: 23500-15-4, stock: 4.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅NO₃.

Δ9,11-7β-Eplerenone, CAS: /, stock: 2.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₀O₅.

Δ9,11-Eplerenone, CAS: 95716-70-4, stock: 2.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₀O₅.

(R)-1-(3-Bromo-2-methyl-1-oxopropyl)-L-proline, CAS: 80629-36-3, stock: 8.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄BrNO₃.

(S)-(-)-3-(Benzoylthio)-2-methylpropanoic Acid, CAS: 72679-02-8, stock: 3.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₃S.

Δ9-Canrenone, CAS: 95716-71-5, stock: 7.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆O₃.

(S)-1-Boc-2,3-dihydro-2-pyrrolecarboxylic Acid, CAS: 178172-26-4, stock: 6.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₉NO₄.

Mexrenone, CAS: 41020-65-9, stock: 7.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₂O₅.

(S)-S-Benzoylcaptopril, CAS: 75107-57-2, stock: 1.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉NO₄S.

(S)-S-Benzoylcaptopril-d3, CAS: /, stock: 7.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆D₃NO₄S.

1-[(2R)-3-Hydroxy-2-methyl-1-oxopropyl]-L-proline, CAS: 613256-52-3, stock: 4.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅NO₄.

1-[(2S)-3-Bromo-2-methyl-1-oxopropyl]-L-proline, CAS: 80629-35-2, stock: 1.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄BrNO₃.

1-[(2S)-3-Bromo-2-methyl-1-oxopropyl]-L-proline N-Cyclohexylcyclohexanamine, CAS: 1275614-30-6, stock: 6.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄BrNO₃ •C₁₂H₂₃N.

1-[(S)-3-(Acetylthio)isobutyryl]-L-proline Hydrate, CAS: /, stock: 4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇NO₄S.

3-Acetylthio-2-methylpropionic Acid, CAS: 33325-40-5, stock: 1.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀O₃S.

3-Mercapto-2-methylpropanoic Acid, CAS: 26473-47-2, stock: 3.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈O₂S.

Captopril, CAS: 62571-86-2, stock: 8.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅NO₃S.

Captopril Disulfide, CAS: 64806-05-9, stock: 1.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₈N₂O₆S₂.

Captopril-cysteine Disulfide, CAS: 75479-46-8, stock: 6.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₀N₂O₅S₂.

Captopril-d3, CAS: 1356383-38-4, stock: 6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂D₃NO₃S.

Captopril-N-acetylcysteine Disulfide, CAS: 78636-31-4, stock: 9.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂N₂O₆S₂.

Epicaptopril, CAS: 63250-36-2, stock: 9.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅NO₃S.

rac-3-Acetylthio-2-methylpropionyl Chloride-d5, CAS: /, stock: 4.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄D₅ClO₂S.

S-(Pentafluoro-6-methylbenzene) Captopril, CAS: /, stock: 3.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆F₅NO₄S.

S-(Pentafluoro-6-methylbenzene) Captopril (Proline-2,5,5-d3), CAS: /, stock: 8.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₃D₃F₅NO₄S.

S-Nitrosocaptopril, CAS: 122130-63-6, stock: 1.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄N₂O₄S.

S-[3-(2,5,6-Trimethyl)bimanyl] Captopril, CAS: /, stock: 6.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₅N₃O₅S.

S-[3-(2,5,6-Trimethyl)bimanyl] Captopril (Proline 2,5,5-d3), CAS: /, stock: 5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂D₃N₃O₅S.

S-[3-(N-(Ethyl-d5)maleimide)] Captopril, CAS: /, stock: 6.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇D₅N₂O₅S.

S-[3-(N-Ethylmaleimide)] Captopril, CAS: 185804-96-0, stock: 3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂N₂O₅S.

2’,3’-Di-O-acetyl-5’-deoxy-5-fluoro-N4-(pentoxycarbonxyl)cytidine, CAS: 162204-20-8, stock: 7.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₆FN₃O₈.

2’,3’-Di-O-acetyl-5’-deoxy-5-fluorocytidine, CAS: 161599-46-8, stock: 3.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆FN₃O₆.

2’-O-(5’-Deoxy-β-D-ribofuranosyl) Capecitabine, CAS: 1262133-66-3, stock: 9.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀FN₃O₉.

2’-O-(5’-Deoxy-β-D-ribofuranosyl) Capecitabine-d11, CAS: /, stock: 5.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₉D₁₁FN₃O₉.

2’-O-(5’’-Deoxy-2’’,3’’-diacetyl-β-D-ribofuranosyl) Capecitabine 3’-O-Benzoate, CAS: /, stock: 8.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₈FN₃O₁₂.

3’-O-(5’-Deoxy-α-D-ribofuranosyl) Capecitabine, CAS: 1262133-68-5, stock: 4.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀FN₃O₉.

3’-O-(5’-Deoxy-β-D-ribofuranosyl) Capecitabine, CAS: 1262133-64-1, stock: 9.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀FN₃O₉.

4-Amino-5-fluoro-1-(2,3-di-O-acetyl-α-D-ribofuranosyl)-2(1H)-pyrimidinone, CAS: /, stock: 7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆FN₃O₆.

4-Amino-5-fluoro-1-(α-D-ribofuranosyl)-2(1H)-pyrimidinone, CAS: /, stock: 5.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂FN₃O₄.

5-Deoxy-2,3-O-(1-methylethylidene)-D-ribofuranoside Methyl Ether, CAS: 78341-97-6, stock: 6.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆O₄.

5-Deoxy-D-ribose, CAS: 13039-75-3, stock: 1.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₄.

5’-Deoxy-5-fluoro Cytidine, CAS: 66335-38-4, stock: 1.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂FN₃O₄.

5’-Deoxy-5-fluoro-2’,3’-O-(1-methylethylidene)-1-α-D-ribosylcytosine, CAS: /, stock: 8.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆FN₃O₄.

5’-Deoxy-5-fluoro-N-[(2-methylbutoxy)carbonyl]cytidine, CAS: 910129-15-6, stock: 8.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂FN₃O₆.

5’-Deoxy-5-fluoro-N-[(3-methylbutoxy)carbonyl]cytidine, CAS: 162204-30-0, stock: 2.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂FN₃O₆.

5’-Deoxy-5-fluorocytidine-13C,15N2, CAS: /, stock: 1.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³CH₁₂FN¹⁵N₂O₄.

5’-Deoxy-5-fluorouridine, CAS: 05/09/3094, stock: 4.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁FN₂O₅.

5’-Deoxyfluorouridine-13C,15N2, CAS: /, stock: 1.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³CH₁₁F¹⁵N₂O₅.

Capecitabine, CAS: 154361-50-9, stock: 1.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂FN₃O₆.

Capecitabine Benzoate (mixture of 2’(3’)-benzoate isomers), CAS: /, stock: 1.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆FN₃O₇.

Capecitabine Impurity M, CAS: /, stock: 9.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄FN₃O₆.

Capecitabine-2’,3’-cyclic Carbonate, CAS: 921769-65-5, stock: 4.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀FN₃O₇.

Capecitabine-d11, CAS: 1132662-08-8, stock: 9.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁D₁₁FN₃O₆.

Cholestyramine (Technical Grade), CAS: 11041-12-6, stock: 9.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  (C₂₆H₄₀ClN)n.

Cinobufotalin, CAS: 1108-68-5, stock: 7.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₄O₇.

Cinobufotalin-d3, CAS: /, stock: 8.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₁D₃O₇.

Doxifluridine, CAS: 05/09/3094, stock: 4.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁FN₂O₅.

Doxifluridine-13C5, CAS: /, stock: 9.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₅H₁₁FN₂O₅.

α-Capecitabine, CAS: /, stock: 2.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂FN₃O₆.

α-Capecitabine-d11, CAS: /, stock: 1.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁D₁₁FN₃O₆.

N-Carbamoyl-2-fluoro-β-alanine, CAS: 5006-64-4, stock: 9.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇FN₂O₃.

N-Carbamoyl-2-fluoro-β-alanine-13C3, CAS: 1216798-07-0, stock: 4.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C¹³C₃H₇FN₂O₃.

n-Pentyl Chloroformate, CAS: 638-41-5, stock: 7.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁ClO₂.

(+)-(2S,5R)-1-Allyl-2,5-dimethylpiperazine, (+)-Camphoric Acid Salt, CAS: 186094-00-8, stock: 7.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₄N₂O₄.

(+)-10-Camphorsulfonimine, CAS: 107869-45-4, stock: 3.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅NO₂S.

(+)-3-(Trifluoroacetyl)camphor, CAS: 51800-98-7, stock: 5.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅F₃O₂.

(+)-3-Bromo-8-camphorsulfonic Acid, CAS: 5344-58-1, stock: 2.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅BrO₄S.

(+)-3-Bromocamphor, CAS: 10293-06-8, stock: 7.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅BrO.

(+)-Juniper Camphor, CAS: 473-04-1, stock: 5.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₆O.

(+)-[(8,8-Dichlorocamphoryl)sulfonyl]oxaziridine, CAS: 127184-05-8, stock: 7.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃Cl₂NO₃S.

(+/-)-Fenchone-D6, CAS: /, stock: 2.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀D₆O.

(-)-2-Methyl Isoborneol, CAS: 68330-43-8, stock: 7.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₀O.

(-)-2-Methyl Isoborneol-d3, CAS: 135441-89-3, stock: 9.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇D₃O.

(-)-Borneol, CAS: 464-45-9, stock: 5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈O.

(-)-[(8,8-Dichlorocamphoryl)sulfonyl]oxaziridine, CAS: 139628-16-3, stock: 8.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃Cl₂NO₃S.

(1R)-(+)-(10-Camphorsulfonyl)imine, CAS: 107869-45-4, stock: 1.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅NO₂S.

(1R)-(+)-2,10-Camphorsultam, CAS: 108448-77-7, stock: 9.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇NO₂S.

(1R)-(-)-(10-Camphorsulfonyl)oxaziridine, CAS: 104372-31-8, stock: 4.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅NO₃S.

(1R)-(-)-10-Camphorsulfonamide, CAS: 72597-34-3, stock: 6.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇NO₃S.

(1R)-(-)-10-Camphorsulfonic Acid, CAS: 35963-20-3, stock: 7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆O₄S.

(1R)-(-)-10-Camphorsulfonyl Chloride, CAS: 39262-22-1, stock: 1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅ClO₃S.

(1R)-(-)Camphorquinone, CAS: 10334-26-6, stock: 4.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄O₂.

(1R)-3-endo-Aminocamphor Hydrochloride, CAS: 31638-54-7, stock: 5.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇NO•HCl.

(1R,3S)-Camphoric Acid, CAS: 124-83-4, stock: 1.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆O₄.

(1R,4S)-Camphorquinone Monooxime, CAS: 22472-58-8, stock: 5.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅NO₂.

(1S)-(+)-(10-Camphorsulfonyl)oxaziridine, CAS: 104322-63-6, stock: 3.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅NO₃S.

(1S)-(+)-10-Camphorsulfonamide, CAS: 60933-63-3, stock: 5.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇NO₃S.

(2S,4S)-4-Methylglutamic Acid, CAS: 6141-27-1, stock: 8.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁NO₄.

(1S)-(+)-10-Camphorsulfonic Acid, CAS: 3144-16-9, stock: 3.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆O₄S.

(6E)-8-Methyl-6-nonenoic Acid, CAS: 59320-77-3, stock: 3.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈O₂.

(6E)-8-Methyl-6-nonenoic Acid Ethyl Ester, CAS: 75335-54-5, stock: 2.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₂.

(1S)-(+)-10-Camphorsulfonic Acid Ethyl Ester, CAS: 154335-57-6, stock: 1.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₀O₄S.

(1S)-(+)-10-Camphorsulfonyl Chloride, CAS: 21286-54-4, stock: 9.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅ClO₃S.

(6E)-8-Methyl-6-nonenoic Acid Ethyl Ester-d5, CAS: /, stock: 1.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇D₅O₂.

(6E)-8-Methyl-6-nonenoic Acid Methyl Ester, CAS: 112375-54-9, stock: 6.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₀O₂.

(1S)-(+)-Camphorquinone, CAS: 2767-84-2, stock: 8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄O₂.

(1S)-(-)-(10-Camphorsulfonyl)imine, CAS: 60886-80-8, stock: 4.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅NO₂S.

(6E)-8-Methyl-6-nonenoic Acid Methyl Ester-d3, CAS: /, stock: 9.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇D₃O₂.

(6Z)-8-Methyl-6-nonenoic Acid (up to 10% trans isomer), CAS: 31467-60-4, stock: 7.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈O₂.

(1S)-(-)-(7,7-Dichloro-10-camphorsulfonyl)imine, CAS: 127184-04-7, stock: 4.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃Cl₂NO₂S.

(1S)-Camphorsultam, CAS: 94594-90-8, stock: 3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇NO₂S.

(6Z)-8-Methyl-6-nonenoic Acid Ethyl Ester, CAS: 1025371-44-1, stock: 6.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₂.

(6Z)-8-Methyl-6-nonenoic Acid Ethyl Ester-d5, CAS: /, stock: 8.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇D₅O₂.

(1S,3R)-Camphoric Acid, CAS: 560-09-8, stock: 8.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆O₄.

(1S,4S)-1,7,7-Trimethylbicyclo[2.2.1]heptan-2-one, CAS: 464-48-2, stock: 5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆O.

(6Z)-8-Methyl-6-nonenoic Acid Methyl Ester, CAS: 112375-42-5, stock: 4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₀O₂.

(6Z)-8-Methyl-6-nonenoic Acid Methyl Ester-d3, CAS: /, stock: 9.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇D₃O₂.

(3R,11bR)-Tetrabenazine (1S)-(+)-10-Camphorsulfonate, CAS: 1223399-57-2, stock: 1.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₃NO₇S.

(±)-Camphor, CAS: 76-22-2, stock: 9.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆O.

1-Monoelaidin, CAS: 2716-53-2, stock: 1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₄₀O₄.

1-Monoelaidin-d5, CAS: /, stock: 6.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₅D₅O₄.

(±)-Camphor-d6, CAS: /, stock: 7.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀D₆O.

(±)-Juniper Camphor, CAS: 75363-78-9, stock: 6.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₆O.

16,17-Dehydro Capsaicin, CAS: 509101-57-9, stock: 8.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₅NO₃.

16,17-Dehydro Capsaicin-d3, CAS: 1346606-76-5, stock: 5.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₂D₃NO₃.

(±)-Juniper Camphor-D6, CAS: /, stock: 6.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀D₆O.

(R)-(+)-Camphor, CAS: 464-49-3, stock: 6.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆O.

16-Hydroxy Capsaicin, CAS: 112848-19-8, stock: 5.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₇NO₄.

16-Hydroxy Capsaicin-d3, CAS: 1346606-77-6, stock: 3.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄D₃NO₄.

(R)-(+)-Camphor-d2, CAS: 34733-73-8, stock: 8.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄D₂O.

(R)-4-(2-Methyl-3,3-diphenylpropyl)morpholine ((1R,4R)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate, CAS: /, stock: 2.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅NO  •  C₁₀H₁₆O₄S.

17-Hydroxy Capsaicin, CAS: 69173-71-3, stock: 9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₇NO₄.

17-Hydroxy Capsaicin-d3, CAS: 1346606-57-2, stock: 3.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄D₃NO₄.

(R)-β-Methyl-α,α-diphenyl-4-morpholinebutanenitrile (R)-10-Camphorsulfonic Acid Salt, CAS: /, stock: 3.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₄N₂O  • C₁₀H₁₆O₄S.

(R)-N-Deacetyl Colchicine d-10-Camphorsulfonate, CAS: 102419-97-6, stock: 1.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₀N₂O₈S.

3-Chloro-4-trifluoromethylpyridazine, CAS: 749258-96-6, stock: 4.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₂ClF₃N₂.

(R/S)-N-Deacetyl Colchicine d-10-Camphorsulfonate, CAS: /, stock: 2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₀N₂O₈S.

3-Fluoro-2-(tributylstannyl)pyridine, CAS: 573675-60-2, stock: 3.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₀FNSn.

4-(Aminomethyl)benzene-1,2-diol Hydrobromide, CAS: 16290-26-9, stock: 3.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉NO₂ • HBr.

(S)-N-Deacetyl Colchicine d-10-Camphorsulfonate, CAS: 102419-98-7, stock: 6.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₀N₂O₈S.

10-Camphorsulfonic Acid Ethyl Ester, CAS: 108481-13-6, stock: 2.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₀O₄S.

4-Ethyl-1,4-dihydro-5-[[(2-methoxyethyl)thio]-carbonyl]-6-methyl-2-phenyl-3-Pyridinecarboxylic Acid Ethyl Ester, CAS: 212200-21-0, stock: 8.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₇NO₄S.

2-(2-Isopropyl-5-methyl-1,4-cyclohexadien-1-yloxy)ethanol, CAS: 856376-26-6, stock: 5.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₀O₂.

2-Thymyloxyethanol, CAS: 55129-21-0, stock: 9.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈O₂.

3-Benzylidenecamphor, CAS: 15087-24-8, stock: 7.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀O.

3-Hydroxy-2-methyl Isoborneol, CAS: 214074-24-5, stock: 3.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₀O₂.

6-Iodonordihydrocapsaicin, CAS: 859171-97-4, stock: 7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₆INO₃.

7-Methyloctanoyl Chloride, CAS: 122876-14-6, stock: 9.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇ClO.

3-Hydroxy-2-methyl Isoborneol-d3, CAS: /, stock: 5.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇D₃O₂.

4-(Isopentyloxy)phenylboronic Acid, CAS: 1198156-69-2, stock: 5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇BO₃.

8-Methyl-6-nonenoic Acid, CAS: 21382-25-2, stock: 6.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈O₂.

8-Methyl-6-nonynoic Acid, CAS: 780760-97-6, stock: 3.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆O₂.

4-Methylbenzylidene Camphor, CAS: 36861-47-9, stock: 2.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₂O.

4-Methylbenzylidene Camphor-d4, CAS: 1219806-41-3, stock: 2.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈D₄O.

BCTC, CAS: 393514-24-4, stock: 9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅ClN₄O.

Capsaicin(E/Z-Mixture), CAS: 7553-53-9, stock: 1.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₇NO₃.

5-Hydroxy-2-methyl Isoborneol, CAS: 604767-98-8, stock: 5.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₀O₂.

5-Hydroxy-2-methyl Isoborneol-d3, CAS: /, stock: 6.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇D₃O₂.

Capsaicin-d3(E/Z-Mixture), CAS: 1185237-43-7, stock: 4.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄D₃NO₃.

Chloroform-13C, CAS: 31717-44-9, stock: 8.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  CHCl₃.

5-Keto-2-methyl Isoborneol, CAS: 1138454-88-2, stock: 8.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₈O₂.

5-Keto-2-methyl Isoborneol-d3, CAS: /, stock: 6.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅D₃O₂.

cis-Capsaicin, CAS: 25775-90-0, stock: 9.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₇NO₃.

cis-Capsaicin-d3, CAS: 1185237-43-7, stock: 6.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄D₃NO₃.

6-Hydroxy-2-methyl Isoborneol, CAS: 1138454-84-8, stock: 7.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₀O₂.

6-Hydroxy-2-methyl Isoborneol-d3, CAS: /, stock: 6.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇D₃O₂.

Denatonium Hydroxide, CAS: 222608-06-2, stock: 5.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₀N₂O₂.

Dihydro Capsaicin, CAS: 19408-84-5, stock: 6.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₉NO₃.

Dihydro Capsaicin-d3, CAS: 1330261-21-6, stock: 1.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆D₃NO₃.

Dihydro Homocapsaicin I, CAS: 20279-06-5, stock: 3.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₁NO₃.

Apioline, CAS: 523-80-8, stock: 9.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄O₄.

Benzylidene Camphor Sulfonic Acid, CAS: 56039-58-8, stock: 3.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀O₄S.

Dihydro Homocapsaicin II, CAS: 71239-21-9, stock: 7.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₁NO₃.

Diphenyl 8-Methyl-1-nonanol Phosphate, CAS: 1346599-15-2, stock: 1.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₁O₄P.

Camphorquinone-10-sulfonic Acid Hydrate, CAS: 355012-89-4, stock: 8.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆O₆S.

Camphorquinone-10-sulfonyl Chloride, CAS: 82594-19-2, stock: 7.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃ClO₄S.

Diphenyl 8-Methyl-1-nonanol Phosphate-d7, CAS: /, stock: 9.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄D₇O₄P.

Homocapsaicin I, CAS: 58493-48-4, stock: 7.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₉NO₃.

Camphorquinone-10-sulfonylnorleucine, CAS: 73413-80-6, stock: 4.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₅NO₆S.

Homocapsaicin II, CAS: 71240-51-2, stock: 2.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₉NO₃.

Isopelargonic Acid, CAS: 693-19-6, stock: 2.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₈O₂.

Cyclopentane-​1,​3-​dicarboxylic Acid, CAS: 4056-78-4, stock: 9.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀O₄.

D-(+)-α-Bromocamphor-8-sulfonic Acid Ammonium Salt, CAS: 14575-84-9, stock: 4.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈BrNO₄S.

N-Vanillylnonanamide, CAS: 2444-46-4, stock: 8.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₇NO₃.

N-Vanillylnonanamide-d3, CAS: /, stock: 6.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₄D₃NO₃.

D-Camphor-10-sulfonic Acid Sodium Salt, CAS: 21791-94-6, stock: 9.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅NaO₄S.

D-Glucuronic Acid, CAS: 03/12/6556, stock: 8.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀O₇.

Nordihydrocapsaicin, CAS: 28789-35-7, stock: 1.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₇NO₃.

Nordihydrocapsaicin-d3, CAS: /, stock: 4.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₄D₃NO₃.

D-Glucuronic Acid-[UL-13C6] Sodium Salt Hydrate, CAS: /, stock: 9.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆H₉NaO₇ •xH₂O.

D-Norleucine-d9, CAS: /, stock: 4.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄D₉NO₂.

Olvanil, CAS: 58493-49-5, stock: 9.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₃NO₃.

PDNHV, CAS: 251362-87-5, stock: 4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₇H₆₈O₁₁.

DL-10-Camphorsulfonic Acid, CAS: 02/08/5872, stock: 6.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆O₄S.

DL-10-Camphorsulfonyl Chloride, CAS: 4552-50-5, stock: 1.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅ClO₃S.

STEARDA, CAS: 105955-10-0, stock: 2.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₅NO₃.

Thiosemicarbazide, CAS: 79-19-6, stock: 2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  CH₅N₃S.

DL-Camphene, CAS: 79-92-5, stock: 6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆.

DL-Camphene (contains up to 20% tricyclene), CAS: 79-92-5, stock: 5.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆.

trans-Capsaicin, CAS: 404-86-4, stock: 2.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₇NO₃.

trans-Capsaicin-d3, CAS: 1217899-52-9, stock: 1.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄D₃NO₃.

DL-Camphene-D6, CAS: /, stock: 9.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀D₆.

DL-Camphorquinone, CAS: 10373-78-1, stock: 2.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄O₂.

Ecamsule, CAS: 92761-26-7, stock: 2.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₄O₈S₂.

Ecamsule-d4, CAS: /, stock: 5.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₀D₄O₈S₂.

Fenchone, CAS: 1195-79-5, stock: 8.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆O.

Isopropyl (1R)-(+)-10-Camphorsulfate, CAS: 1242184-40-2, stock: 8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₂O₄S.

Isopropyl (1R)-(+)-10-Camphorsulfate-d7, CAS: /, stock: 4.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅D₇O₄S.

Isopropyl (1S)-(+)-10-Camphorsulfate, CAS: 247078-58-6, stock: 9.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₂O₄S.

L(-)-Alpha-Bromocamphor-Pi-Sulfonic Acid, Ammonium Salt, CAS: 74165-69-8, stock: 4.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅O₄SBr.NH₃.

L-(-)-α-Bromocamphor-8-sulfonic Acid Ammonium Salt, CAS: 55870-50-3, stock: 4.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈BrNO₄S.

Methyl (1S)-(+)-10-Camphorsulfonate, CAS: 62319-13-5, stock: 1.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₈O₄S.

N-(2-Carboxy-4,5-dichlorobenzoyl)-(-)-10,2-camphorsultam, CAS: 193202-37-8, stock: 1.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉Cl₂NO₅S.

N-(2-Carboxybenzoyl)-(-)-10,2-camphorsultam, CAS: 179950-32-4, stock: 9.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₁NO₅S.

Naphthalene, CAS: 91-20-3, stock: 3.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈.

Naphthalene-13C10, CAS: 219526-41-7, stock: 3.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₁₀H₈.

Naphthalene-13C6, CAS: 287399-34-2, stock: 9.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₆H₈.

Norcamphor, CAS: 497-38-1, stock: 1.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀O.

Norcamphor-d4, CAS: /, stock: 3.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆D₄O.

Octahydro-4,7-methano-1H-inden-5-ol, CAS: 13380-89-7, stock: 2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆O.

Omeprazole-N-(S)-camphorsulfonamide, CAS: 869087-33-2, stock: 7.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₃N₃O₆S₂.

Piperitone, CAS: 89-81-6, stock: 7.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆O.

rac Isopropyl (±)-10-camphorsulfate, CAS: /, stock: 4.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₂O₄S.

rac Isopropyl (±)-10-camphorsulfate-d7, CAS: /, stock: 1.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅D₇O₄S.

rac-5-Hydroxy Camphor, CAS: 1391053-35-2, stock: 8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆O₂.

rac-β-Methyl-α,α-diphenyl-4-morpholinebutanenitrile (R)-10-Camphorsulfonic Acid Salt, CAS: /, stock: 8.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₄N₂O  • C₁₀H₁₆O₄S.

Thymol, CAS: 89-83-8, stock: 6.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄O.

trans-Clopenthixol-d4 (-)-10-Camphorsulfonic Acid Salt, CAS: /, stock: 5.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₇D₄ClN₂O₅S₂.

Zuclopenthixol (-)-10-Camphorsulfonic Acid Salt, CAS: /, stock: 2.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₁ClN₂O₅S₂.

Zuclopenthixol-d4 (-)-10-Camphorsulfonic Acid Salt, CAS: /, stock: 4.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₇D₄ClN₂O₅S₂.

(3β,5α,6β,22R,24R)-6-Methoxy-3,5-Cycloergostan-22-ol, CAS: 71473-15-9, stock: 3.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₅₀O₂.

(3β,5α,6β,24R)-6-Methoxy-3,5-cycloergostane, CAS: 71496-86-1, stock: 7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₅₀O.

(S)-1-Bromo-2,3-dimethylbutane, CAS: 15164-29-1, stock: 7.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃Br.

20-(α/β)-Campestanol-d7, CAS: /, stock: 5.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₃D₇O.

3-O-tert-Butyldimethylsilyl-24-methyl-24-phenylsulfonyl-cholest-5-ene-3-ol-d7, CAS: /, stock: 2.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₅₉D₇O₃SSi.

3-O-tert-Butyldimethylsilyl-24-methyl-cholest-5-ene-3,24-diol-d7, CAS: /, stock: 5.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₅₅D₇O₂Si.

3-O-tert-Butyldimethylsilyl-24-phenylsulfonyl-cholest-5-ene-3-ol-d7 (Mixture of Diastereomers), CAS: /, stock: 4.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₅₇D₇O₃SSi.

3-O-tert-Butyldimethylsilyl-cholest-5-ene-3-ol 24-(2-Hydroxyisopropyl) 24-Phenyl Sulfinate, CAS: /, stock: 9.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₆₄O₄SSi.

3-O-tert-Butyldimethylsilyl-cholest-5-ene-3-ol Phenyl Sulfinate, CAS: /, stock: 6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₅₈O₃SSi.

6β-Methoxy-3α,5-cyclo-5α-pregnane-20α-carboxaldehyde, CAS: 25819-77-6, stock: 2.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₆O₂.

Campestanol, CAS: 474-60-2, stock: 4.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₅₀O.

Campestanol-d7, CAS: /, stock: 5.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₃D₇O.

Campesterol, CAS: 474-62-4, stock: 4.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₈O.

Campesterol-d3, CAS: /, stock: 8.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₅D₃O.

Campesterol-d3  (Mixture of Diastereomers), CAS: /, stock: 2.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₅D₃O.

Campesterol-d7 (Mixture of Diastereomers), CAS: /, stock: 1.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₁D₇O.

Campesteryl Ferulate, CAS: 20972-07-0, stock: 4.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₅₆O₄.

Fungisterol, CAS: 516-78-9, stock: 3.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₈O.

(1α,3β,5Z,7E,22E)-24-Cyclopropyl-1,3-dihydroxy-9,10-Secochola-5,7,10(19),22-tetraen-24-one (90%), CAS: 126860-83-1, stock: 1.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₈O₃.

(24R)-Calcipotriene, CAS: 112827-99-3, stock: 6.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₀O₃.

(3R,3a’R,5S,7a’R)-1’-((2R,5S,E)-5-Cyclopropyl-5-hydroxypent-3-en-2-yl)-7a’-methyl-1’,2,2’,3,3’,3a’,4,5,5’,6,6a,6’,7’,7a’-tetradecahydro-1aH-spiro[cyclopropa[a]indene-1,4’-indene]-3,5-diol, CAS: /, stock: 1.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₀O₃.

(5E)-Calcipotriene, CAS: 113082-99-8, stock: 5.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₀O₃.

(5E)-Calcipotriene-d4, CAS: /, stock: 5.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₅D₄O₃.

1,3-Bis-O-(tert-butyldimethylsilyl)calcipotriene, CAS: 112875-61-3, stock: 2.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₆₈O₃Si₂.

Bis-O-(tert-butyldimethylsilyl)-trans-calcipotriol, CAS: 112849-27-1, stock: 7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₆₈O₃Si₂.

Calcipotriene, CAS: 112965-21-6, stock: 7.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₀O₃.

Calcipotriol Impurity G, CAS: /, stock: 2.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₄H₇₈O₅.

Calcipotriol Impurity H, CAS: /, stock: 2.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₄H₇₈O₅.

(E)-Neochlorogenic Acid, CAS: 906-33-2, stock: 2.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈O₉.

1,3-Dicaffeoylquinic Acid, CAS: 19870-46-3, stock: 8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₄O₁₂.

1,4-O-Dicaffeoylquinic acid, CAS: 1182-34-9, stock: 3.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₄O₁₂.

4,5-Dicaffeoylquinic Acid, CAS: 57378-72-0, stock: 4.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₄O₁₂.

4-O-Caffeoylquinic Acid, CAS: 905-99-7, stock: 9.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈O₉.

Chlorogenic Acid, CAS: 327-97-9, stock: 4.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈O₉.

Chlorogenic Acid-13C3, CAS: /, stock: 1.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃¹³C₃H₁₈O₉.

Chlorogenic Acid-13C6, CAS: 1323443-06-6, stock: 8.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀¹³C₆H₁₈O₉.

Cynarin, CAS: 30964-13-7, stock: 7.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₄O₁₂.

Isochlorogenic Acid A, CAS: 2450-53-5, stock: 9.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₄O₁₂.

Isochlorogenic Acid B, CAS: 14534-61-3, stock: 9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₄O₁₂.

10-Hydroxy Cabotegravir, CAS: /, stock: 8.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇F₂N₃O₆.

10-Hydroxy Cabotegravir-d3, CAS: /, stock: 1.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₄D₃F₂N₃O₆.

13-Hydroxy Cabotegravir, CAS: /, stock: 6.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇F₂N₃O₆.

13-Hydroxy Cabotegravir-d3, CAS: /, stock: 6.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₄D₃F₂N₃O₆.

21-Hydroxy Cabotegravir, CAS: /, stock: 5.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇F₂N₃O₆.

21-Hydroxy Cabotegravir-d3, CAS: /, stock: 4.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₄D₃F₂N₃O₆.

24-Hydroxy Cabotegravir, CAS: /, stock: 6.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇F₂N₃O₆.

24-Hydroxy Cabotegravir-d3, CAS: /, stock: 4.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₄D₃F₂N₃O₆.

26-Hydroxy Cabotegravir, CAS: /, stock: 8.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇F₂N₃O₆.

26-Hydroxy Cabotegravir-d3, CAS: /, stock: 8.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₄D₃F₂N₃O₆.

Cabotegravir, CAS: 1051375-10-0, stock: 6.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇F₂N₃O₅.

Cabotegravir 2,3,4-Tri-O-acetyl-O-β-D-glucuronide Methyl Ester, CAS: /, stock: 9.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₃F₂N₃O₁₄.

Cabotegravir O-β-D-Glucuronide, CAS: /, stock: 2.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₅F₂N₃O₁₁.

Cabotegravir O-β-D-Glucuronide Methyl Ester, CAS: /, stock: 5.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₇F₂N₃O₁₁.

Cabotegravir O-β-D-Glucuronide-d3, CAS: /, stock: 2.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₂D₃F₂N₃O₁₁.

(E)-1,2-Dichloroethene (stabilized with MEHQ), CAS: 156-60-5, stock: 6.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₂Cl₂.

Cabotegravir-d3, CAS: /, stock: 7.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₄D₃F₂N₃O₅.

(Z)-1,2-Dichloroethene, CAS: 156-59-2, stock: 9.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₂Cl₂.

1,3,7-Trimethyluric Acid, CAS: 5415-44-1, stock: 5.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀N₄O₃.

1,3,7-Trimethyluric Acid-d3, CAS: 188297-95-2, stock: 3.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇D₃N₄O₃.

1,3,7-Trimethyluric Acid-d9, CAS: 117490-42-3, stock: 4.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈HD₉N₄O₃.

1,3,9-Trimethyluric Acid, CAS: 7464-93-9, stock: 3.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀N₄O₃.

1,3-Dimethylparabanic Acid, CAS: 5176-82-9, stock: 5.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆N₂O₃.

1,3-Dimethylparabanic Acid-d6, CAS: /, stock: 4.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅D₆N₂O₃.

1,3-Dimethyluric Acid, CAS: 944-73-0, stock: 2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₄O₃.

1,3-Dipropyl-7-methylxanthine, CAS: 31542-63-9, stock: 3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₄O₂.

1,3-Dipropylxanthine, CAS: 31542-62-8, stock: 1.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₄O₂.

1,7,9-Trimethyluric Acid, CAS: 55441-64-0, stock: 6.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀N₄O₃.

1,7-Dimethyluric Acid, CAS: 33868-03-0, stock: 2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₄O₃.

1,7-Dimethyluric Acid-d3, CAS: 1189713-08-3, stock: 4.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅D₃N₄O₃.

1,9-Dimethyluric Acid, CAS: 55441-62-8, stock: 8.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₄O₃.

3,7-Dimethyluric Acid, CAS: 13087-49-5, stock: 9.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₄O₃.

3-Methyluric Acid, CAS: 605-99-2, stock: 4.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₄O₃.

3-Methyluric Acid-d3, CAS: /, stock: 8.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃D₃N₄O₃.

4-Amino-5-[(ethoxycarbonyl)amino]-1-methyl-d3 Uracil, CAS: 1794768-19-6, stock: 6.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉D₃N₄O₄.

5-Acetyl-d3-amino-6-formylamino-3-methyluracil, CAS: 1185082-65-8, stock: 6.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇D₃N₄O₄.

5-Acetylamino-6-amino-3-methyluracil Hydrate, CAS: 1196153-01-1, stock: 3.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂N₄O₄.

5-Acetylamino-6-amino-3-methyluracil-d3 Hydrate, CAS: 1246816-23-8, stock: 4.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉D₃N₄O₄.

5-Acetylamino-6-formylamino-3-methyl-d3-uracil, CAS: 1216442-68-0, stock: 2.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇D₃N₄O₄.

5-Acetylamino-6-formylamino-3-methyluracil, CAS: 85438-96-6, stock: 2.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀N₄O₄.

6-Amino-1,3-dimethyluracil, CAS: 6642-31-5, stock: 4.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉N₃O₂.

6-Amino-5-(hydroxyamino)-3-methylpyrimidine-2,4(1H,3H)-dione, CAS: /, stock: 7.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈N₄O₃.

6-Amino-5-(N-formyl-N-methyl)-3-methyluracil, CAS: 55782-76-8, stock: 9.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀N₄O₃.

7-(2-Cyanoethyl)-theophylline, CAS: 1811-38-7, stock: 6.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁N₅O₂.

7-Methyl Xanthine, CAS: 552-62-5, stock: 6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₄O₂.

7-Methyl-3-methyluric Acid-d3, CAS: 383160-11-0, stock: 9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅D₃N₄O₃.

8-(3-Chlorostyryl)caffeine, CAS: 147700-11-6, stock: 2.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅ClN₄O₂.

8-Bromo-1,3,7-trimethylxanthine, CAS: 10381-82-5, stock: 6.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉BrN₄O₂.

8-Bromo-3,7-dihydro-7-(2-methoxyethyl)-3-methyl-1H-purine-2,6-dione, CAS: 313470-45-0, stock: 2.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁BrN₄O₃.

8-Chloro Caffeine, CAS: 4921-49-7, stock: 9.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉ClN₄O₂.

Bisdionin C, CAS: 74857-22-0, stock: 4.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀N₈O₄.

Bisdionin C-d6, CAS: /, stock: 2.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄D₆N₈O₄.

Caffeidine, CAS: 20041-90-1, stock: 9.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂N₄O.

Caffeidine Acid Sodium Salt, CAS: /, stock: 7.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁N₄NaO₃.

Caffeidine Acid-d9, CAS: /, stock: 8.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₃D₉N₄O₃.

Caffeidine-d9, CAS: /, stock: 3.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃D₉N₄O.

Caffeine, CAS: 58-08-2, stock: 7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀N₄O₂.

Caffeine (1 mg/mL in Methanol), CAS: 58-08-2, stock: 8.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀N₄O₂.

Caffeine Citrate, CAS: 69-22-7, stock: 4.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈N₄O₉.

Caffeine-13C, CAS: 202282-98-2, stock: 3.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇¹³CH₁₀N₄O₂.

Caffeine-13C3, CAS: 78072-66-9, stock: 2.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³C₃H₁₀N₄O₂.

Caffeine-d9, CAS: 72238-85-8, stock: 3.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈HD₉N₄O₂.

Dihydro Ferulic Acid, CAS: 1135-23-5, stock: 8.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₄.

Dihydro Ferulic Acid Methyl Ester, CAS: 56024-44-3, stock: 7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄O₄.

Dihydrolysergic Acid, CAS: 5878-43-3, stock: 6.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈N₂O₂.

Fencamine, CAS: 28947-50-4, stock: 3.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈N₆O₂.

Fencamine-d3, CAS: 1346598-20-6, stock: 3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅D₃N₆O₂.

Furafylline, CAS: 80288-49-9, stock: 3.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂N₄O₃.

Furafylline-d3, CAS: 149981-47-5, stock: 3.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉D₃N₄O₃.

Isocaffeine, CAS: 519-32-4, stock: 3.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀N₄O₂.

Isocaffeine-d3, CAS: /, stock: 5.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇D₃N₄O₂.

Liberine, CAS: 56119-16-5, stock: 4.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀N₄O₃.

Methacrylonitrile (stabilized with hydroquinone monomethyl ether), CAS: 126-98-7, stock: 8.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅N.

Methacrylonitrile-15N (stabilized with hydroquinone monomethyl ether), CAS: 204523-22-8, stock: 1.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅¹⁵N.

Methylliberine, CAS: 51168-26-4, stock: 7.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₄O₃.

N-(6-Amino-1,2,3,4-tetrahydro-1,3-dimethyl-2,4-dioxo-5-pyrimidinyl)-N-methylformamide, CAS: 33130-55-1, stock: 2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂N₄O₃.

N-(6-Amino-3-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)acetamide, CAS: 19893-78-8, stock: 9.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀N₄O₃.

N-Methylurea, CAS: 598-50-5, stock: 2.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₆N₂O.

N-Methylurea-d6, CAS: 56683-43-3, stock: 3.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂D₆N₂O.

Paraxanthine, CAS: 611-59-6, stock: 8.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₄O₂.

Paraxanthine-1-methyl-d3, CAS: 188297-90-7, stock: 2.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅D₃N₄O₂.

Paraxanthine-d3, CAS: 65566-70-3, stock: 3.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅D₃N₄O₂.

Tetramethyluric Acid, CAS: 2309-49-1, stock: 3.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₄O₃.

Theobromine, CAS: 83-67-0, stock: 1.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₄O₂.

Theobromine-d3 (7-methyl-d3), CAS: 65566-69-0, stock: 7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇D₃N₄O₂.

Theobromine-d6, CAS: 117490-40-1, stock: 3.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₂D₆N₄O₂.

(1α,3β)-9,10-Secocholesta-5(10),8-dien-6-yne-1,3,25-triol, CAS: 134458-49-4, stock: 5.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₂O₃.

(1α,3β,10α)-Cholesta-5,7-diene-1,3,25-triol, CAS: 156197-52-3, stock: 1.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O₃.

(1α,3β,9β)-Cholesta-5,7-diene-1,3,25-triol, CAS: 168609-17-4, stock: 1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O₃.

(1R,3aR,7aR)-1-[(1R)-1,5-Dimethyl-5-[(trimethylsilyl)oxy]hexyl]-2,3,3a,6,7,7a-hexahydro-7a-methyl-1H-inden-4-yl Ester 1,1,1-Trifluoro-methanesulfonic Acid, CAS: 222317-53-5, stock: 8.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₉F₃O₄SSi.

(1R,3aR,7aR)-1-[(1R)-1,5-Dimethyl-5-[(trimethylsilyl)oxy]hexyl]octahydro-7a-methyl-4H-inden-4-one, CAS: 81506-41-4, stock: 5.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₄₀O₂Si.

(1S,2R,4S,6S)-2-Ethynyl-1-methyl-7-oxabicyclo[4.1.0]heptane-2,4-diyl Diacetate, CAS: /, stock: 1.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆O₅.

(24R)​-​24-​Hydroxycalcitriol, CAS: 56142-94-0, stock: 10g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O₄.

(24R)​-​24-​Hydroxycalcitriol-d6, CAS: /, stock: 2.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₈D₆O₄.

(2S)-2-((7aR,E)-4-(((4S,6R)-4,6-Bis((tert-butyldimethylsilyl)oxy)-2,2-dioxido-1,3,4,5,6,7-hexahydrobenzo[c]thiophen-1-yl)methylene)-7a-methyloctahydro-1H-inden-1-yl)propyl 4-Methylbenzenesulfonate, CAS: /, stock: 1.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₆₈O₇S₂Si₂.

(3β)-3-[(Tetrahydro-2H-pyran-2-yl)oxy]-chol-5-en-24-al, CAS: 66414-44-6, stock: 7.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₆O₃.

(8β)-8-(Hydroxymethyl)ergoline-1,6-dicarboxylic Acid 1,6-Bis(1,1-dimethylethyl) Ester, CAS: 1075250-75-7, stock: 5.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₄N₂O₅.

(4S,6R)-4,6-Bis((tert-butyldimethylsilyl)oxy)-1-((E)-((7aR)-1-((S)-1-hydroxypropan-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)methyl)-1,3,4,5,6,7-hexahydrobenzo[c]thiophene 2,2-dioxide, CAS: /, stock: 8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₆₂O₅SSi₂.

(8β)-8-[[[(1,1-Dimethylethyl)dimethylsilyl]oxy]methyl]-6-methylergoline, CAS: 955957-39-8, stock: 1.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₄N₂OSi.

(8β)-8-[[[(1,1-Dimethylethyl)dimethylsilyl]oxy]methyl]ergoline, CAS: 1075250-74-6, stock: 7.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₂N₂OSi.

(εR,1R,3aR,4S,7aR)-Octahydro-4-hydroxy-α,α,ε,7a-tetramethyl-1H-indene-1-pentanol, CAS: 66774-84-3, stock: 1.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₄O₂.

(8β)-9,10-Didehydro-8-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-6-methylergoline, CAS: 1075250-72-4, stock: 5.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₂N₂OSi.

(8β)-Ergoline-1,6,8-tricarboxylic Acid 1,6-Bis(1,1-dimethylethyl) Ester, CAS: 1075250-76-8, stock: 5.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₂N₂O₆.

(8β)-N-[3-(Methylamino)propyl]-6-(2-propenyl)-ergoline-8-carboxamide, CAS: 478815-26-8, stock: 2.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₀N₄O.

1-epi-Calcitriol, CAS: 66791-71-7, stock: 1.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O₃.

(8β)-N-[3-(Methylamino)propyl]-6-(2-propenyl)-ergoline-8-carboxamide N-(4-Nitrophenyl) Ester, CAS: /, stock: 5.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₃N₅O₅.

1α,25-Dihydroxy Vitamin D2, CAS: 60133-18-8, stock: 4.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₄O₃.

1α,25-Dihydroxy Vitamin D2 1α-O-β-D-Glucuronide, CAS: /, stock: 4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₅₂O₉.

1-[6-(2-propenyl)-ergoline-8β-carbonyl]-3-methyl-perhydropyrimidine-2-one Methanolate, CAS: /, stock: 3.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₂N₄O₃.

1α,25-Dihydroxy Vitamin D2-d6, CAS: 216244-04-1, stock: 4.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₈D₆O₃.

22-Oxacalcitriol, CAS: 103909-75-7, stock: 4.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₂O₄.

1-[6-(2-propenyl)-ergoline-8β-carbonyl]-3-methyl-perhydropyrimidine-2-one-d3, CAS: /, stock: 6.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₅D₃N₄O₂.

6-Allyl-8β-carboxyergoline, CAS: 81409-74-7, stock: 2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀N₂O₂.

22-Oxacalcitriol-d6, CAS: /, stock: 4.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₆D₆O₄.

6-Allyl-8β-carboxyergoline Methyl Ester, CAS: 72821-79-5, stock: 6.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂N₂O₂.

6-Allyl-8β-carboxyergoline-d5, CAS: /, stock: 7.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₅D₅N₂O₂.

24-Homo Calcitriol, CAS: 103656-40-2, stock: 2.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₆O₃.

24-Homo Calcitriol-d6, CAS: /, stock: 4.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₀D₆O₃.

6-Allyldihydronorisolysergic Acid, CAS: 86891-15-8, stock: 2.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀N₂O₂.

6-Allyldihydronorisolysergic Acid Methyl Ester, CAS: 86891-16-9, stock: 3.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂N₂O₂.

26,27-Didesmethyl-1,3-(tert-butyldimethylsilyl) (5E)-Calcitriol 24-Carboxylic Acid Methyl Ester, CAS: 161885-78-5, stock: 7.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₆₈O₄Si₂.

26,27-Didesmethyl-1,3-(tert-butyldimethylsilyl) (5Z)-Calcitriol 24-Carboxylic Acid Methyl Ester, CAS: 145372-43-6, stock: 6.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₆₈O₄Si₂.

8S-Cabergoline, CAS: 856676-33-0, stock: 1.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₇N₅O₂.

9,10-Didehydro Cabergoline, CAS: 1380085-95-9, stock: 5.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₅N₅O₂.

Allyl Acetate, CAS: 591-87-7, stock: 1.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈O₂.

Allyl Acetate-d5, CAS: /, stock: 8.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₃D₅O₂.

5,6-trans-Calcitriol, CAS: 73837-24-8, stock: 4.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O₃.

5,6-trans-Calcitriol-d6, CAS: /, stock: 8.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₈D₆O₃.

Cabergoline, CAS: 81409-90-7, stock: 1.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₇N₅O₂.

Cabergoline N-Oxide, CAS: /, stock: 5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₇N₅O₃.

5-trans-1,6-Anhydro-6,6’-dihydro-9-hydroxyoxacalcitriol, CAS: /, stock: 5.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₂O₄.

9,10-Secocholesta-5(10),8-dien-6-yne (1α,3β)-Di-t-Butyldimethylsilyl Ether 25-Trimethylsilyl Ether, CAS: /, stock: 1.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₇₈O₃Si₃.

Cabergoline-d5, CAS: 1426173-20-7, stock: 8.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₂D₅N₅O₂.

Calcipotriol Monohydrate, CAS: 147657-22-5, stock: 8.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₂O₄.

Des-N-allylcabergoline, CAS: 153415-36-2, stock: 4.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₃N₅O₂.

Desethylcarbamoyl Cabergoline, CAS: 85329-86-8, stock: 3.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₂N₄O.

Desethylcarbamoyl Cabergoline-d5, CAS: 1316849-28-1, stock: 3.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇D₅N₄O.

Dihydro Cabergoline-(d5 major), CAS: /, stock: 9.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₄D₅N₅O₂.

Dihydrolysergic Acid Methyl Ester, CAS: 35470-53-2, stock: 3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀N₂O₂.

Calcitroic Acid, CAS: 71204-89-2, stock: 1.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₄O₄.

EB 1089, CAS: 134404-52-7, stock: 9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₆O₃.

Dimethyl Cabergoline, CAS: /, stock: 9.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₁N₅O₂.

Ergoline-8β-carboxylic Acid Methyl Ester Hydrochloride, CAS: 1075250-77-9, stock: 7.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉ClN₂O₂.

Falecalcitriol, CAS: 83805-11-2, stock: 7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₈F₆O₃.

N-Methyl-N-[3-[[[(8β)-6-(2-propen-1-yl)ergolin-8-yl]carbonyl]amino]propyl]carbamic Acid 1,1-Dimethylethyl Ester, CAS: 1390658-68-0, stock: 1.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₈N₄O₃.

N1-Ethylcarbamoyl Cabergoline, CAS: 126554-50-5, stock: 4.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₂N₆O₃.

Octahydro-4-hydroxy-δ,7a-dimethyl-1H-indene-1-pentanoic Acid Methyl Ester, CAS: 122958-43-4, stock: 9.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₀O₃.

Octahydro-4-methoxymethoxy-δ,7a-dimethyl-1H-indene-1-pentanoic Acid Methyl Ester, CAS: /, stock: 3.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₄O₄.

N1-Ethylcarbamoyl Cabergoline-d5, CAS: /, stock: 7.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₇D₅N₆O₃.

N8-Desethylcarbamoyl-N1-ethylcarbamoyl Cabergoline, CAS: 166533-36-4, stock: 6.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₇N₅O₂.

pre-Calcitriol PTAD Adduct(Mixture of Diastereomers), CAS: 86307-44-0, stock: 2.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₄₉N₃O₅.

Pro-Calcitriol PTAD Adduct, CAS: 137342-95-1, stock: 1.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₄₉N₃O₅.

N8-Desethylcarbamoyl-N1-ethylcarbamoyl Cabergoline-d5, CAS: /, stock: 3.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₂D₅N₅O₂.

[4aR-[4aα,6aα,7α(1R*,2E,4R*),9aβ,11α(S*)]]-4a,6,6a,7,8,9,9a,11-Octahydro-11-(5-hydroxy-2-methyl-1-cyclohexen-1-yl)-6a-methyl-2-phenyl-7-(1,4,5-trimethyl-2-hexenyl)-1H,5H-cyclopenta[f][1,2,4]triazolo[1,2-a]cinnoline-1,3(2H)-dione, CAS: 86307-31-5, stock: 8.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₄₉N₃O₃.

1,1-Cyclobutanedicarboxylic Acid, CAS: 5445-51-2, stock: 2.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈O₄.

Carboplatin, CAS: 41575-94-4, stock: 9.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂N₂O₄Pt.

Carboplatin-d4, CAS: /, stock: 2.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈D₄N₂O₄Pt.

Diethyl 1,1-Cyclobutanedicarboxylate, CAS: 3779-29-1, stock: 5.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆O₄.

Diethyl 1,1-Cyclobutanedicarboxylate-d4, CAS: /, stock: 4.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂D₄O₄.

Diethyl 3-Bromopropylmalonate, CAS: 10149-21-0, stock: 6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇BrO₄.

Etanidazole, CAS: 22668-01-5, stock: 2.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀N₄O₄.

IPI-926 Hydrochloride, CAS: 1169829-40-6, stock: 1.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₉ClN₂O₃S.

Butenafine, CAS: 101828-21-1, stock: 8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇N.

Butenafine Hydrochloride, CAS: 101827-46-7, stock: 1.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈ClN.

Desmethyl Butenafine Hydrochloride, CAS: 101828-08-4, stock: 8.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆ClN.

N-(1-Naphthylmethyl)methylamine hydrochloride, CAS: 65473-13-4, stock: 7.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄ClN.

N-Methyl-N-(1-naphthalenylmethyl)-1-naphthalenemethanamine, CAS: 5418-22-4, stock: 4.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₁N.

1-[2-Chloro-4-(4-chlorophenyl)butyl]-1H-imidazole, CAS: 67085-12-5, stock: 7.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄Cl₂N₂.

Butoconazole Nitrate, CAS: 64872-77-1, stock: 6.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₈Cl₃N₃O₃S.

α-[2-(4-Chlorophenyl)ethyl]-1H-imidazole-1-ethanol, CAS: 67085-11-4, stock: 7.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅ClN₂O.

rac Butoconazole-d5 Nitrate, CAS: /, stock: 1.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₃D₅Cl₃N₃O₃S.

1,4-Cyclohexanediol-d8(cis and trans mixture), CAS: /, stock: 6.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄D₈O₂.

1-Chloroethyl Cyclohexyl Carbonate, CAS: 99464-83-2, stock: 6.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅ClO₃.

1-Chloroethylcyclohexyl-d11 Carbonate, CAS: /, stock: 6.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₄D₁₁ClO₃.

1-Phenyl-pyrazole 4-pyruvic Acid, CAS: 1052567-31-3, stock: 5.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀N₂O₃.

2-(2-Methoxyphenyl)-4,4-dimethyl-4,5-dihydrooxazole, CAS: 57598-33-1, stock: 5.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO₂.

2-Ethoxy-3H-benzimidazole-4-carboxylic Acid Methyl Ester, CAS: 150058-27-8, stock: 4.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁N₂O₃.

2-Ethoxy-3H-benzimidazole-4-carboxylic Acid Methyl Ester-d5, CAS: 1215647-69-0, stock: 7.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₇D₅N₂O₃.

2-Methoxy-1H-benzimidazole-4-carboxylic Acid Methyl Ester, CAS: 1246817-06-0, stock: 9.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀N₂O₃.

2-Oxo-2-(1-phenyl-1H-pyrazol-4-yl)acetic Acid, CAS: 1152495-65-2, stock: 8.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₈N₂O₃.

Candesartan-d4, CAS: 1346604-70-3, stock: 2.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₆D₄N₆O₃.

cis-1,4-Cyclohexanediol, CAS: 931-71-5, stock: 7.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₂.

2-(2-Diethylaminoethoxy)ethanol, CAS: 140-82-9, stock: 7.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₉NO₂.

2-[(2-Diethyl-d10)aminoethoxy]ethanol, CAS: 1189917-69-8, stock: 3.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉D₁₀NO₂.

Butamirate, CAS: 18109-80-3, stock: 6.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₉NO₃.

Butamirate Citrate, CAS: 18109-81-4, stock: 2.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₇NO₁₀.

Butamirate-d5 Citrate, CAS: 1215650-08-0, stock: 6.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₂D₅NO₁₀.

α-Desethyl Butamirate, CAS: 47092-75-1, stock: 4.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₅NO₃.

1,3-Bis(2-cyanophenoxy)-2-propanol, CAS: /, stock: 8.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄N₂O₃.

Bunitrolol, CAS: 34915-68-9, stock: 4.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀N₂O₂.

Bunitrolol-D5, CAS: /, stock: 9.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅D₅N₂O₂.

()-1,1,1-Trifluoro-2-butanamine hydrochloride, CAS: 758-33-8, stock: 6.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈F₃N • HCl.

(2R)-4-Phenylbutan-2-amine p-Toluenesulfonic Acid, CAS: /, stock: 1.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₃NO₃S.

(2R)-4-Phenylbutan-2-amine-d3, CAS: /, stock: 9.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂D₃N.

(Dichloromethylene)bis[phosphonic acid] mono(tributylamine) salt, CAS: 163706-61-4, stock: 1.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₇N  •  (CH   ₄Cl₂O₆P₂).

(N,N-Dimethyl-1-butanamine) Zolmitriptan Dimer, CAS: 1350928-05-0, stock: 9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₅₃N₇O₄.

(R)-4,4,4-Trifluoro-2-methyl-1-butanamine Hydrochloride, CAS: 136564-83-5, stock: 4.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀F₃N • (HCl).

(R)-4-Phenyl-2-butanamine, CAS: 937-52-0, stock: 4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅N.

(R)-N-[2-[3,4-Bis[(trimethylsilyl)oxy]phenyl]-2-[(trimethylsilyl)oxy]ethyl]-4-(phenylmethoxy)benzenebutanamine, CAS: 195716-45-1, stock: 4.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₅₃NO₄Si₃.

(S)-(+)-3,3-Dimethyl-2-butylamine, CAS: 22526-47-2, stock: 5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₅N.

(S)-1-(tert-Butyldimethylsilyloxy)-2-butanamine, CAS: 157555-74-3, stock: 2.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₅NOSi.

(S)-2-Butanamine, CAS: 513-49-5, stock: 3.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₁N.

(S)-2-Butylamine-d5 Hydrochloride Salt, CAS: /, stock: 2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆D₅N • (HCl).

(S)-3-Methyl-2-butanamine, CAS: 22526-46-1, stock: 6.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₃N.

1,3-Dimethylbutylamine, CAS: 108-09-8, stock: 6.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₅N.

1,3-Dimethylbutylamine Hydrochloride, CAS: 71776-70-0, stock: 2.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₆ClN.

1-(1H-Tetrazol-5-yl)cyclobutanamine, CAS: 1249656-01-6, stock: 7.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉N₅.

1-(2-Pyridinyl)cyclobutylamine, CAS: 1159734-98-1, stock: 5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂.

1-(3-Bromophenyl)cyclobutanamine, CAS: 1098349-39-3, stock: 3.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂NBr.

1-(4-Bromophenyl)cyclobutanamine, CAS: 1094218-30-0, stock: 8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂NBr.

1-(4-Bromophenyl)cyclobutanamine Hydrochloride, CAS: 1193389-40-0, stock: 2.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂NBr • HCl.

1-(4-Chlorophenyl)cyclobutanamine Hydrochloride, CAS: 1228878-71-4, stock: 3.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂NCl • HCl.

1-(4-Methoxyphenyl)cyclobutanamine, CAS: 1017387-07-3, stock: 4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO.

1-(4-Methoxyphenyl)cyclobutanamine Hydrochloride, CAS: 1228879-06-8, stock: 5.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO • HCl.

1-(Pyridin-4-yl)cyclobutanamine, CAS: 1211593-50-8, stock: 2.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂.

1-Butanamine-d9, CAS: 776285-22-4, stock: 6.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₂D₉N.

1-Butylamine, CAS: 109-73-9, stock: 1.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₁N.

1-Ethoxy-3-methyl-2-butanamine Hydrochloride, CAS: 1185299-36-8, stock: 2.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₇NO  •  HCl.

1-Methoxy-3-methyl-2-butanamine Hydrochloride, CAS: 1185294-54-5, stock: 2.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₅NO  •  HCl.

1-Methyl-3-phenylpropylamine, CAS: 22374-89-6, stock: 1.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅N.

1-Methylcyclobutanamine, CAS: 40571-47-9, stock: 4.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁N.

1-Phenylcyclobutanamine Hydrochloride, CAS: 120218-45-3, stock: 2.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄ClN.

1-Pyrenebutylamine, CAS: 205488-15-9, stock: 7.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₉N.

1-[3,4-(Methylenedioxy)phenyl]-2-butanone, CAS: 23023-13-4, stock: 6.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₃.

2,​2-Dimethylcyclobutanamine Hydrochloride, CAS: 1803562-44-8, stock: 6.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃N • HCl.

2-Methoxy-1-butanamine Hydrochloride, CAS: 1050509-60-8, stock: 2.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₃NO  •  HCl.

3,3-Difluorocyclobutanamine Hydrochloride, CAS: 637031-93-7, stock: 4.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈ClF₂N.

3,3-Dimethyl-1-butanamine Hydrochloride, CAS: 30564-98-8, stock: 5.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₅N • HCl.

3,3-Dimethylbutylamine, CAS: 15673-00-4, stock: 7.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₅N.

3-Benzylcyclobutanamine HCl, CAS: 1464091-61-9, stock: 8.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅N.HCl.

3-Bromopropyldibutylamine Hydrobromide, CAS: 88805-95-2, stock: 6.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₅Br₂N.

3-Chloro-N,N-dimethyl-butylamine Hydrochloride, CAS: 5495-65-8, stock: 8.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₅Cl₂N.

3-Chloro-N,N-dimethyl-butylamine-d6 Hydrochloride, CAS: /, stock: 3.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉D₆Cl₂N.

3-Fluorocyclobutanamine Hydrochloride, CAS: 1284245-36-8, stock: 6.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉ClFN.

3-Methoxycyclobutanamine, CAS: 1268521-35-2, stock: 9.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁NO.

3-Methoxycyclobutanamine Hydrochloride, CAS: 1404373-83-6, stock: 6.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₂ClNO.

3-Methyl-1-propoxy-2-butanamine Hydrochloride, CAS: 1185164-25-3, stock: 2.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₉NO  •  HCl.

3-Methyl-2-butanamine, CAS: 598-74-3, stock: 6.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₃N.

4-(1-Pyrrolidinyl)-1-butanamine, CAS: 24715-90-0, stock: 6.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₈N₂.

4-(4-Methoxyphenyl)butan-1-amine, CAS: 72457-26-2, stock: 8.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇NO.

4-(Methylthio)-1-butylamine, CAS: 55021-77-7, stock: 5.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₃NS.

4-Aminobutyl-d8 Guanidine Dihydrochloride, CAS: /, stock: 3.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈D₈Cl₂N₄.

4-Azidobutyl-d8-amine, CAS: /, stock: 4.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₂D₈N₄.

4-Azidobutylamine, CAS: 88192-20-5, stock: 9.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₀N₄.

4-​(N,​N-​Dimethylamino)​butanal Dimethyl Acetal, CAS: 19718-92-4, stock: 6.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₉NO₂.

4-​(Phenylmethoxy)​-benzenebutanamine, CAS: 1465616-80-1, stock: 4.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁NO.

4-Chloro-α-ethylbenzeneethanamine, CAS: 2275-64-1, stock: 2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄ClN.

4-Dimethylaminobutyraldehyde Diethyl Acetal, CAS: 1116-77-4, stock: 8.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₃NO₂.

4-Fluoro-benzenebutanamine, CAS: 149080-28-4, stock: 5.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄NF.

4-[2-(3-Methylphenyl)-1H-indol-3-yl]-1-butanamine Oxalate, CAS: 1177350-95-6, stock: 9.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂N₂ • C ₂H₂O₄.

Aminocyclobutane, CAS: 2516-34-9, stock: 4.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉N.

Barucainide, CAS: 79784-22-8, stock: 3.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₀N₂O₂.

Bis(N,N-dibutylamine)-N,N’-disulfide-d36, CAS: 1216478-97-5, stock: 1.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆D₃₆N₂S₂.

Bis(tributylammonium) Pyrophosphate, CAS: 5975-18-8, stock: 3.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₅₈N₂O₇P₂.

Cyclobutylamine Hydrochloride, CAS: 06/01/6291, stock: 9.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₀ClN.

Dibutylamine, CAS: 111-92-2, stock: 1.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₉N.

Dibutylamine-d18, CAS: 203578-32-9, stock: 1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈HD₁₈N.

Dibutylammonium Acetate (0.5M Solution in Water), CAS: 19070-91-8, stock: 6.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₃NO₂.

Isoamylamine, CAS: 107-85-7, stock: 9.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₃N.

γ-Methylaminobutyraldehyde Diethyl Acetal, CAS: 114094-45-0, stock: 1.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₁NO₂.

N-(2,2,2-Trifluoroethyl)cyclobutanamine Hydrochloride, CAS: 1116589-04-8, stock: 2.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀NF₃ • HCl.

N-(2,2-Difluoroethyl)cyclobutanamine Hydrochloride, CAS: 1010097-91-2, stock: 6.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁NF₂ • HCl.

N-(2-Chlorobenzyl)-1-butanamine Hydrochloride, CAS: 16183-40-7, stock: 9.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆NCl  •  HCl.

N-(2-Chlorobenzyl)-2-butanamine Hydrochloride, CAS: 1049773-97-8, stock: 6.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆NCl  •  HCl.

N-(2-Furylmethyl)-1-butanamine Hydrochloride, CAS: 858796-69-7, stock: 7.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅NO • (HCl).

N-(2-Furylmethyl)-3-methyl-2-butanamine Hydrochloride, CAS: 1269053-15-7, stock: 9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇NO  •  HCl.

N-(3,3,3-trifluoropropyl)cyclobutanamine hydrochloride, CAS: 1384427-48-8, stock: 8.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂NF₃.HCl.

N-(3-Thienylmethyl)-2-butanamine Hydrochloride, CAS: 1049713-37-2, stock: 1.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅NS  •  HCl.

N-(4-Methylbenzyl)-1-butanamine Hydrochloride, CAS: 16183-22-5, stock: 3.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₉N  •  HCl.

N-(4-Methylbenzyl)-2-butanamine Hydrochloride, CAS: 1049678-12-7, stock: 3.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₉N  •  HCl.

N-(4-Pyridinylmethyl)-1-butanamine Hydrochloride, CAS: 1158322-38-3, stock: 1.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆N₂ • HCl.

N-(Cyclopropylmethyl)cyclobutanamine Hydrochloride, CAS: 1010097-75-2, stock: 4.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅N.HCl.

N-(propan-2-yl)cyclobutanamine hydrochloride, CAS: 1333772-81-8, stock: 5.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅N.HCl.

N-Benzyl-1-butanamine, CAS: 2403-22-7, stock: 9.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇N.

N-Benzyl-3-methyl-2-butanamine, CAS: 110871-35-7, stock: 1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₉N.

N-Butyl-N-(3-chloropropyl)butan-1-amine, CAS: 36421-15-5, stock: 2.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₄ClN.

N-Ethylbutylamine, CAS: 13360-63-9, stock: 9.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₅N.

N-Methyl-3-pyridinebutanamine, CAS: 3000-74-6, stock: 1.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆N₂.

N-Methyl-3-pyridinebutanamine Dihydrochloride, CAS: /, stock: 2.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈Cl₂N₂.

N-Methylisoamylamine Hydrochloride, CAS: 2419-59-2, stock: 2.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₅N  •HCl.

N-Nitroso-di-n-butylamine, CAS: 924-16-3, stock: 1.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₈N₂O.

N-Nitroso-di-n-butylamine-d18, CAS: 1219798-82-9, stock: 1.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈D₁₈N₂O.

N-Nitroso-N-ethylbutylamine, CAS: 4549-44-4, stock: 1.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄N₂O.

N-Nitroso-N-ethylbutylamine-d4, CAS: /, stock: 8.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀D₄N₂O.

N-[2-(4-bromophenyl)propan-2-yl]cyclobutanamine, CAS: 1249019-72-4, stock: 1.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈NBr.

N-[2-(azepan-1-yl)ethyl]cyclobutanamine, CAS: 1248947-58-1, stock: 4.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₄N₂.

N1-(3-Dimethylaminopropyl)-N4-(4-aminobutyl)piperazine, CAS: 1771557-38-0, stock: 5.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₃₀N₄.

Perfluorotributylamine (>80%), CAS: 311-89-7, stock: 8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂F₂₇N.

rac Benzodioxole-5-butanamine Ηydrochloride, CAS: 42542-07-4, stock: 2.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆ClNO₂.

rac Benzodioxole-5-butanamine-d3 Ηydrochloride, CAS: 1217180-38-5, stock: 4.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃D₃ClNO₂.

Rizatriptan 1,2-(4-dimethylamino)butane, CAS: 1135479-41-2, stock: 9.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₄₉N₁₁.

Rizatriptan 2,2-Dimer, CAS: 1135479-44-5, stock: 4.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₄₉N₁₁.

tert-Amylamine, CAS: 594-39-8, stock: 3.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₃N.

tert-Octylamine, CAS: 107-45-9, stock: 8.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₉N.

Tetrahydro-1(2H)-pyrimidinebutanamine, CAS: 73453-98-2, stock: 3.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₉N₃.

Tributylamine, CAS: 102-82-9, stock: 5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₇N.

Ultraviolet Absorbent UV-1084, CAS: 14516-71-3, stock: 5.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₅₁NNiO₂S.

Uridine 5’-(Tetrahydrogen Triphosphate) Tris-N,N-dibutyl-1-butanamine, CAS: /, stock: 6.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₉₆N₅O₁₅P₃.

Uridine 5’-Monophosphate N,N-Dibutyl-1-butanamine, CAS: 87713-40-4, stock: 7.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₄₀N₃O₉P.

Bumetanide β-D-Glucuronide, CAS: 102623-14-3, stock: 3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈N₂O₁₁S.

Bumetanide β-D-Glucuronide Allyl Ester, CAS: /, stock: 6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₂N₂O₁₁S.

Ethacrynic Acid L-Cysteine Adduct, CAS: 51246-37-8, stock: 6.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉Cl₂NO₆S.

Ethacrynic Acid Mercapturate (Mixture of diastereomers), CAS: 54546-23-5, stock: 1.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₁Cl₂NO₇S.

Ethacrynic Acid Mercapturate-d3 (Mixture of Diastereomers), CAS: /, stock: 9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈D₃Cl₂NO₇S.

1,2,3,6-Tetra-dehydro Droperidol, CAS: 60373-77-5, stock: 6.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₉BrFN₃O₂.

1-(3,4-Dimethoxyphenyl)-2-methyl-1-propanone, CAS: 14046-55-0, stock: 4.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O₃.

1-(3-Chloropropoxy)-4-fluorobenzene, CAS: 1716-42-3, stock: 2.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀ClFO.

R-(+)-DIOA, CAS: 81166-47-4, stock: 7.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄Cl₂O₄.

1-(4-Hydroxyphenyl)-2-phenyl-1-butanone, CAS: 6966-21-8, stock: 4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆O₂.

1-(4-tert-Butylphenyl)-4-chloro-1-butanone, CAS: 43076-61-5, stock: 9.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉ClO.

1-​(2,​3-​Dichloro-​4-​hydroxyphenyl)​butan-​1-​one, CAS: 2350-46-1, stock: 5.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀Cl₂O₂.

1-Phenyl-1,3,8-triazaspiro[4.5]decan-4-one, CAS: 1021-25-6, stock: 5.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇N₃O.

1-phenyl-2-(propylamino)-1-Butanone Hydrochloride, CAS: 18267-91-9, stock: 8.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉NO  • HCl.

2,3,4,5-Benzazepin-2-one 7-oxoacetic Acid, CAS: 1094543-96-0, stock: 9.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁NO₄.

2-(p-Methoxyphenyl)butyrophenone, CAS: 35258-39-0, stock: 1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈O₂.

2-(Pyrrolidin-1-yl)-1-(thiophen-2-yl)butan-1-one Hydrochloride, CAS: /, stock: 3.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈ClNOS.

2-Benzyl-2-(dimethylamino)-4’-morpholinobutyrophenone, CAS: 119313-12-1, stock: 6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₀N₂O₂.

N-(3-N-Butyl)norbuprenorphine-d9, CAS: /, stock: 2.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₄D₉NO₄.

2-Methyl-1-[4-(methylsulfonyl)phenyl]-1-propanone, CAS: 53207-59-3, stock: 5.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄O₃S.

3-Methyl-2-phenyl-butyrophenone, CAS: 13742-09-1, stock: 7.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈O.

N-Cyanonorbuprenorphine, CAS: 799773-67-4, stock: 5.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₄N₂O₄.

3’,4’-(Methylenedioxy)butyrophenone, CAS: 63740-97-6, stock: 1.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₃.

3’,4’-Dihydroxy-1-phenyl-2-butanone, CAS: 17386-89-9, stock: 2.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₃.

N-Methylnorbuprenorphine, CAS: 228550-34-3, stock: 3.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₇NO₄.

4,4,4-Trifluoro-3-hydroxy-3-(trifluoromethyl)butyrophenone, CAS: 731-00-0, stock: 9.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₈F₆O₂.

4-Bromo-1-(4-fluorophenyl)-1-butan-1-one, CAS: 40132-01-2, stock: 2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀BrFO.

N-Methylnorbuprenorphine 3-Methyl Ether, CAS: 16196-70-6, stock: 6.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₉NO₄.

N-Methylnorbuprenorphine 3-Methyl Ether-d9, CAS: /, stock: 6.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₀D₉NO₄.

4-Chloro-4’-fluorobutyrophenone, CAS: 3874-54-2, stock: 8.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀ClFO.

4-Chloro-4’-fluorobutyrophenone-d4, CAS: 1814904-27-2, stock: 2.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆D₄ClFO.

4-Desfluoro-2-Fluoro Droperidol, CAS: 1026015-45-1, stock: 8.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂FN₃O₂.

4-[4-(4-Chlorophenyl)-3,6-dihydro-1(2H)-pyridinyl]-1-(4-fluorophenyl)-1-butanone, CAS: 52669-92-8, stock: 2.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁ClFNO.

4-[4-(4-Chlorophenyl-d4)-3,6-dihydro-1(2H)-pyridinyl]-1-(4-fluorophenyl)-1-butanone, CAS: /, stock: 7.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₇D₄ClFNO.

4’-Chloro-2-(ethylamino)-butyrophenone Hydrochloride, CAS: 91802-62-9, stock: 3.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆ClNO •HCl.

4’-Chlorobutyrophenone, CAS: 4981-63-9, stock: 3.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁OCl.

4’-Ethyl-3-methylbutyrophenone, CAS: 137128-80-4, stock: 5.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈O.

4’-Hydroxybutyrophenone, CAS: 1009-11-6, stock: 7.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₂.

Norbuprenorphine-d3, CAS: 350482-19-8, stock: 7.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₂D₃NO₄.

4’-Methylbutyrophenone, CAS: 4160-52-5, stock: 9.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄O.

(R)-(+)-Bupivacaine Hydrochloride, CAS: 27262-46-0, stock: 2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₉ClN₂O.

Azaperone, CAS: 1649-18-9, stock: 5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂FN₃O.

Azaperone (1.0 mg/mL in Methanol), CAS: 1649-18-9, stock: 5.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂FN₃O.

(S)-(-)-Bupivacaine, CAS: 27262-47-1, stock: 7.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₈N₂O.

(S)-(-)-Bupivacaine Hydrochloride, CAS: 27262-48-2, stock: 7.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₉ClN₂O.

1,1’-(Pyrimidine-2,5-diyl)dipiperazine, CAS: /, stock: 1.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₀N₆.

Azaperone-d4, CAS: 1173021-72-1, stock: 2.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₈D₄FN₃O.

1-(2,6-Dimethylphenyl)-1,5,6,7-tetrahydro-2H-azepin-2-one, CAS: 1797894-80-4, stock: 6.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇NO.

1-(2,6-Dimethylphenyl)-3,3-bis(phenylselanyl)azepan-2-one, CAS: /, stock: 4.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₇NOSe₂.

2,2’-(1,4-Piperazinediyl)bis-pyrimidine, CAS: 84746-24-7, stock: 7.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₆.

2,2’-(1,4-Piperazinediyl)bis-pyrimidine-d8, CAS: /, stock: 8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₆D₈N₆.

1-(2,6-Dimethylphenyl)-3-(phenylselanyl)azepan-2-one, CAS: /, stock: 7.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃NOSe.

1-(2,6-Dimethylphenyl)-4-(phenylseleninyl)azepan-2-one, CAS: /, stock: 2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃NO₂Se.

2,2’-(4,4’-(Oxybis(butane-4,1-diyl))bis(piperazine-4,1-diyl))dipyrimidine Dihydrochloride, CAS: /, stock: 1.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₈N₈O  • 2(HCl).

2,2’-(4,4’-(Oxybis(butane-4,1-diyl))bis(piperazine-4,1-diyl))dipyrimidine-D16 Dihydrochloride, CAS: /, stock: 3.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₂D₁₆N₈O • 2(HCl).

1-(2,6-Dimethylphenyl)azepan-2-one, CAS: /, stock: 2.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO.

2,6-Dichloro-N-(2,6-dimethylphenyl)hexanamide, CAS: 1037184-07-8, stock: 2.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉Cl₂NO.

2,2’-[Butane-1,4-diylbis(piperazine-1,4-diyl)]dipyrimidine, CAS: 257877-45-5, stock: 10g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀N₈.

2-(1-Piperazinyl)pyrimidine, CAS: 20980-22-7, stock: 2.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂N₄.

Butropipazon, CAS: 2354-61-2, stock: 8.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃FN₂O.

2,6-Dichlorohexanoic Acid, CAS: 5077-75-8, stock: 6.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀Cl₂O₂.

2,6-Dimethylaniline, CAS: 87-62-7, stock: 4.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁N.

3’-[3-(2,3-Dihydro-2-oxo-1H-benzimidazol-1-yl)propyl] Domperidone(Domperidone Impurity E), CAS: 1346602-50-3, stock: 5.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₄ClN₇O₃.

4,4-Tetramethyleneglutarimide, CAS: 1075-89-4, stock: 8.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃NO₂.

2,6-Dimethylaniline-d6, CAS: 919785-81-2, stock: 3.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅D₆N.

2’,6’-Picolinoxylidide, CAS: 39627-98-0, stock: 3.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄N₂O.

4-(4-(Pyrimidin-2-yl)piperazin-1-yl)butyl 2-(1-(2-Oxo-2-((4-(4-(pyrimidin-2-yl)piperazin-1-yl)butyl)amino)ethyl)cyclopentyl)acetate, CAS: /, stock: 4.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₅₁N₉O₃.

4-(5-Chloro-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)-1-formylpiperidine, CAS: 1346598-11-5, stock: 8.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄ClN₃O₂.

Butyrophenone, CAS: 495-40-9, stock: 4.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O.

Dechloro Haloperidol, CAS: 04/12/3109, stock: 9.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₄FNO₂.

4-Hydroxy-N-desbutyl Bupivacaine, CAS: 51989-48-1, stock: 5.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀N₂O₂.

6-(Butyl-d9-amino)-N-(2,6-dimethylphenyl)hexanamide, CAS: /, stock: 2.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₁D₉N₂O.

5-(Benzyloxy)-2-(methylthio)-4-pyrimidinol, CAS: 4874-30-0, stock: 9.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂N₂O₂S.

Droperidol, CAS: 548-73-2, stock: 2.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂FN₃O₂.

Droperidol (1.0 mg/mL in Chloroform), CAS: 548-73-2, stock: 9.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂FN₃O₂.

6-(Butylamino)-N-(2,6-dimethylphenyl)hexanamide, CAS: 1330172-81-0, stock: 2.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₀N₂O.

6-(Butylamino)-N-(2,6-dimethylphenyl)hexanamide Hydrochloride, CAS: /, stock: 7.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₁ClN₂O.

5-(Benzyloxy)-2-(methylthio)pyrimidine, CAS: 4874-32-2, stock: 8.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂N₂OS.

5-(Benzyloxy)-2-thiouracil, CAS: 63204-39-7, stock: 5.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀N₂O₂S.

Droperidol N-Oxide, CAS: 466118-75-2, stock: 7.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂FN₃O₃.

Eutylone, CAS: 802855-66-9, stock: 4.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₃.

6-(Propylamino)-2-hydroxy-N-(2,6-dimethylphenyl)hexanamide, CAS: /, stock: 1.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₈N₂O₂.

6-(Propylamino)-N-(2,6-dimethylphenyl)hexanamide, CAS: /, stock: 4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₈N₂O.

5-(Benzyloxy)-4-chloro-2-(methylthio)-pyrimidine, CAS: 4973-78-8, stock: 6.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁ClN₂OS.

5-Benzyloxy-2-methylsulfonylpyrimidine, CAS: 16290-89-4, stock: 3.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂N₂O₃S.

Fluanisone, CAS: 1480-19-9, stock: 3.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅FN₂O₂.

Fluanisone-d4, CAS: 1794737-47-5, stock: 6.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁D₄FN₂O₂.

6-Amino-N-(2,6-dimethylphenyl)-2-hydroxyhexanamide, CAS: /, stock: 2.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂N₂O₂.

6-Amino-N-(2,6-dimethylphenyl)hexanamide, CAS: 102089-67-8, stock: 2.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂N₂O.

5-Chloro Buspirone, CAS: /, stock: 4.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₀ClN₅O₂.

5-Hydroxy Buspirone, CAS: 105496-33-1, stock: 4.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₁N₅O₃.

Isobutyrophenone, CAS: 611-70-1, stock: 1.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O.

6-Bromo-N-(2,6-dimethylphenyl)-hexanamide, CAS: 77470-80-5, stock: 9.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀BrNO.

6-Chlorohexanoic Acid, CAS: 4224-62-8, stock: 9.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁ClO₂.

5-Hydroxy Buspirone-d8, CAS: 1330164-16-3, stock: 9.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃D₈N₅O₃.

6,10-Dihydroxy Buspirone, CAS: 658701-59-8, stock: 6.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₁N₅O₄.

Bupivacaine, CAS: 38396-39-3, stock: 2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₈N₂O.

Bupivacaine Hydrochloride, CAS: 18010-40-7, stock: 5.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₈N₂O •HCl.

6,10-Dihydroxy Buspirone-d8, CAS: 1346599-17-4, stock: 5.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃D₈N₅O₄.

6-Hydroxy Buspirone-d8, CAS: 1189644-16-3, stock: 1.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃D₈N₅O₃.

α-Bromobutyrophenone, CAS: 877-35-0, stock: 10g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁BrO.

Bupivacaine Hydrochloride, CAS: 18010-40-7, stock: 5.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₈N₂O  • HCl.

Bupivacaine Hydrochloride, CAS: 14252-80-3, stock: 1.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₈N₂O  •  HCl.

6’-Hydroxy Buspirone, CAS: 125481-61-0, stock: 6.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₁N₅O₃.

8,8’-(1,4-Butanediyl)bis-8-azaspiro[4.5]decane-7,9-dione, CAS: 257877-44-4, stock: 3.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₂N₂O₄.

Bupivacaine N-Oxide Hydrochloride Salt, CAS: 1796927-05-3, stock: 9.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₉ClN₂O₂.

Bupivacaine-d9 Hydrochloride, CAS: 1286973-34-9, stock: 6.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀D₉ClN₂O.

8,8’-(1,4-Butanediyl)bis-8-azaspiro[4.5]decane-7,9-dione-d8, CAS: /, stock: 7.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄D₈N₂O₄.

8-(2-Pyrimidinyl)-8-aza-5-azoniaspiro[4.5]decane Bromide, CAS: 81461-73-6, stock: 7.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₉BrN₄.

Lenperone, CAS: 24678-13-5, stock: 4.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₃F₂NO₂.

Bupivacaine-d9 N-Oxide, CAS: 1346598-03-5, stock: 6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉D₉N₂O₂.

Metazachlor Oxalamide, CAS: /, stock: 3.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆N₄O₂.

8-(4-Bromobutyl)-8-azaspiro[4.5]decane-7,9-dione, CAS: 80827-62-9, stock: 4.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀BrNO₂.

8-(4-Chlorobutyl)-8-azaspiro[4.5]decane-7,9-dione, CAS: 21098-11-3, stock: 7.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀ClNO₂.

Lenperone-d4, CAS: 1794787-73-7, stock: 1.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₉D₄F₂NO₂.

Melperone Hydrochloride, CAS: 1622-79-3, stock: 3.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃ClFNO.

Metazachlor-D6 Oxalamide, CAS: /, stock: 8.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀D₆N₄O₂.

8-(4-Chlorobutyl)-8-azaspiro[4.5]decane-7,9-dione-d8, CAS: /, stock: 2.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂D₈ClNO₂.

Bis(4-(4-(pyrimidin-2-yl)piperazin-1-yl)butyl) 2,2’-(Cyclopentane-1,1-diyl)diacetate, CAS: /, stock: 3.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₅₀N₈O₄.

Melperone Hydrochloride, CAS: 1622-79-3, stock: 6.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂FNO • (HCl).

N-Desbutyl Bupivacaine, CAS: 15883-20-2, stock: 4.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀N₂O.

Buspirone, CAS: 36505-84-7, stock: 5.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₁N₅O₂.

Buspirone EP Impurity J, CAS: /, stock: 2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₅₂N₆O₅.

Melperone Hydrochloride-d4, CAS: /, stock: 6.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉D₄ClFNO.

N-Desbutyl Bupivacaine-d6, CAS: /, stock: 2.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄D₆N₂O.

N-Despropyl (R)-Ropivacaine, CAS: 27262-43-7, stock: 4.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀N₂O.

Buspirone Hydrochloride, CAS: 33386-08-2, stock: 6.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₂ClN₅O₂.

Phlorisovalerophenone, CAS: 26103-97-9, stock: 6.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄O₄.

rac 1-[3,4-(Dibenzyloxy)phenyl]-2-bromo-1-butanone, CAS: 24538-60-1, stock: 6.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₃BrO₃.

N-Despropyl Ropivacaine, CAS: 27262-40-4, stock: 2.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀N₂O.

Buspirone N-Oxide, CAS: 220747-81-9, stock: 4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₁N₅O₃.

Buspirone N-Oxide Oxalate Salt, CAS: /, stock: 8.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₃N₅O₇.

rac 1-[3,4-(Dibenzyloxy)phenyl]-2-[(diphenylmethyl)amino]-1-butanone Hydrochloride, CAS: 855220-23-4, stock: 4.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₃₆ClNO₃.

Timiperone, CAS: 57648-21-2, stock: 8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄FN₃OS.

Buflomedil Hydrochloride, CAS: 35543-24-9, stock: 9.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₆ClNO₄.

Buspirone-d8 Dihydrochloride, CAS: /, stock: 5.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅D₈Cl₂N₅O₂.

Timiperone-d4 (Major)(Contain d0), CAS: 1185042-00-5, stock: 6.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₀D₄FN₃OS.

Desmethyl Buflomedil Hydrochloride, CAS: 70585-57-8, stock: 2.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄ClNO₄.

Desmethyl Buflomedil Hydrochloride-d6, CAS: /, stock: 4.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈D₆ClNO₄.

Dihydroxy Buspirone, CAS: 125481-59-6, stock: 9.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₁N₅O₄.

endo-Tandospirone, CAS: 87721-89-9, stock: 1.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₉N₅O₂.

Trifluperidol Hydrochloride, CAS: 2062-77-3, stock: 2.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₃F₄NO₂ • (HCl).

N-Boc-piperazine-2,2,6,6-D4, CAS: 118220-98-7, stock: 6.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄D₄N₂O₂.

rac-BMS 204352, CAS: 183720-28-7, stock: 6.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₀ClF₄NO₂.

seco-(8,9)-Buspirone (Butyl-d8) Carboxylic Acid, CAS: /, stock: 9.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆D₈ClN₅O₃.

seco-(8,9)-Buspirone Carboxylic Acid, CAS: 257877-43-3, stock: 10g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₃N₅O₃.

Tandospirone, CAS: 87760-53-0, stock: 6.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₉N₅O₂.

Tandospirone-d8, CAS: 1794835-73-6, stock: 2.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁D₈N₅O₂.

1,6-Dimethanesulfonate-D-mannitol, CAS: 1187-00-4, stock: 2.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₈O₁₀S₂.

1-Acetate 4-Methanesulfonate 1,4-Butanediol, CAS: 19859-00-8, stock: 3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄O₅S.

Acetyl Methanesulfonate, CAS: 5539-53-7, stock: 2.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₆O₄S.

Busulfan, CAS: 55-98-1, stock: 8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄O₆S₂.

Busulfan Propyl Mesylate, CAS: /, stock: 6.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₂O₉S₃.

Busulfan Propyl Mesylate-d4, CAS: /, stock: 6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈D₄O₉S₃.

Busulfan-d8, CAS: 116653-28-2, stock: 5.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆D₈O₆S₂.

Sulfolan-3-ol, CAS: 13031-76-0, stock: 4.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈O₃S.

(1-((1-Methoxyethyl)amino)-1-oxopropan-2-yl)carbamic Acid tert-Butyl Ester, CAS: /, stock: 8.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₂N₂O₄.

(1-(3-Chlorophenyl)-1-oxopropan-2-yl)carbamic Acid tert-Butyl Ester, CAS: /, stock: 2.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈ClNO₃.

(1R,2S)-erythro-Dihydro Bupropion Hydrochloride, CAS: 357628-62-7, stock: 2.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₁Cl₂NO.

(11β,16α)-11,16-Dihydroxyandrosta-1,4-diene-3,17-dione, CAS: 910299-74-0, stock: 3.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄O₄.

(1R,2S)-erythro-Dihydro Bupropion-d9 Hydrochloride, CAS: /, stock: 7.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂D₉Cl₂NO.

(1S,2R)-erythro-Dihydro Bupropion Hydrochloride, CAS: 357637-16-2, stock: 8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₁Cl₂NO.

(11β,16α)-11-Hydroxy-16-(1-oxobutoxy)-androsta-1,4-diene-3,17-dione, CAS: 85234-64-6, stock: 5.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₀O₅.

(1S,2R)-erythro-Dihydro Bupropion-d9 Hydrochloride, CAS: /, stock: 3.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂D₉Cl₂NO.

(3S,5R,6R)-6-(3-Chlorophenyl)-6-hydroxy-5-methylthiomorpholine-3-carboxylic Acid, CAS: 2133460-43-0, stock: 9.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄ClNO₃S.

(11β,16α)-21-(Acetyloxy)-11,16,17-trihydroxypregna-1,4,14-triene-3,20-dione, CAS: 131918-72-4, stock: 3.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈O₇.

(11β,16α)-21-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-11,16,17-trihydroxy-pregna-1,4-diene-3,20-dione, CAS: 1221150-20-4, stock: 6.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₂O₆Si.

(3S,5S,6S)-6-(3-Chlorophenyl)-6-hydroxy-5-methylthiomorpholine-3-carboxylic Acid, CAS: 2133460-42-9, stock: 9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄ClNO₃S.

(R)-1-(3-Chlorophenyl)-2-hydroxy-1-propanone, CAS: 291275-46-2, stock: 7.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉ClO₂.

(11β,16α,17α)-16,21-Epoxy-11,21-dihydroxy-pregna-1,4-diene-3,20-dione, CAS: 77017-17-5, stock: 9.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆O₅.

(11β,17ξ)-16,21-Epoxy-11,21-dihydroxy-pregna-1,4,20-trien-3-one, CAS: 1174448-05-5, stock: 10g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆O₄.

(R)-Bupropion D-Tartaric Acid Salt, CAS: /, stock: 9.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₄ClNO₇.

(R,R)-Dihydro Bupropion Hydrochloride, CAS: 357637-18-4, stock: 5.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₁Cl₂NO.

(16α)-21-(Acetyloxy)-16,17-dihydroxypregna-1,4-diene-3,11,20-trione, CAS: 3949-79-9, stock: 9.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈O₇.

(22R)-Budesonide, CAS: 51372-29-3, stock: 6.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₄O₆.

(R,R)-Dihydro Bupropion β-D-Glucuronide, CAS: /, stock: 2.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₈ClNO₇.

(R,R)-Dihydro Bupropion-d9 Hydrochloride, CAS: 1392209-60-7, stock: 3.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂D₉Cl₂NO.

(22S)-Budesonide, CAS: 51372-28-2, stock: 6.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₄O₆.

(2R,3R,4aS,4bS,10aR,10bS,11S,12aS)-2,3,11-Trihydroxy-2-(hydroxymethyl)-10a,12a-dimethyl-2,3,4,4a,5,6,10b,11,12,12a-decahydrochrysene-1,8(4bH,10aH)-dione, CAS: /, stock: 2.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₈O₆.

(R,R)-Hydroxy Bupropion, CAS: 192374-15-5, stock: 9.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈ClNO₂.

(R,S)-Hydrobupropion Glucuronide (EGLUC2)’, CAS: /, stock: 7.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₈ClNO₇.

(4aR,4bS,5S,6aS,7aR,11aR,12aS,12bS)-5,7a-dihydroxy-4a,6a-dimethyl-10-propyl-4b,5,6,6a,7a,8,11a,12,12a,12b,13,14-dodecahydro-2H-chryseno[3,2-d][1,3]dioxine-2,7(4aH)-dione, CAS: /, stock: 4.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₄O₆.

(8S,9S,10R,11S,13S,14S,16R,17S)-17-(2-((tert-Butyldimethylsilyl)oxy)acetyl)-11,17-dihydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-16-yl Butyrate, CAS: /, stock: 6.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₄₈O₇Si.

(S)-1-(3-Chlorophenyl)-2-hydroxy-1-propanone, CAS: 287477-53-6, stock: 1.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉ClO₂.

(S)-Bupropion L-Tartaric Acid Salt, CAS: /, stock: 7.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₄ClNO₇.

(8S,9S,10R,11S,13S,14S,17R)-11-Hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,10,11,12,13,14,15,17-decahydro-3H-cyclopenta[a]phenanthrene-3,16(6H)-dione, CAS: 111088-90-5, stock: 9.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆O₅.

(S,S)-Dihydro Bupropion Hydrochloride, CAS: 292055-71-1, stock: 3.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₁Cl₂NO.

(S,S)-Dihydro Bupropion β-D-Glucuronide, CAS: /, stock: 2.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₈ClNO₇.

1,2-Dihydrobudesonide (Mixture of diastereomers), CAS: 137174-25-5, stock: 3.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₆O₆.